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To explain all nature is too dicult a task for any one man
or even for any one age. 'Tis much better to do a little with
certainty, & leave the rest for others that come aer you, than to
explain all things by conjecture withoutmaking sure of any thing.
Isaac Newton

Preface
Ahoy Matey!
Conducting research has felt to me like sailing the sea for four years
straight. Each day was an adventure into unknown waters. e distance,
daily covered, strongly depended on the direction and the speed of the wind.
Two aspects I soon realised were beyond my control, I could merely adjust
the sails accordingly. On windless days, however, every eort on moving
forward usually shattered to pieces. Luckily, during those moments, I could
rely on a fantastic crew to help paddle the boat, allowing me to visit places I
never expected to go. It is only fair to acknowledge each and every one for
their contribution.
So, rst and foremost, my gratitude goes out to you, Cap’n Patrick, for
giving me the opportunity to aboard your ship ‘bioMMeda’. Your enthusiasm,
inquisitiveness and technical expertise inspired me to work hard to the point
I can nally thank you for it. I genuinely appreciate your support, especially
in times when confronted by stormy weather and in danger of sailing adri.
Charlotte, I am also deeply indebted to you. When I started, you eagerly
helped to raise the sails, set the course and steer the tiller in the right direction.
It allowed for much more comfortable sailing than would otherwise have
been possible. Your guidance, kindness and patience made all the dierence
between success and failure. I know that I’m leaving this ship in good hands,
and hope that it may one day help you to rule the seven seas.
Next, I would like to express my gratitude to you, Wim, for embodying
the barrelman of the ship despite a large amount of other duties. Stationed
in the crow’s nest, you navigated this venture from a dierent point of view.
I can state for a fact that your contribution and clinical expertise were as
decisive as José Izquierdo was to Club Brugge for reclaiming the title of
champions aer 11 long years. Pieter, Tim and Ingrid, you also deserve my
deep appreciation for freeing up time and accompanying me all the way to
the crow’s nest to cast the livers.omas and colleagues at the UGCT, thank
you for micro-CT imaging the many liver casts. A lot of credit and a sincere
thank you also go toWinnok and Jan for introducing me to the world of deep
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tissue microscopy. In danger of forgetting someone, I would like to express
my gratitude to everyone else with whom I had the pleasure and privilege of
working, in particular my fellow ‘bioMMeda’ crew members. Never will I
forget (or was it remember?) our Brazilian starters party, nor will the shame
of the 2.0 awakening fade away. Special thanks go out to Saskia and Jurgen
for all their administrative and technical support. Additionally, I would like
to thank all jury members for their interest and for reading this dissertation.
is research would also not have taken place without the nancial support
of the Agency for Innovation by Science and Technology in Flanders (IWT
131446).
Which brings us ever so smoothly to the drunks of the boat, hidden
somewhere in a cabin. While they were not instrumental to the whole,
they sure knew how to lighten up the atmosphere when things didn’t go
as planned. So, friends of ESC and Pulsh, thank you for the occasional
distraction, allowing the eorts of the day evaporate away. When I’m through
with this, I solemnly swear to join you guys more oen on your drinking
escapades. Also, let us soon brace once more for winter and enjoy the sunrise
at 6 am, with or without sonnebril.
At this point, I would like to thank my family, in particular my parents -
the anchors I have always been able to hold onto. You not only taught me
the skills necessary to build a boat, but also showed how to sail one properly.
Without your support, I would have not made it this far. Come to think of it,
I would probably have capsized shortly aer breaking the champagne across
the ship’s bow. Know that I am more than grateful for all the opportunities
you have given me. Wouter, Margo and Elise, I like how we are nding our
own paths through life, aer having shared the same one for a long time.
ank you for always being ready to help and support me.
And last, but certainly not least, Delphine, you are the mermaid I
have fallen in love with along the way. ank you for being there for
me no matter what. Your love and tireless encouragements truly helped
me to overcome the tough nautical miles. As this venture is about to
end, I cannot emphasize enough how much I am looking forward to em-
barking onmanymore adventures with you, and of course our good seal, Baz.
Land Ho...
Gent, 2017
Geert Peeters
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Samenvatting
Inleiding
De lever is een belangrijk orgaan dat allerlei vitale functies uitvoert om de
lichaamshomeostase te handhaven (bijv. vorming van gal en cholesterol,
detoxicatie van giige stoen en de synthese van eiwitten). Het is een uniek
orgaan in de zin dat de lever als enigste kan regenereren na weefselschade.
Indien het leverweefsel echter aanhoudend verwoest wordt, zal de lever
evolueren naar cirrose.
Cirrose is een schadelijke leveraandoening die vaak wordt toegeschreven
aan een ongezonde levensstijl, zoals overmatig alcoholgebruik of consumptie
van vetrijk voedsel. De aandoening wordt gekenmerkt door ernstige bescha-
diging van het leverweefsel met een aantasting van zowel de leverperfusie
als -functie. Van zodra cirrose de gedecompenseerde fase bereikt, kan het
nog functionerende deel van de lever onvoldoende compenseren voor het
aangetaste deel en worden complicaties klinisch zichtbaar. In geval van verge-
vorderde cirrose kan acuut leverfalen of een verdere evolutie naar leverkanker
optreden. Cirrose is de twaalfde doodsoorzaak ter wereldmet een sterecijfer
dat in 2010 een miljoen overschreed.
Momenteel wordt cirrose nog steeds beschouwd als een onomkeerbare
aandoening waardoor de behandeling voornamelijk gericht is op het ver-
tragen van het ziekteproces en het verminderen van de complicaties. Bij
vergevorderde stadia van cirrose blij een levertransplantatie de enige the-
rapeutische mogelijkheid. In dit geval kan de lever zijn functies niet meer
naar behoren uitvoeren en zullen levensbedreigende complicaties opduiken.
Een nauwkeurige opvolging en inschatting van de lever(functie) bij cirrose is
dus essentieel om de behandeling af te stemmen op de vereisten van de pati-
ënt. Tot op heden is een dergelijke patiëntgerichte aanpak nog niet mogelijk
wegens een gebrek aan kennis over de pathogenese van cirrose.
In dit doctoraat focussen we op één aspect van cirrose, zijnde de
bloedvaten en hoe deze hermodelleren doorheen het ziekteproces. Deze
adaptatie van de levervasculatuur vormt een sleutelfactor bij het ontstaan
van cirrose. De ermee gepaard gaande verstoring van de leverperfusie is
echter nog onvoldoende gekend. De belangrijkste doelstelling van dit werk
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is dan ook de aanpassing van de vasculatuur van de lever doorheen de
ontwikkeling van cirrose te documenteren en analyseren, enerzijds in relatie
tot de aangetaste architectuur en anderzijds in relatie tot de verminderde
perfusie van de lever. Dit proefschri is onderverdeeld in drie delen waarvan
deel I een uitgebreid overzicht gee van de lever en cirrose. In deel II wordt
dieper ingegaan op het onderzoek dat werd uitgevoerd in het kader van dit
doctoraat. Tenslotte worden in deel III de belangrijkste bevindingen opgelijst
en worden enkele toekomstperspectieven besproken.
Deel I. Van gezonde tot cirrotische lever
In dit deel staat de beschrijving van zowel de gezonde als de cirrotische lever
centraal. Daarnaast worden ook de technieken die reeds gebruikt werden
om cirrose te bestuderen gedetailleerd besproken.
Hoofdstuk 1. De gezonde lever
De lever is een complex en veelzijdig orgaan dat verantwoordelijk is voor
meer dan 500metabolische en ontgiende functies (bijv. bloedglucosespiegel
regelen). Zijn vasculair systeem is uniek ten opzichte van andere organen
omwille van de dubbele bloedtoevoer: de hepatisch arteriële vaatboom
voorziet de lever van zuurstofrijk bloed, terwijl de portaal veneuze vaatboom
voedingsrijk bloed aanlevert. Beide aerente vatensystemen lopen parallel
doorheen de lever en vertakken herhaaldelijk. Het bloed dat doorheen hun
terminale vertakkingen vloeit, wordt vervolgens gemengd in de sinusoïden.
Deze laatste zijn leverspecieke capillairen die openingen in hun vaatwand
(fenestrae) hebben om de moleculaire uitwisseling tussen het bloed en de
parenchymale levercellen (hepatocyten) te faciliteren. Het bloed stroomt
doorheen de sinusoïden tot het wordt gecollecteerd in centrale venen
die samen met de hepatische venen de afvoer van het bloed uit de lever
verzekeren.
De hepatische microarchitectuur bestaat uit vijf cellulaire componenten.
De hepatocyten zijn de functionele cellen en vertegenwoordigen ongeveer
80% van het leverweefsel. De overige cellen (sinusoïdale endotheelcellen,
Kuper cellen, hepatische stellaatcellen en pit cellen) bevinden zich in of
vlakbij de sinusoïden. De interactie tussen de verschillende cellen is van
vitaal belang om de lichaamshomeostase en fysiologische processen (zoals
leverregeneratie) te behouden en reguleren. Anomalieën in de intercellulaire
communicatie worden daarom ook steeds vaker geïdenticeerd als een
belangrijke factor bij de totstandkoming van vrijwel elke leverziekte.
Hoofdstuk 2. De cirrotische lever
Cirrose kan worden gezien als het gemeenschappelijke eindpunt van eender
welke chronische leverziekte. Het is een pathologische aandoening die
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ontstaat door aanhoudende vernietiging en regeneratie van het leverweefsel.
Dit meedogenloos proces verstoort de hepatische architectuur en tast ook
de leverperfusie en -functie aan. Cirrose wordt vaak toegeschreven aan
alcoholmisbruik, virale infecties of metabolische syndromen die gerelateerd
zijn aan obesitas of diabetes. Deze liggen aan de basis van chronische
leverziektes zoals leververvetting of een chronische leverontsteking die verder
kunnen evolueren in de richting van cirrose.
Gedurende de progressie naar cirrose wordt de normale hepatische
architectuur geleidelijk aan vervangen door diuse brose, vasculaire septa
en zogenaamde regeneratieve noduli. Deze morfologische kenmerken zijn te
wijten aan mechanismen die geactiveerd worden om de hepatocellulaire
schade te herstellen. Eén van deze mechanismen is brogenese. Door
brose (bindweefsel) te produceren tracht dit mechanisme het beschadigde
gebied in te kapselen en te beschermen. De chronische leverziekte leidt
echter tot aanhoudende leverschade waardoor abnormale hoeveelheden
littekenweefsel worden geproduceerd. Als gevolg hiervan ontwikkelen zich
brotische septa tussen de portale triaden en de centrale venen. Deze septa
omsluiten bloedvaten die volledig van het functionele leverweefsel worden
geïsoleerd. Vervolgens veranderen enkele van deze bloedvaten in bredere
shuntvaten. Het bloed dat hier door stroomt, omzeilt de sinusoïden zonder
detoxicatie en verarmt de hepatocyten van de nodige voedingsstoen. Dit
draagt bij tot hepatocellulaire necrose en de ongecontroleerde proliferatie
van de overblijvende hepatocyten. Uiteindelijk vormen er zich regeneratieve
noduli. Zowel het overmatige littekenweefsel als de regeneratieve noduli
drukken de leverbloedvaten samen waardoor de vasculaire weerstand van
de lever toeneemt. Daarnaast dragen dynamische veranderingen van de
vasculatuur (bijv. actieve vasoconstrictie van de sinusoïden en angiogenese)
bij tot de toename van de intrahepatische vasculaire weerstand. Op een
bepaald moment overschrijdt de vasculaire weerstand een drempel en treedt
er portale hypertensie op.
Portale hypertensie is de vroegste enmeest voorkomende complicatie van
cirrose en wordt gekenmerkt door een verhoogde bloeddruk in de portaal
veneuze vaatboom die ontstaat door obstructie van de bloedstroom. De com-
plicaties die gerelateerd zijn aan cirrose (bijv. ascites en variceale bloedingen)
beginnen vaak bij een abnormaal hoge bloeddruk in de leverpoortader. De
behandeling van cirrose is daarom gericht op het verlagen van de portaaldruk,
het vertragen van de ziekteprogressie en het onderdrukken van complicaties.
Bij vergevorderde stadia van cirrose blij een levertransplantatie echter de
enige therapeutische optie. Vroege en nauwkeurige diagnose is bijgevolg
noodzakelijk om de progressieve leverziekte te behandelen of om te keren.
Dit blij echter een complex gegevenmede omdat de pathogenese van cirrose
nog niet volledig gekend is. Als gevolg hiervan baseren artsen zich nog steeds
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voornamelijk op hun expertise om de situatie van de lever(functie) en het
verder verloop van de leverziekte in te schatten.
Hoofdstuk 3. Technieken om cirrose te modelleren
In de voorbije decennia is er veelvuldig onderzoek naar de pathogenese
van cirrose verricht. Dit resulteerde in de ontwikkeling van verschillende
modelleringstechnieken.
Diermodellen van cirrose (bijv. in muizen, ratten en varkens) gaven
onderzoekers de mogelijkheid om het pathologische proces op een gecontro-
leerde manier te reproduceren en bestuderen. Deze modellen blijven echter
een benadering van het humane ziekteproces, aangezien nog geen enkel
model ontwikkeld werd dat alle kernmerken/fasen van humane cirrose weer-
spiegelt. Momenteel worden drie modellen veelvuldig gebruikt om cirrose
te induceren in ratten: het tetrachloormethaan-, het galwegligatie- en het
thioaceetamide-model. In dit proefschri kozen we voor het thioaceetamide-
model vanwege zijn betrouwbaarheid en reproduceerbaarheid.
Naast diermodellen werden ook diverse experimentele methoden ontwik-
keld om de hemodynamica en functionele parameters van de lever in vivo te
meten. Invasieve methoden, zoals de microbubbels-techniek, werden vooral
aangewend om de (micro)hemodynamica in verscheidene diermodellen
te kwanticeren. Niet-invasieve methoden (bijv. intravitale uorescentie-
microscopie en elastograe) lieten daarentegen ook toe de morfologische
afwijkingen en gewijzigde mechanische eigenschappen van het leverweefsel
(bijv. stijfheid) te bepalen. Naast het verschaen van nieuwe inzichten in
cirrose, leenden de experimentele data zich ook tot de ontwikkeling van
kwantitatieve mathematische modellen.
Wat mathematische modellen betre, vermeldt de literatuur modellen
van de adaptieve levervasculatuur, de verstoorde leverperfusie en de vermin-
derde leverfunctie in het geval van cirrose. Twee experimentele technieken,
nl. vasculaire afgietsels en immuunhistochemie, werden vaak toegepast om
het vertakkingspatroon en de geometrische eigenschappen van de levervas-
culatuur te kwanticeren en modelleren. De leverperfusie werd doorgaans
onderzocht aan de hand van numerieke vloeistofdynamische modellen en
elektrisch analogemodellen. Studies die focusten op leverfunctie, hanteerden
een multischaal-benadering om op deze manier biologische processen te
integreren in perfusiemodellen. Zodoende werden modellen ontwikkeld om
zowel de dynamische leverrespons te voorspellen na leverbeschadiging (bijv.
leverregeneratie) als het risico in te schatten op een (langdurig) leverletsel na
blootstelling aan schadelijke chemicaliën.
Hoewel bepaalde onderdelen van de puzzel werden oplost in deze
vroegere studies, is nog steeds meer kwantitatieve informatie nodig omtrent
de levervasculatuur op zich, alsook omtrent de perfusie en functie van lever,
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en dit vooral op microniveau doorheen de verschillende stadia van cirrose-
ontwikkeling.
Deel II. Modelleren van het cirroseproces in ratten
Dit tweede deel omvat eigen origineel onderzoek en beoogt een systematische
en kwantitatieve studie van de ziekteprogressie in een gevestigd rattenmodel
van cirrose (thioaceetamide), enerzijds in relatie tot de beschadigde levervas-
culatuur en anderzijds in relatie tot de verminderde leverperfusie.
Hoofdstuk 4. 3D-reconstructie van de hepatische vasculatuur van ratten
Kennis over de topograsche organisatie van de levervasculatuur in (cirroti-
sche) ratten was relatief beperkt bij aanvang van dit doctoraat. Bijgevolg werd
een methodologisch kader ontwikkeld en geïmplementeerd om de vascula-
tuur kwantitatief te analyseren en te modelleren over meerdere lengteschalen
heen. In dit hoofdstuk worden de methodologie en de optimalisatie hiervan
in gezonde rattenlevers uitgebreid beschreven.
In het experimentele luik werden twee technieken toegepast om morfolo-
gische data van de levervasculatuur te verkrijgen, nl. vasculaire afgietsels en
immuunhistochemie. Hoewel beide technieken eerder werden gebruikt om
de vasculatuur te bestuderen, vertoonden ze een aantal belangrijke tekort-
komingen voor dit werk. Het protocol om afgietsels van de vasculatuur te
genereren werd aangepast opdat het mogelijk zou zijn om alle vaatbomen te
bekomen van één en dezelfde lever. Daarnaast werd het immuunhistochemie-
protocol uitgebreid met een aangepaste klaringstechniek (CUBIC) om de
visualisatiediepte van de confocale microscoop te vergroten van 50–60 µm
naar 150–200 µm. Naast het experimentele luik werd ook een analytische luik
geïmplementeerd om de beeldgegevens semiautomatisch te verwerken. So-
ware (DeLiver) werd ontwikkeld om demicrovasculatuur te segmenteren en
de vertakkingstopologie en geometrische eigenschappen van de hepatische
vasculatuur te kwanticeren.
Hoofdstuk 5. Vasculaire hermodellering van de rattenlever tijdens
cirrogenese
De levervasculatuur (van ratten) ondergaat desastreuze veranderingen tijdens
cirrogenese. Kennis enmorfologische data over de vasculaire hermodellering
zijn echter nog beperkt, maar zijn wel cruciaal om het ziekteproces beter
te begrijpen. In dit hoofdstuk trachten we deze lacune op te vullen door
de hepatische macro- en microvasculatuur van de rat te kwanticeren op
verschillende tijdspunten tijdens cirrogenese.
Cirrose werd chemisch geïnduceerd in ratten door middel van het
thioaceetamide(TAA)-model. De levervasculatuur van enkele ratten werd
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gexeerd op vier verschillende tijdspunten (0, 6, 12 en 18 weken) en
gevisualiseerd door het gebruik van vasculaire afgietsels en geavanceerde
immuunhistochemie (geoptimaliseerd in hoofdstuk 4). Vervolgens werden
de hepatische vaatbomen gereconstrueerd en geanalyseerd over meerdere
lengteschalen heen. Door het tten van trendlijnen aan de morfologische
data werd de impact van cirrose op de levervasculatuur gekwanticeerd. Op
macroniveau stelden we vast dat regeneratieve noduli de soepele veneuze
bloedvaten progressief samendrukten vanaf 12 weken TAA-toediening, met
een sterk verminderde perfusie doorheen deze bloedvaten tot gevolg. Op
het microniveau observeerden we eveneens een progressieve toename van
de vasculaire weerstand van sinusoïden. De mate waarin de weerstand
toenam was afhankelijk van de locatie, aangezien de aantasting sterker was
voor de sinusoïden die zich dicht tegen het leveroppervlak bevonden. De
gegenereerde datasets vormden de basis van het computermodel beschreven
in hoofdstuk 6.
Hoofdstuk 6. Modelleren van de hemodynamica bij ratten tijdens
cirrogenese
Cirrose wordt gekenmerkt door een ernstig beschadigde leverarchitectuur
die leidt tot een progressieve toename van de intrahepatische vasculaire weer-
stand. Een verhoogde vasculaire weerstand zal resulteren in de ontwikkeling
van portale hypertensie alsook abnormaliteiten van het bloedvatenstelsel. In
dit hoofdstuk hebben we, doormiddel van een zogenaamd lumped parameter
model, de impact onderzocht van de hepatisch vasculaire weerstand op de
gehele bloedcirculatie van de rat tijdens cirrogenese.
De vertakkingstopologie van de hepatische vaatbomen uit hoofdstuk
5 werd geanalyseerd en gekwanticeerd per leverlob. De geometrische
analyses (lengte, straal en aantallen bloedvaten) leverden de input om
een elektrisch analoog levermodel te ontwikkelen. Dit levermodel werd
vervolgens geïntegreerd in een elektrisch analoog model van de gehele
bloedcirculatie van ratten. Zodoende kon het geïntegreerde model de
hepatische en globale hemodynamica voorspellen voor verschillende stadia
van de cirrogenese.
De simulaties illustreerden duidelijk het eect van de toenemende
vasculaire weerstand op de hemodynamica. Na 12 weken TAA-toediening
werden portale hypertensie en abnormale stromingspatronen in bepaalde
leverlobben waargenomen (bijv. terugstroom in de PV-vaatboom). Deze
fenomenen worden regelmatig opgemerkt bij patiënten met cirrose. Nadien
werd het model uitgebreid om het eect van compensatiemechanismen van
de bloedomloop in het geval van cirrose te simuleren. De simulatieresultaten
toonden aan dat deze mechanismen de globale hemodynamica ernstig
verstoren en bijdragen tot een verergering van de portale hypertensie.
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Deel III. Conclusies
Hoofdstuk 7. Conclusies en toekomstperspectieven
Een belangrijke verwezenlijking van dit onderzoek is de implementatie
van een methodologisch kader om de vasculaire hermodellering van de
rattenlever tijdens cirrogenese te kwanticeren. Dit methodologisch kader
leverde nieuwe en unieke morfologische data op van de hepatische macro- en
microcirculatie doorheen de ontwikkeling van cirrose. Deze data vormden
de basis van een computermodel om de bloedcirculatie te simuleren tijdens
verschillende fases van het ziekteproces. Aan de hand van dit computermodel
konden we de gevolgen van cirrose inschatten op de globale hemodynamica
en verworven we nieuwe inzichten in het ontstaan van portale hypertensie.
Dit werk vormt een stap voorwaarts in het ontrafelen van de complexe
pathogenese van cirrose. Niettemin is verder onderzoek ongetwijfeld nodig
om de volledige puzzel op te lossen. Eén van de interessante gebieden voor
toekomstig onderzoek is het modelleren van de wisselwerking tussen de
leverperfusie en -functie in het geval van cirrogenese.

Summary
Introduction
Cirrhosis is a detrimental condition of the liver, oen attributed to an
unhealthy lifestyle (e.g. alcohol abuse and fatty diet). It is characterized
by severe distortion of the hepatic architecture, impairing the hepatic
perfusion and function. Once cirrhosis reaches the decompensated stage, i.e.
when complications become clinically present, it may culminate into liver
insuciency or cancer. Cirrhosis is ranked the twelh leading cause of death
worldwide, with mortality rates exceeding a million deaths in 2010.
Cirrhosis is still considered irreversible and early aetiological treatment
focuses on delaying disease progression and reducing complications. How-
ever, liver transplantation remains the only therapeutic option when liver
insuciency and/or complications occur. Hence, it has become impera-
tive to precisely assess the patient’s liver (function) to tailor the treatment.
However, a patient-centred therapeutic approach remains challenging as the
pathogenesis of cirrhosis is still not fully understood.
As disruption and remodelling of the hepatic vasculature is recognized a
key factor of cirrhogenesis, this work aimed at clarifying the intricate relation
between the progression of the disease, the hepatic (angio)architectural
disarrangement, and the impaired vascular perfusion. is dissertation
is divided into three major parts. Part I gives a background overview of
cirrhosis, while part II focuses on the original research conducted within the
framework of this PhD. Part III concludes this dissertation by describing the
key ndings and a number of interesting prospects for future research.
Part I. From healthy to cirrhotic liver
is part provides a background overview on the healthy liver, the cirrhotic
liver, and the state-of-the-art techniques in cirrhosis modelling.
Chapter 1.e healthy liver
e liver is the largest internal organ in humans, performing over 500
metabolic and detoxifying functions. Its vascular system is uniquewith regard
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to other organs because of its dual blood supply: the hepatic artery provides
the liver with oxygenated blood, whereas the portal vein delivers nutrient-
enriched but partially oxygen-depleted blood. Both vessels run in parallel
throughout the liver’s interior and divide repeatedly through several orders
of branches until reaching the terminal ramications, the so-called portal
triads. Blood guided through these portal triads is mixed in the sinusoids,
where the molecular exchange with the parenchymal liver cells occurs.e
blood stream continues down the sinusoids until collected in the central
veins, which join to form hepatic veins and ensure liver drainage.
e hepatic microarchitecture consists of ve cellular components.
Hepatocytes are the parenchymal cells, making up 80% of the liver tissue.
e remaining cell types, i.e. sinusoidal endothelial cells, Kuper cells,
hepatic stellate cells, and pit cells, are harboured in the sinusoids. e
cellular cross-talk between the group of sinusoidal cells and hepatocytes
is critical to maintain body homeostasis and physiological processes such as
liver regeneration. As these complex communication pathways are tightly
regulated, abnormalities in intercellular communication are increasingly
being recognized to underlie virtually every liver disease.
Chapter 2.e cirrhotic liver
Cirrhosis is dened as the common end-point of any chronic liver disease.
Its pathogenesis results from repetitive destruction and regeneration of
hepatocytes. is relentless process disturbs the hepatic architecture,
eventually impairing the hepatic perfusion and liver function. Cirrhosis
is oen attributed to alcohol abuse, viral infections, or metabolic syndromes
related to obesity and diabetes.ese causes may elicit the development of
chronic liver diseases, such as fatty liver disease or chronic viral hepatitis,
and the consecutive progression to cirrhosis.
With progression to cirrhosis, the hepatic architecture is gradually
replaced by diuse brosis, vascularized brous septa, and regenerative
nodules.ese morphological features mainly result from overly exuberant
wound-healing mechanisms, activated to repair the hepatocellular damage.
One of these mechanisms is brogenesis, i.e. the production of brous tissue
to limit and encapsulate the injured area. However, the ongoing damage
leads to the exorbitant deposition of this high-density brous tissue. As
a consequence, septa may develop to form brous bridges between portal
triads and central veins. Blood vessels embedded in these septa become
isolated from the parenchyma and may transform into widened shunt vessels.
ese low-resistance blood channels bypass and impoverish the hepatocytes
of nutritive blood, contributing to the hepatocellular necrosis. e latter
instigates the uncontrolled proliferation of the remaining hepatocytes, leading
to the formation of regenerative nodules.e excessive brous tissue and
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regenerative nodules severely compress the hepatic blood vessels and, as
such, increase the overall intrahepatic vascular resistance to blood ow.
Dynamic vascular changes (i.e. sinusoidal remodelling and angiogenesis)
also contribute to the progressive increase of intrahepatic vascular resistance,
eventually leading to portal hypertension.
Portal hypertension is the earliest and most common complication of
cirrhosis. It is characterized by an elevated portal pressure due to the
obstruction of portal ow. Many of the complications (e.g. ascites and
variceal haemorrhage) related to cirrhosis commence in the setting of
worsening portal hypertension. Treatment of cirrhosis is therefore directed at
lowering the portal pressure, delaying the disease progression, or suppressing
complications. For advanced stages of cirrhosis, liver transplantation remains
the only available therapeutic option. Early and accurate detection has thus
become imperative for eective treatment or reversal of the progressive liver
disease. However, the latter remains a complex issue, as the pathogenesis of
cirrhosis is still not fully understood.
Chapter 3. Techniques to model cirrhosis
Over the past decades, a plethora of modelling techniques has been applied
to gain more insight into the pathogenesis of cirrhosis.
Animal models (e.g. mice, rats, and pigs) allowed researchers to revisit
the process of cirrhogenesis in a controlled way. Note, however, that a model
reecting all characteristics/stages of human cirrhosis is yet to be developed.
Currently, three rodent models are widely used to induce cirrhosis: the
carbon-tetrachloride model, the chronic bile duct ligation model, and the
thioacetamide model. In this dissertation, we chose the thioacetamide rat
model to mimic cirrhogenesis because of its documented reliability and
reproducibility.
Besides animal models, several experimental methods have been adopted
tomeasure the hepatic haemodynamics or functional/mechanical parameters
of the (cirrhotic) liver in vivo. Invasive methods (e.g. the microspheres
technique and the multiple-indicator dilution technique) were mostly
applied to quantify the altered hepatic (micro)haemodynamics in animals,
while non-invasive methods (e.g. intravital uorescence microscopy and
elastography techniques) also allowed for assessment of morphological
derangements and altered mechanical properties of liver tissue (e.g. stiness).
Interestingly, experimental data not only increased our understanding of
the pathogenesis of cirrhosis, but also provided fundamental information to
develop quantitative computational models.
Available computational models have focused on the adaptive hepatic
vasculature, impaired liver perfusion, or liver dysfunction in the case of
cirrhosis. Two experimental approaches (i.e. vascular corrosion casting and
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immunohistochemistry) were frequently used to study the altered branching
pattern and/or geometrical features of the hepatic vasculature for varying
animal species. e hepatic perfusion was generally assessed based on
computational uid dynamics (CFD) models and electrical analog models.
Models of liver (dys)function, on the other hand, applied a multiscale
modelling approach to integrate biological processes into perfusion systems.
ey allowed for prediction of the dynamic hepatic response aer liver
damage (e.g. liver regeneration), or the risk of (long-term) liver injury aer
environmental exposure to chemical substances.
While the aforementioned research solved some pieces of the puzzle,
more information is needed to reveal the complete picture and understand
the complex pathogenesis of cirrhosis.
Part II. Modelling cirrhogenesis in rats
is part focused on elucidating the intricate relation between the progression
of the disease, the hepatic (angio)architectural disarrangement, and the
impaired vascular perfusion using an established rat model of cirrhosis.
Chapter 4. 3D reconstruction of the rat hepatic vasculature
Since relatively little was known about the topographical organisation of
the rat hepatic vasculature, a methodological framework was developed and
implemented to quantitatively analyse and model the vasculature of rat livers
across multiple scales. In this chapter, the framework was developed and
optimised for healthy rat livers.
e framework comprised two experimental techniques, i.e. vascular
corrosion casting (VCC) and immunohistochemistry (IHC), to acquire
morphological data on the hepatic vasculature. While both techniques
were previously used to study the hepatic vasculature, they still faced a
number of challenges. We optimised these techniques and combined their
complementary strengths to reconstruct in 3D the rat hepatic circulation
across multiple scales. e VCC and micro-CT scanning protocol was
improved by enabling dual casting via the hepatic artery and portal vein,
whereas the IHC was extended with an adapted clearing technique (CUBIC)
to allow for deep tissue imaging when combined with confocal microscopy.
Using soware developed in-house, the vascular network - in both VCC
and IHC datasets - was automatically segmented and/or morphologically
analysed. Hence, the framework allowed for detailed 3D visualization of
the hepatic vasculature and automated quantication of the morphological
parameters and branching topology.
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Chapter 5. Vascular remodelling of the rat liver during cirrhogenesis
Knowledge on the dynamically evolving pathological changes of the hepatic
vasculature during cirrhogenesis is limited. More specically, detailed
morphological data of the vascular adaptations during disease development
is lacking. In this chapter, we addressed this lacuna through quantication of
the rat hepatic macro- and microvasculature at dierent time points during
cirrhogenesis.
Cirrhosis was chemically induced using the thioacetamide (TAA) rat
model. At four time points (0, 6, 12, and 18 weeks), the hepatic vasculature
was xed and visualized using a combination of vascular corrosion casting
and deep tissue microscopy (optimised in chapter 4). 3D reconstruction
and data tting enabled cirrhogenic features to be extracted at multiple
scales, portraying the impact of cirrhosis on the hepatic vasculature. At the
macrolevel, we noticed that regenerative nodules severely compressed pliant
venous vessels from 12weeks of TAA intoxication onwards. Especially, hepatic
veins were highly aected by this compression, with collapsed vessel segments
severely reducing perfusion capabilities. At the microlevel, we discovered
zone-specic sinusoidal degeneration with sinusoids located near the surface
being more aected than those in the middle of a liver lobe. e datasets
shed more light on the evolving angioarchitecture during cirrhogenesis and
formed the basis of the computational model as presented in chapter 6.
Chapter 6. Modelling rat haemodynamics during cirrhogenesis
Cirrhosis is characterized by severe distortion of the hepatic architecture
and mechanical properties (chapter 5).e architectural disarrangements
progressively increase the intrahepatic vascular resistance, leading to portal
hypertension and systemic circulatory disorders. In this chapter, we assessed
the impact of these changing vascular resistances on the hepatic and global
circulation haemodynamics during cirrhogenesis.
Morphological quantication of the branching topology of the hepatic
vascular trees, as generated in chapter 5, provided the input for a lobe-specic
lumped parameter model of the liver. is liver model was coupled to a
closed-loop model of the entire circulation of the rat.e integrated model
allowed hepatic and systemic haemodynamics to be predicted for dierent
stages of cirrhogenesis.
e simulations showed the eect of the altering hepatic vascular resis-
tances (driven by the hepatic venous resistance increase) on the haemody-
namics, with portal hypertension observed aer 12 weeks of TAA intoxication.
Moreover, the lobe-specic liver model revealed abnormal ow patterns (e.g.
reversal of portal venous ow) in the diseased animals.ese phenomena
are not uncommon in patients with cirrhosis.e closed-loop model was
further extended to account for compensation mechanisms and disorders
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of the systemic circulation, frequently observed in cirrhosis.eir impact
on the hepatic, systemic, and pulmonary haemodynamics was simulated.
Results clearly explained how cirrhosis-induced vascular changes severely
disrupt both hepatic and global haemodynamics. Since the model is able
to simulate the main characteristics of cirrhosis, it may be translated to hu-
mans for the assessment of liver interventions (e.g. transjugular intrahepatic
portosystemic shunt (TIPS) surgery).
Part III. Conclusions
Chapter 7. Conclusions and future perspectives
A key achievement of this dissertation is the development and implementa-
tion of a methodological framework to quantify the vascular remodelling of
the rat liver during cirrhogenesis.is allowed novel and unique 3D mor-
phological data to be generated on the hepatic macro- and microcirculation
throughout cirrhosis development.ese data then formed the basis for a
computational model to simulate the rat blood circulation during cirrhogene-
sis.is computational model allowed for assessment of the haemodynamic
consequence of cirrhogenesis and provided unique insights into the mani-
festation of portal hypertension. We consider our work a step forward in
the unravelling of the complex pathogenesis of cirrhosis. However, a lot of
ground is yet to be uncovered. An interesting eld for future research may be
the integration of functional models into the presented computational model
to study the interplay between the hepatic perfusion and liver function in
the case of cirrhosis.
Introduction
Clinical and socio-economic context
e liver is a complex and vital organ, responsible formore than 500 functions
(e.g. the synthesis of proteins and breakdown of toxins) to maintain body
homeostasis. Its ability to perform these functions is highly dependent on a
well-functioning blood circulation and well-organised vascular architecture.
Impairment of either one due to injury or disease may instigate a cascade of
events, aecting the overall liver function and the functioning of the organism.
Fortunately, the liver can withstand a certain degree of damage due to its
unique capacity to regenerate tissue aer injury. However, persistent injury
may eventually cause the liver to progress towards cirrhosis.
Cirrhosis is oen attributed to an unhealthy lifestyle (e.g. alcohol abuse,
fatty diet, and drug intoxication) or chronic viral infection (e.g. hepatitis
B and C). It is characterized by a distortion of the hepatic architecture
and mechanical properties, leading to impaired hepatic perfusion and
function. Its genesis is insidious and may take up to many years before
reaching a decompensated stage in which complications (e.g. ascites, variceal
haemorrhage, jaundice, and encephalopathy) become clinically present (see
Figure 1). Once decompensation is established, cirrhosis may culminate into
liver insuciency or liver cancer (e.g. hepatocellular carcinoma) [219].
According to the Global Burden of Diseases study [174], cirrhosis is
the twelh leading cause of death with mortality rates exceeding a million
deaths in 2010, as such equalling 2% of all deaths worldwide. Even more,
evidence suggests that the reported liver-related mortality rates may have
been underestimated and cirrhosis actually ranks as the eighth leading cause
of death and the third leading cause of death in persons 45–64 years of age
[10].is discrepancy may be attributed to the fact that cirrhosis generally
remains unnoticed until complications become clinically present.
ere is no therapy to treat cirrhosis directly, except for aetiological treat-
ments and interventions to manage, stabilize, or recompensate complications
of the disease. In early stages, aetiological treatment (e.g. antiviral drugs) may
help to delay disease progression and reduce complications to develop. How-
ever, liver transplantation remains the sole option when liver insuciency or
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Figure 1: Evolution of cirrhosis. Chronic injury due to e.g. alcohol abuse, viral
infection, or obesity may cause the development of cirrhosis. Its genesis is insidious
and may take up to many years before reaching a decompensated stage in which
complications become clinically present. For advanced stages of cirrhosis, liver
transplantation remains the sole treatment option to prevent liver insuciency or
the progression to liver cancer (hepatocellular carcinoma). Adapted from [219].
complications occur. Not surprisingly, cirrhosis has become a global health
issue associated with a substantial economic burden, estimated to $3–5 billion
per year in the USA alone [130]. Moreover, physicians have to base their
clinical decisions on their experience-based intuitive prediction of the spon-
taneous course of disease development. Scoring systems (e.g. Child-Pugh
and MELD-Score) are being used, however, they represent rough statistical
models and as such do not reect the wide array of the clinical picture.e
precise assessment of the patient’s liver and its functions has thus become
imperative to tailor the therapeutic treatment approach patient-specically.
Unfortunately, the latter remains challenging, as the pathogenesis of cirrhosis
is still not fully understood.
Research goals
With remodelling and disruption of the hepatic vasculature being recognized
a key factor of cirrhogenesis, we believe that fundamental insight into this
particular aspect may help to broaden our understanding of the complex
pathogenesis of cirrhosis and to determine the “point-of-no-return”, beyond
which the progressive disease can no longer be reversed. While there is some
previous research on modelling of the vasculature and perfusion in the case
of cirrhosis, most of the liver-related research on perfusion modelling has
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focused on the healthy liver.is work therefore focused on clarifying the
intricate relation between cirrhogenesis, the hepatic (angio)architectural
disarrangement, and the impaired vascular perfusion from a modelling point
of view, making use of a well-established animal (rat) model. In this respect,
three research goals were dened, each facing specic challenges:
Goal 1. Develop a multilevel methodology to analyse the hepatic
vasculature of rats
Goal 2. Quantify and map the vasculature of the rat liver
throughout its progression towards cirrhosis
Goal 3. Develop a computational model to assess the haemody-
namic consequences of cirrhosis-induced vascular adaptations
Structure overview
is dissertation is divided into three major parts.
Part I provides a background summary commencing with the anatomy
of the healthy liver in chapter 1. Subsequently, chapter 2 discusses the
chronic liver diseases most commonly progressing to cirrhosis followed
by the characteristic morphological features of cirrhotic livers. Here, special
attention is paid to the remodelling of the microcirculation. Chapter 3 gives
an overview of the techniques previously used to study cirrhosis, including
animal models, in vivo functional methods, and mathematical models.
In part II, chapter 4 presents the newly developed methodological
framework to quantitatively analyse and model the rat hepatic vasculature
across multiple scales.is framework is used in chapter 5 to generate and
analyse data on the altering vasculature of rat livers throughout cirrhogenesis.
ese quantitative morphological data form the input for a closed-loop
lumped parameter model on the rat blood circulation, developed in chapter 6
to predict the haemodynamic changes due to cirrhosis-induced vascular
adaptations.
Finally, part III recapitulates the key ndings and concludes with relevant
prospects for future research (chapter 7).
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The healthy liver
Before addressing cirrhosis in the next chapter, it is important to investigate
the anatomical architecture of the liver in physiological conditions. In this
chapter, we will present the anatomy of the healthy human liver going from
the macroscopic level down to the cellular components.
1.1 Macroscopic anatomy of the human liver
1.1.1 Gross anatomy
e wedge-shaped liver is the largest and heaviest parenchymal organ in
humans, weighing approximately 1.5 kg in an average adult. It is vital to life
and is the most versatile and vascular organ, performing over 500 known
functions. Even at rest, about 25% of the total cardiac output is conducted
to the liver, which is more than any other organ [3]. Moreover, it is the only
organ that possesses the capacity to regenerate tissue aer injury [190].
e liver is located in the right upper quadrant of the abdominal cavity
(Figure 1.1A). It sits just beneath the diaphragm where it is almost completely
sheltered by the rib cage. Additional protection is provided by a thin layer of
connective tissue (Glisson’s capsule) covering and extending into the structure
of the liver.e liver is kept in position by peritoneal ligaments and its surface
is embedded in the visceral peritoneum, which serves as a conduit for blood
vessels, lymph vessels, and nerves. At the bare area (Figure 1.2A) - where the
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Figure 1.1: A Anterior view of the human body showing the supercial organs.
Adapted from [179]. B Schematic overview of the general pattern of the human blood
circulation. Noteworthy, the liver has a unique dual blood supply: the hepatic artery
provides oxygenated blood, whereas the portal vein delivers nutrient-enriched but
partially oxygen-depleted blood from the digestive organs and the spleen. Adapted
from [181].
liver is attached to the diaphragm by areolar tissue - the surface is devoid of
such peritoneal covering [203].
Traditionally, the human liver is subdivided in four anatomical liver lobes:
two main lobes (the right and le lobe), which are morphologically divided
by a falciform and round ligament, and two poorly demarcated smaller lobes
(the caudate and quadrate lobe), as depicted in Figure 1.2. e right lobe
contains a deep ssure (called porta hepatis or liver hilum; Figure 1.2B) in the
visceral surface through which all the neurovascular structures (except the
hepatic veins) and hepatic ducts are transmitted. A pear-shaped gallbladder
that is connected to the liver by the biliary system is found between the right
and quadrate lobe [70, 269].
1.1.2 Hepatic mass transport systems
e liver relies on three mass transport systems to ensure the metabolic work
load and detoxication.ese systems include the vascular system, the biliary
system, and the lymphatic system.
e vascular system of the liver is unique with regard to other organs
because of its dual blood supply (Figure 1.1B). e hepatic artery (HA),
coming from the coeliac axis, provides the liver with oxygenated blood at
a mean pressure of ± 100 mmHg, accounting for nearly one third (± 25–
30%) of the total blood ow (1.5 l ⋅min−1) to the liver.e remaining blood
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Figure 1.2: e surfaces and external features of the human liver viewed from
dierent angles: A superior, B posterior, C anterosuperior, and D posteroinferior
view of the liver. Adapted from [70].
supply (± 70–75%) is delivered by the valveless portal vein (PV) and contains
nutrient-enriched but partially oxygen-depleted blood coming from the
digestive organs and the spleen (Figure 1.1B). In contrast to the HA, the PV
is a low-pressure system with pressures of typically 3 to 5 mmHg [214]. Both
vessels ramify at the level of the porta hepatis (hilum) in branches towards
the right and le lobes. Venous drainage from the liver is ensured via the
right and le hepatic veins (HV), which emerge from the back of the liver
and enter the vena cava inferior (VCI) (Figure 1.3) [3, 67, 269].
e total hepatic blood inow is tightly regulated by several mechanisms
to maintain perfusion of the liver containing adequate nutrition and oxygen
levels. One of these mechanisms is the hepatic arterial buer response
(HABR) which is assumed to operate based on the adenosine washout
hypothesis. In short, adenosine is released at a constant rate in the space
around PV and HA vessels and is subsequently washed away by blood ow.
A decrease/increase in PV ow would lead to higher/lower adenosine levels
around the HA vessels, which trigger a dilation/contraction of the arterial
vessels to increase/decrease its share of hepatic blood ow, thereby providing
a compensatory mechanism for the total hepatic blood inow [71].
In addition to the vascular system, the hepatic biliary tree counts two
hepatic bile ducts originating from the liver. Both unite in the liver hilum to
form the common hepatic duct.is is soon joined by the cystic duct from
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Figure 1.3:e vascular system of the human liver. Blood is delivered by the hepatic
artery and portal vein, which run in parallel throughout the liver’s interior in so-
called portal triads (PTs).ese PTs also contain vessels of the biliary tree and ramify
repeatedly through several orders of branches until reaching the microlevel. Venous
drainage from the liver is ensured via the hepatic veins. Adapted from [203].
the gallbladder to form the common bile duct, guiding the synthesized bile
from the liver into the small intestine (duodenum) [3]. e common bile
duct is guarded by the muscular sphincter of Oddi, which - in closed position -
forces newly produced bile to be temporarily stored in the gallbladder. Bile
is an important digestive uid, assisting in the breakdown and absorption of
lipids.
e liver also generates a large amount of lymph, mainly produced at
the microstructural level. As such, a deep lymphatic system is present in the
liver to ensure drainage of the produced lymph, which is suggested to be
25–50% of the lymph owing through the thoracic duct (largest duct of the
lymphatic system).e hepatic lymphatic vessels are categorized based on
their location into portal, sublobular, and supercial lymphatic vessels. It has
been reported that about 80% of the hepatic lymph is conducted through the
portal lymphatic vessels [209].
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1.2 Microscopic anatomy of the human liver
1.2.1 Frommacro- to microcirculation
About 80% of liver tissue in the average human adult is functional tissue
(parenchyma).e remaining 20% is connective tissue (stroma) that forms
the Glisson capsule. It serves as a protective structure. At the liver hilum,
this capsule accompanies the branching pattern of the entering HA and PV,
and the emerging bile duct into the liver. e combination of branches
of these three structures (HA, PV, and bile duct) are known as portal
triads (PTs).ey run in parallel throughout the liver’s interior and divide
repeatedly through several orders of branches (about 17-20 orders) [203].
eir diameters progressively taper until reaching the terminal ramications
known as hepatic arterioles, portal venules, and bile ductules, respectively
(Figure 1.4) [42, 203].
Figure 1.4: Microscopic anatomy of the human liver. e three-dimensional
representation shows the internal organization of the vascular and biliary system.
Blood is guided through the hepatic arterioles and portal venules into intertwined
and interconnected sinusoids, which are separated from the parenchymal cells
(hepatocytes) by the perisinusoidal space of Disse. Adapted from [203].
e portal venules are enveloped by scanty periportal connective tissue
and are classied as preterminal portal venules or terminal portal venules.
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From these venules, very short side branches emerge that are called inlet
venules (Figure 1.4).ese inlet venules penetrate the periportal connective
tissue sheath and open directly into liver-specic capillaries (sinusoids).e
inlets are guarded by sphincters, controlling the amount of PV blood owing
into the sinusoids [42].
Hepatic arterioles do not necessarily drain directly into sinusoids [42].
In fact, the blood ow in terminal arteries is directed via three routes:
into periportal arterioles which release blood close to the PT, into longer
intralobular arterioles which transport the arterial blood further from the
PT; and into portal arterioles which supply the vessel walls of PVs and bile
ducts (Figure 1.4).e main part of the arterial blood ow is assumed to be
distributed via periportal arterioles [129, 203].
Blood guided through periportal or intralobular arterioles and portal
venules is mixed in the intertwined and interconnected sinusoids. e
sinusoids are separated from the parenchymal cells (hepatocytes) by the
perisinusoidal space, known as the space of Disse. In physiological conditions,
this extravascular space is composed of permeable connective tissue with few
collagen brils, thereby facilitating molecular exchange between sinusoids
and hepatocytes [42]. While blood plasma components are transported to
and absorbed by hepatocytes, the blood stream continues to travel down the
sinusoids until collected in the central vein (CV).ese CVs join to form
sublobular veins, which unite into the larger HV (see Figure 1.3) [203].
1.2.2 Structural and functional units
At the microlevel, the hepatic parenchyma is believed to be organized in
repetitive anatomical and functional units. Dening the fundamental struc-
tural and functional unit of the liver, however, has preoccupied researchers
since the rst description of liver lobules in 1665 [29].
To date, the classical lobule, documented by Kiernan [137], remains the
prevailing theory by which the hepatic microarchitecture is described.e
concept states that the hepatic parenchyma is divided by connective tissue in
so-called hexagonal lobules. In humans, these lobules are poorly demarcated
due to the scarce amount of connective tissue in between lobules, though they
are suggested to be arranged in a tessellated pattern. As such, each lobule is
provided with blood by PTs at the periphery between the corners of adjacent
liver lobules, and is drained by a CV in the central axis of the lobule (see
Figure 1.5A).e PTs and CVs are usually separated by approximately 0.5
mm [67].
Subdivisions of the classical hexagonal lobule into smaller structural or
functional units may be more useful to describe the liver microanatomy.
Recent years have seen various formulations. From a metabolic perspective,
the most popular functional unit is the liver acinus proposed by Rappaport
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Figure 1.5: Structural and functional liver units. Ae classic hexagonal liver lobule
is arranged in a tessellated pattern with portal triads (PTs) penetrating the peripheral
corners, and with a central vein (CV) in the centre of the lobule. Be hepatic
acinus leads to metabolic zonation (periportal zone 1, intermediate zone 2, and
pericentral zone 3). Ce primary lobule emanates from the PTs and drains into
the CV. Adapted from [62]. D Teutsch’s secondary module is subdivided by vascular
septa and branches of PTs into (six) primary modules. Adapted from [281].
[230].e acinus is dened as a triangle formed by PTs at the base points
and an euent vein in the sharp apex of the triangle (see Figure 1.5B). In the
idealized hexagonal lobule, there are six acinar units.e centripetal blood
ow in the triangular acinus leads to metabolic zonation, with dierentiation
of a peripheral (periportal, zone 1) and centrilobular (perivenous, zone 3) area,
which enclose the transition zone (intermediate, zone 2)(Figure 1.5). Zones
1, 2, and 3 are regions which receive blood progressively scarcer in oxygen
and nutrients [42].e structure and function of the hepatocytes is adapted
accordingly with the oxidative metabolism predominantly happening in the
periportal area (zone 1). On the other hand, glycolysis, lipogenesis, and
ureagenesis primarily occur in the perivenous area (zone 3) [127].
e primary lobule concept, introduced byMatsumoto in 1979, is another
formulation [185] used to depict the building blocks of the liver. e
theory postulates that the classical hexagonal lobule (which is renamed
secondary lobule) is subdivided into 6–8 primary lobules. In this case, each
primary lobule is regarded as a vascular septum (VS) emanating from the
PT and draining into the terminal hepatic venule (Figure 1.5C). In 2005,
Teutsch extended Matsumoto’s primary lobule to resolve the problem of
morphological homogeneity, which concealed the liver’s internal organization
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[281]. is was accomplished by introducing the primary and secondary
module, in which morphogenetic plasticity (variation in shape and size,
including number and area of the PTs and VS) was considered a key feature
(Figure 1.5D).With amodularmicroarchitecture, Teutschmade a rst attempt
to capture the true complexity of the hepatic 3D microstructure, which is yet
to be conceptualized.
1.2.3 Cellular elements
1.2.3.1 Hepatocytes
About two thirds of the liver cells are hepatocytes.ey make up the hepatic
parenchyma and are arranged as a labyrinth of cellular plates in between
sinusoids. Hepatocytes are epithelial cells about 20 µm by 30 µm in size
and have microvilli extending into the space of Disse to enable active and
passive transport of nutrients and other molecules across their membrane
(Figure 1.6) [42, 203].
e hepatocyte has three surfaces: the sinusoidal surface facing the
sinusoid and space of Disse, the canalicular surface facing the bile canaliculus
and the lateral surface facing the intercelullar space between hepatocytes.
e sinusoidal and lateral surfaces constitute the basolateralmembrane of
the hepatocyte, while the canalicular surface makes up the apicalmembrane.
Hepatocytes are highly polarized cells with transport directed from the
sinusoidal domain to the canalicular domain. is polarity is preserved
by tight junctions formed between adjacent hepatocytes, creating a barrier
between uid in the intercellular space and bile in the canaliculus. e
intralobular canalicular network drains into larger bile ducts located near
the PTs (Figure 1.6) [42].
e typical life span of hepatocytes is approximately 150 days [67].
Hepatocytes may die as a result of necrosis or apoptosis. Necrosis is associated
with the loss of plasma membrane integrity and subsequent local release of
cellular contents, triggering an inammatory reaction in its environment.
e inammatory response can induce necrosis of surrounding hepatocytes.
Apoptosis is the process of programmed cell death controlled by a diverse
range of cell signals.e process causes senescent or damaged cells to self-
destruct by producing apoptotic bodies.e latter are easily engulfed and
removed by phagocytic cells to minimize the production of inammatory
products [124, 131].
As mentioned earlier, the liver has the remarkable capacity to regenerate
tissue aer injury. Typically, an equilibrium is pursued between cell death
and regeneration to preserve the structural mass and functionality of the liver
[190]. is equilibrium is reached when the mitotic rate (number of cells
dividing) balances the rate of apoptosis [73]. It may, however, happen that
during regeneration additional hepatocytes are needed. In that case, quiescent
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Figure 1.6: Schematic representation of the hepatic microarchitecture. Hepatocyte
cords are separated from sinusoids by the perisinusoidal space, known as the space
of Disse, which in normal conditions comprises delicate collagen bres. Microvilli
extend from hepatocytes into the space of Disse to enable molecular transport across
their membrane. Tight junctions are formed between neighbouring hepatocytes,
thereby creating a barrier between the uid in the space of Disse and the bile in
the bile canaliculi. While Kuper cells adhere to the vascular side of sinusoids,
(quiescent) stellate cells lie within the space of Disse. Adapted from [42].
cells or even stem cells (oval cells and bonemarrow cells) can be stimulated to
move into a primed state, in which growth factors stimulate DNA synthesis
and cellular replication [157]. It is generally assumed that a well-orchestrated
regenerative response of functioning hepatocytes allows the liver to restore
lost tissue up to two thirds of its total mass, while simultaneously performing
the vital functions to maintain body homeostasis [67, 280].
1.2.3.2 Sinusoidal cells
Hepatic sinusoids harbour four main cell types which diers them from
normal blood capillaries: sinusoidal endothelial cells, Kuper cells, hepatic
stellate cells, and pit cells.
• e sinusoidal endothelial cells (SECs) form a continuous lining of
the sinusoids, separating the parenchyma from the sinusoidal blood
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ow (Figure 1.6). SECs are unique compared to endothelial cells as they
lack a distinct basement membrane and contain multiple fenestrae (or
pores) allowing plasma constituents to gain access to the perisinusoidal
space of Disse (Figure 1.7) [55].e fenestrae are grouped in sieve plates
containing clusters of 10–50 pores (± 0.15 µm in diameter).ey have
a dynamic cytoskeleton that responds to changes of the sinusoidal
blood ow and perfusion pressure by regulating its diameter [40].e
fenestrae literally sieve the uids, solutes, and particles exchanged
bidirectionally between sinusoids and the interstitial space of Disse.
e fenestrated SECs thus act as a biolter, keeping macromolecules
larger than 0.2 µm and red blood cells within the vascular space [77].
SECs also have a high capacity for endocytosis, enabling scavenger
pathways to actively clear macromolecules and small particles from the
circulation [266].eir endocytotic capacity makes SECs an important
part of the innate immune system [39].
Figure 1.7: A Scanning electron microscopy (SEM) image of the sinusoidal lumen of
a rat liver. Note the fenestrations (f) of about 0.1 µm in the endothelial lining, acting
as sieve plates between the sinusoid and the space of Disse (SD). Adapted from [42].
B Transmission electron micrograph shows the normal hepatic sinusoidal wall of
rat in a transverse section.e sinusoid is lined by fenestrated (f) endothelial cells
(En) and its lumen (SL) encloses a lysosome-laden (Ly) Kuper cell (Kc). A hepatic
stellate cell (HSC) containing two fat droplets (d) sits in the space of Disse, which
separates sinusoids from hepatocytes (H). Adapted from [201].
• Kuper cells (KCs) are highly mobile macrophages that anchor on the
vascular side of sinusoids (Figures 1.6 and 1.7B).esemacrophages are
crucial in the host defence system, ensuring the removal of damaged
and worn-out blood cells as well as the capture and degradation of
noxious substances (such as bacteria, viruses, parasites, and tumour
cells) through endocytosis [286]. It may happen that products secreted
by KCs are toxic to parenchymal and endothelial cells and, as such,
contribute to the pathogenesis of liver diseases [144]. On the other
hand, activated KCs are also vital to reach the optimal regenerative
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capacity of the liver, most likely by releasing cytokines which instigate
the proliferation of hepatocytes [24].
• Hepatic stellate cells (HSCs) (or Ito cells) lie within the space of Disse
and are, in a quiescent state, a major storage site of lipid droplets
containing retinoids (vitamin A and its metabolites) (Figures 1.6
and 1.7B). ese cells, which are in close contact with sinusoids,
are also assumed to have vasoregulating properties, and therefore
play a central role in regulating the blood ow through sinusoids
[300]. Following hepatic injury, HSCs start to proliferate and migrate
towards the damaged area.ey lose their retinoid storage capacity
and transform into a myobroblast-like phenotype. HSC-derived
myobroblasts have increased contractile properties and secrete high-
density extracellular matrix (ECM) in the extravascular space. e
abnormal ECM deposition decreases the permeability of the space of
Disse, induces loss of hepatocyte microvilli, and reduces the size and
number of fenestrae (see section 2.3.1 for more information) [160, 165,
241].
• Pit cells are located in the space of Disse where they eectuate the
role of liver-specic natural killer cells.ese cells contribute to the
immune response and have a high cytotoxicity level against tumour
cells [317].
e cellular cross-talk between the group of sinusoidal cells and hepato-
cytes is critical to maintain homeostasis and physiologic processes such as
liver regeneration [180]. During liver injury, for example, cytokines produced
by SECs activate hepatocytes to proliferate in an attempt to restore the lost
tissue. Conversely, hepatocytes may release the vascular endothelial growth
factor (VEGF), which is believed to play a critical role in maintaining the SEC
fenestrated [64]. Since these complex communication pathways are tightly
regulated, abnormalities in the intercellular communication are increasingly
being recognized to underlie virtually every liver disease [256].
1.3 Liver functions
Over 500 dierent metabolic and detoxifying functions are carried out by
the liver to maintain body homeostasis. Below, a brief outline of the most
important functions is given.
As the main site of glycogen degradation and synthesis, the liver plays
an important role in regulation of the blood glucose level. In short, excess
glucose is removed from the blood circulation and converted into glycogen,
which is stored (temporarily) in hepatocytes. When blood glucose levels
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decline, the liver is triggered to reconvert the stored glycogen into glucose
and release it into the blood stream to attain glucose homeostasis. Other
important metabolic functions include the breakdown of proteins and lipids,
as well as the storage of iron and vitamins, such as vitamin A and D.e
most prominent detoxifying function of the liver is the biotransformation
of harmful lipophilic substances (e.g. medication, nutritive additives, and
steroid hormones) into more water-soluble and inactive products, secretable
by the kidneys [42, 67, 179].
e liver also performs vital secretory functions. Daily, about 600–
1200 ml of bile is produced by hepatocytes that either drains via the biliary
tract directly into the small intestines (duodenum) or is stored temporarily
in the gallbladder. Besides assisting the breakdown and absorption of lipids
in the small intestines, bile also serves as a medium for the body to excrete
waste products from the blood. In addition, approximately 1–2 l of lymph is
synthesized daily by the liver, mainly at the microlevel. Hence, the hepatic
lymphatic system plays an important role in functions related to the immune
system, the removal of waste products, and the transportation of fats and
white blood cells [42, 179, 209].
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The cirrhotic liver
In this chapter, we will describe the cirrhotic human liver. First, a denition
is given, followed by an overview of the liver diseases most commonly
progressing to cirrhosis.e next section introduces the morphological features
characteristic to cirrhosis. We will also address the vascular remodelling
events of the microcirculation. Lastly, available diagnostic imaging tools and
therapeutic treatments are discussed.
2.1 Definition of cirrhosis
Cirrhosis is dened as the common end-point of any given chronic liver
disease [222]. Progression to cirrhosis is very insidious and occurs as
a result of repetitive destruction and regeneration of parenchymal liver
cells, thereby activating necroinammatory and brogenic pathways.is
relentless process disturbs the hepatic (angio)architecture replacing it with
diuse brosis, vascularized brotic septa, and regenerative nodules (see
Figure 2.1). It is typically assumed to be irreversible, though brosis regression
may improve the clinical outcome [219, 249, 283].
Cirrhosis may become life-threatening and progress into clinically
relevant portal hypertension (PHT), liver failure, or hepatocellular carcinoma.
PHT is assumed to be responsible for the more severe and oen lethal
complications of cirrhosis and reects an increased portal blood pressure.
Over the past decades, global mortality rates due to cirrhosis have increased
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monotonically, exceeding one million deaths in 2010. ese mortality
rates appear to vary strongly among continents and countries, as shown
in Figure 2.2 [192].
Figure 2.1: e macroscopic appearances of A normal human liver [62] and B
cirrhotic human liver, induced by the hepatitis B virus [208]. Note the smooth
reddish-brown surface in the healthy liver, while the cirrhotic liver shows an
irregular and rough surface with shrinkage of the right lobe (RL) and compensatory
hypertrophy of the le lobe (LL).
Figure 2.2: Age-adjusted liver cirrhosis mortality (per 100,000) for both sexes in
2010. Adapted from [192].
2.2 Aetiology and epidemiology
e genesis of cirrhosis is mostly instigated by alcohol abuse, viral hepatitis
infections, or metabolic syndromes related to obesity and diabetes. Other
less frequent causes include drug abuse, diseases involving the biliary tract,
and multiple (hereditary) genetic liver disorders (Figure 2.3)[192].
In the Western world, alcoholism is considered by far the main cause of
cirrhosis. One-third of the cirrhotic cases is associated with alcohol abuse. In
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Central Asia and Africa, cirrhosis largely results from the high prevalence of
hepatitis B and C viruses, accounting for more than half of the cirrhotic cases.
In the majority of these cases, co-factors such as age, sex, obesity, alcohol,
and genetic factors aggravate the prevailing cause. For example, deaths due
to cirrhosis are on average twice as high for men than for women. Cirrhosis
of which the aetiology cannot be diagnosed is termed cryptogenic cirrhosis
[26, 67, 192].
Figure 2.3: Population attributable fractions of liver cirrhosis in 2010. Source data:
[192].
e transition of the liver from healthy over chronically inamed
to cirrhotic involves complex pathogenic pathways that depend on the
pathogenesis of the chronic liver disease (see Figure 2.4).e liver diseases
most commonly progressing into cirrhosis are fatty liver disease, chronic
viral hepatitis, and autoimmune-mediated diseases. A basic knowledge of
their pathogenic pathways is a necessary prerequisite to gain insight in the
aetiology of cirrhosis.
2.2.1 Fatty liver disease
Fatty liver disease or steatosis develops aer excessive accumulation of fat in
the liver, thereby exceeding 5% of the total liver volume. e abnormal
retention of fat in the liver may indicate defects in lipid metabolism or
result from an oversupply of fat brought to the liver. e excess fat is
stored as triacylglycerol (TAG) in the vacuoles of hepatocytes, leading to
cellular ballooning. Ballooning is detrimental to cells and causes injury to
the cytoskeleton, dilation of the endoplasmic reticulum, and impairment
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Figure 2.4: Natural history of cirrhosis. Irrespective of the underlying aetiology,
persistent and repetitive hepatic injury causes inammation, deposition of brous
tissue, hepatocellular death, and angiogenesis leading to progressive brosis.e
brosis progression is very insidious and may take up to many years to develop
cirrhosis. Cofactors (such as obesity and alcohol) can modulate the risk of brosis
progression. In early hepatic brosis, resolution to near-normal liver architecture
may occur if the underlying cause is addressed. Cirrhosis, on the other hand,
cannot be reversed, though regression of brosis may improve clinical outcome. For
advanced cirrhosis, liver transplantation is the only available treatment to prevent
fulminant liver failure or progression to liver cancer. Adapted from [219].
of the cell size regulation [43, 159]. Typically, steatosis can be reversed if
the underlying cause is taken away. However, when the cause remains
unaddressed, it may happen that steatosis leads to hepatic inammation
and mild scarring.is condition is known as steatohepatitis. A hallmark of
steatohepatitis is the degeneration of the ballooned cells [42].
ere are two basic patterns of steatosis: macrovesicular and microvesi-
cular steatosis.e former is characterized by large fat vacuoles, deforming
the cell architecture.ese macrovesicules displace the nucleus to the periph-
ery and may cause the cellular volume to double in size.is architectural
disturbance reduces the interstitial space and narrows sinusoids, leading to
an increased intrahepatic vascular resistance (IHVR). In microvesicular stea-
tosis, the cell architecture remains more or less intact with small-droplet fat
vacuoles diusely dispersed in the cytoplasm. Nevertheless, microvesicular
steatosis is considered the more severe type of steatosis, as it can rapidly
progress to fulminant liver failure or even death [105, 119].
Fatty liver disease is categorized based on the aetiology into alcoholic or
non-alcoholic fatty liver disease.
2.2.1.1 Alcoholic fatty liver disease
Chronic alcohol exposure favours the development of alcoholic liver disease.
e mechanisms involved in alcohol-related hepatotoxicity are multifaceted
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and comprise complex pathways, some of which are discussed below.
Alcoholic fatty liver is the earliest stage, characterized by the excessive
deposition of fat. Concomitant inammatory reactions lead to alcoholic
steatohepatitis, which may further progress towards alcoholic cirrhosis [92].
• Alcohol is detoxied and eliminated in the liver through a series of
oxidative metabolic reactions. In the cytosol (intracellular uid) of
hepatocytes, about 85% of the ethanol is converted into acetaldehyde
by alcohol dehydrogenase (ADH). Acetaldehyde is a toxic culprit that
contributes to various metabolic imbalances detrimental to the liver.
Alcohol oxidation is believed to play a pivotal role in the onset of
alcoholic fatty liver disease [193, 257].
• Alcohol leads to an excess of synthesized fatty acids (important source
of energy) by substituting them for ethanol as the major hepatic fuel.
e oversupply of free fatty acids (FFA) is stored as TAG in liver
cells. TAGs are the main constituents of body fat.is pathological
process is further exacerbated by the alcohol-induced inhibition of
TAG clearance from the liver [193].
• Hazardous alcohol consumption increases the intestinal permeability
to bacterial endotoxins.ese endotoxins sensitize Kuper cells (KCs)
to release cytokines, which may induce steatosis, inammatory, and/or
apoptotic processes [92].
• Excess alcohol intake increases the oxidative stress via generation of
highly reactive oxygen species (ROS). Consequences of increased oxid-
ative stress include depletion of mitochondrial activity (responsible for
generating energy), hepatocellular degeneration, DNA damage, and
the release of proinammatory cytokines [193].
2.2.1.2 Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is related to insulin resistance (IR)
and its clinical expressions or features such as metabolic syndrome, obesity,
and diabetes. It comprises a spectrum of disorders characterized by fatty
liver (in the absence of alcohol), ranging from asymptomatic non-alcoholic
fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH). In this context,
NASH can be distinguished from a simple fatty liver by the histopathologic
nding of hepatocellular injury/inammation with or without brosis (see
Figure 2.5). NASH, in contrast to NAFL, is associated with an increased
risk of progression to cirrhosis and hepatocellular carcinoma.e biological
mechanism responsible for the hepatocellular injury in NASH, which is most
evident as cellular ballooning, can be condensed to a two hit hypothesis:
accumulation of fat followed by oxidative stress [67, 169, 221].
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1. In NAFLD, fat accumulates in the liver due to an imbalance between
caloric intake and systemic utilization inherent to the metabolic
syndrome. e fat derives predominantly from circulating dietary
FFA and two other phenomena - both related to IR - namely increased
hepatic FFA inux from adipose tissue, and de novo lipogenesis in the
liver.e elevated levels of FFA are absorbed by the liver, resulting in
steatosis - the rst “hit” [169, 221].
2. Cellular injury to a lipid-laden hepatocyte is instigated by an impaired
aerobic metabolism, leading to oxidative stress and degradation of the
lipids.e process is worsened by mitochondrial dysfunction which
activates an inammatory cascade - the second “hit” [67].
Figure 2.5:Microscopic ndings in haematoxylin and eosin (H&E) stained sections
of livers with non-alcoholic fatty liver disease. A Ballooning degeneration (marked
with black arrow). Many of the cells are enlarged with rarefaction of the cytoplasm.
Some of the cell swelling is caused by the accumulation of fat, but may also be the
result of excess cytoplasmic uid. B Liver tissue showing amixture of macrovesicular
and microvesicular steatosis; there is no brosis present. C e neutrophilic
inammation (arrowheads) surrounding the fatty hepatocytes and mild scarring
induces the transition of steatosis to steatohepatitis. Adapted from [136].
2.2.2 Chronic viral hepatitis
Hepatotropic viruses are responsible for viral hepatitis, generally dierenti-
ated based on the viral type, duration of infection, and the developed patho-
logical syndrome. In acute hepatitis, the viral infection is outpaced by the
response of the active immune system, as such eliminating all of the infected
cells. Some hepatotropic viruses, however, developed strategies to remain
undetected by the immunological radar, leading to a chronic state. Common
viral types that may progress to cirrhosis are the hepatic B virus (HBV) and
hepatic C virus (HCV) infections.eir main pathological features comprise
inammatory-cell inltration, hepatocyte death, atrophy and regeneration,
and brosis [232].
ere appear to be general mechanisms of injury and repair, which are
common to all hepatotropic viral infections. Some involve viral determinants,
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others are dened by the host response.eir complex interaction determines
the outcome of viral hepatitis [321].
Some hepatotropic viruses produce gene products that interfere with
cell-mediated immune responses, causing or inhibiting apoptosis of infected
cells [66]. Mutations of the virus may lead to escape from immune responses
and cytokine actions, allowing it to remain undetected, inltrate hepatocytes,
and replicate within the infected cell [142]. Furthermore, the host’s innate
and adaptive immune system may react by initiating a response to prevent
viral spread or clear the virus from the liver. One such response is apoptosis
of infected cells [48, 91]. Attempts at eradicating the virus by killing infected
cells - without ecient regeneration of hepatocytes - typically lead to massive
hepatocellular necrosis, frequently observed in chronic viral hepatitis B [118].
Irrespective of the specic mechanisms, the virus manages to infect
hepatocytes beyond the ability of the host immune system to kill infected
cells or to suppress viral replication. Eventually, a chronic presence of the
virus is established, causing ongoing immune-mediated damage to the liver.
is leads to fulminant impairment of the hepatic architecture and liver
function [42, 95].
2.2.3 Autoimmune-mediated diseases
2.2.3.1 Primary biliary cholangitis
Primary biliary cholangitis (PBC) is an autoimmune disease of the liver whose
aetiology remains cryptic, though evidence supports a combination of genetic
and environmental factors [42].e loss of tolerance to mitochondrial and
nuclear autoantigens is considered an early event [121]. PBC progressively
destroys the small intrahepatic bile ducts (40–80 µm in diameter), thereby
evoking development of brosis and cholestasis [67]. Cholestasis is dened
as a defect in the bile secretory mechanisms, leading to retention in blood
of substances normally excreted through bile [327]. Pathologically, PBC is
characterized by portal inammation, destruction of small intrahepatic bile
ducts, and concomitant parenchymal necroinammatory changes involving
lobular and periportal areas [42].
2.2.3.2 Primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a chronic cholestatic disorder of
the intra- and/or extrahepatic bile ducts [224]. It has been suggested that
PSC develops in genetically predisposed individuals, exposed to triggering
antigens. PSC is characterized by cholangitis (inammation of bile ducts)
as well as the deposition of non-specic inammatory brosis in the wall of
the biliary tree, leading to an unevenly distributed stenosis [42].is bro-
obliterative lesion impedes bile ow, as such further perpetuating injury to
the liver and bile ducts [224].
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2.2.3.3 Autoimmune hepatitis
For autoimmune hepatitis (AIH), a loss of tolerance against hepatic tis-
sue (mainly hepatocytes) is regarded as the underlying reason of this self-
perpetuating disease process [210]. It has been implicated that the develop-
ment of AIH requires the interplay of many dierent factors. Besides genetic
predisposition, infection agents such as viruses or bacteria, and environ-
mental agents (drugs and chemicals) have been suspected as triggers of this
autoimmune process. To date, a causal relationship between these triggers
and AIH has yet to be established [42]. Furthermore, AIH may occur in
combination with autoimmune disorders aecting other organs and tissues
[67].
2.3 Morphological features
As mentioned briey in the denition, the pathway to cirrhosis entails
persistent destruction of liver tissue. Overly exuberant wound-healing
mechanisms are activated to limit and repair the cellular damage. One of
these reparative mechanisms is brogenesis, i.e. the deposition of brous
tissue, leading to hepatic brosis.erefore, cirrhosis is oen erroneously
labelled as an advanced stage of hepatic brosis. Although both conditions are
characterized by an excessive build-up of dense extracellular matrix (ECM),
the lobular architecture of the liver remains unaected in hepatic brosis. In
cirrhosis, on the other hand, the architecture is completely replaced by diuse
brosis, complete vascularized brous septa, and regenerative nodules [8].
2.3.1 Diuse brosis
Fibrous connective tissue is produced to limit and encapsulate the injured
area. In acute injury, the architectural changes are mostly transient and res-
olution of early brosis may occur if the underlying cause is eliminated. In
chronic situations, however, ongoing signals associated with the persistent
hepatocellular damage lead to the exorbitant formation of high-density scar
tissue [165]. Deposition of this dense scar tissue is frequently observed in
spaces of Disse, along portal triads (PTs), and in regions with necroinam-
matory activity. With scar tissue being insuciently degraded, exchange of
solutes between sinusoids and hepatocytes is severely impaired [79].
e progression of liver brosis varies strongly among individuals
and depends to some extent on the cause of hepatic injury [18]. For
example, chronic hepatitis C is typically characterized by slow brosis
progression, while high grades of steatosis are more likely to worsen the
hepatic brosis. Interestingly, co-factors such as alcohol consumption, male
gender, and greater age (at the time of infection) can modulate the risk of
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brosis progression. Genetic determinants are also considered to aect the
progression rate of hepatic brosis [67].
Fibrogenesis is a complex and tightly regulated mechanism balanced
between matrix production and degradation. It is orchestrated by a wide
range of hepatic cells and mediators. Myobroblasts are the main eectors of
brosis. Its phenotype is intermediate between matrix-producing broblasts
and contractile smooth muscle cells. Myobroblasts are absent in the normal
liver, but accumulate at sites of injury where they produce dense ECM [166].
Once homeostasis has restored aer injury, myobroblasts either revert
to quiescent phenotypes or are cleared by apoptosis. e cross-linking of
collagen and the maturation of the hepatic scar tissue, however, remains the
main determinant of brosis reversibility [79]. Hepatic stellate cells (HSCs)
and portal broblasts are the main sources of myobroblasts. Both cell types
dier in location and physiology.
2.3.1.1 Hepatic stellate cell-derived myobroblasts
HSCs lie within the spaces of Disse, i.e. the subendothelial space between
hepatocytes and sinusoidal endothelial cells. In quiescent state, HSCs
generate primarily strands of non-brillar collagen (type IV and VI), which
combined with the other low-density components (such as glycoproteins and
proteoglycans) constitute the extracellular tissue matrix.is low-density
matrix provides cellular support and allows unimpeded exchange of solutes
and growth factors between sinusoids and hepatocytes [67].
During hepatic injury, HSCs are activated to transform into a
myobroblast-like phenotype. e HSC-activation comprises two major
phases: (i) initiation and (ii) perpetuation [165]. Initiation is driven by
paracrine stimuli such as degradation of lipids, products from injured
hepatocytes, and signals from neighbouring cells (e.g. endothelial cells (ECs),
Kuper cells).ese stimuli trigger HSCs to proliferate and transform into
myobroblasts. e myobroblasts migrate to sites of injury and start to
secrete copious amounts of ECM, containing collagen type I and III. In the
perpetuation phase, myobroblasts undergo additional behavioural changes.
ey lose their retinoid droplets and show increased contractility, among
others [165].e net eect of these changes is an overall increase of the ECM
in spaces of Disse with collagen types IV and VI being progressively replaced
by brillar collagen types I and III [165].
2.3.1.2 Portal myobroblasts
Portal broblasts are another major source of myobroblasts.ey reside
within the vicinity of PTs and bile ductules. ese cells are distinct from
HSCs and could give rise to a population of portal myobroblasts (PMFs)
[166]. PMFs are thought to play a pivotal role in cholestatic liver diseases and
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ischemia [79]. Upon liver injury, excessive amounts of ECM are produced
by PMFs near PTs and bile ducts. e rapid proliferation of PMFs may
instigate biliary brosis to run an aggressive course [208]. Moreover, PMFs
are assumed to be important eectors of the vascular changes associated with
cirrhosis, as angiogenesis is promoted by the interaction of PMFs and ECs
via growth factors (see section 2.4.2) [166, 167].
2.3.2 Vascularized brous septa
e genesis of vascularized brous septa (or sheet-like structures) is largely
determined by the condition of the liver. In the presence of steatosis, large
fat droplets may merge to form fatty cysts, around which micromembranes
grow. Eventually, the fat disappears from the cysts and the connective tissue
framework condenses into septa. Concomitantly, stress-induced ssures
appear between areas of irregular distributed fat. Fine connective tissue
membranes are deposited in these ssures and cumulate into straight septa
(Figure 2.6A and D) [203, 227].
Fibrotic membranes laid down around inamed PTs or central elds are
more important during the septa-forming process, especially in the absence
of steatosis. ese connective tissue membranes radiate from the PTs or
central veins (CVs) into the parenchyma and converge aerwards to become
brous septa. Furthermore, hepatocellular damage also contributes to septa
formation, as irregular tissue stresses result in intralobular and periportal
ssures. In these ssures, membranes are deposited that can aggregate into
septa (see Figure 2.6A and D) [203]. Aer massive necrosis, the architectural
framework collapses and portal and central elds come closer. Severe stress is
induced in the surrounding tissue and copious ssures appear in which septa
develop.ese septa may progress to become broad bands of post-necrotic
scar tissue (Figure 2.6B and E). Generally, a rearrangement and distortion of
the hepatic architecture is expected due to septa formation [203, 227].
In chronic biliary diseases, ber strands, and not the typical septa, are
formed around bile ducts.e accumulation of these strands increases the
ECM without signicantly disrupting the lobular architecture. In later stages
andmainly due to persistent inammatory reactions, septa still form between
the ber strands (Figure 2.6C and F) [203].
With the septa aggregating to form bona de brous bridges between PTs
and terminal hepatic veins (HV), vessels embedded in the connective tissue
become completely isolated from the parenchyma and may transform into
widened portohepatic or arteriovenous shunts (Figure 2.7) [42, 227]. Blood
entering the liver through PTs is guided into these low-resistance vascular
channels. ese pathways act as shunts bypassing and impoverishing the
remaining hepatocytes of nutritive blood, as such aggravating the ongoing
hepatocellular necrosis and septa formation [67, 227]. In advanced cirrhosis,
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Figure 2.6: Pathways of septa formation. A In the presence of steatosis, micromem-
branes develop that radiate from portal triads (1), around fatty cysts (2), in necrotic
areas (3), and in stress-induced ssures between areas of irregularly distributed fat
(4). B In parenchymal collapse, following massive necrosis, copious stress-induced
ssures appear (5) in which ne connective tissue is deposited. C In biliary diseases,
ber strands (6) and not the typical septa are formed around the diseased bile ducts.
D Progression to fatty septal cirrhosis.e micromembranes aggregate to brous
septa (S), thereby dissecting the lobules and constraining regenerative nodules (RN).
E In postnecrotic cirrhosis, brous septa progress to become broad bands of scar
tissue.e massive collapse induces extensive regeneration of the surrounding re-
sidual tissue, leading to multi-lobular macronodules. F In advanced biliary diseases,
septa eventually form between the ber strands, thereby dividing the lobules and
disturbing the circulation. Adapted from [203].
most of the hepatic blood supply appears to be shunted via these low-
resistance channels into the CVs [42].
2.3.3 Regenerative nodules
Regenerative nodules develop from the localized proliferation of hepatocytes
and their entrapment by the septa.e regenerative response usually occurs
aer necrosis or due to altered haemodynamics [120]. e regenerative
process leads to enlargement and concentrical rearrangement of liver cell
plates, with the plates’ normal thickness increasing from one to two cells
known as ‘twinning’.is regenerative eort combined with the uncontrolled
proliferation of hepatocellular islands, isolated during necrosis, causes the
diuse formation and progression of regenerative nodules (Figure 2.7)
[101, 226]. In case regenerative nodules become isolated from the portal
blood supply, it is suggested that angiogenic pathways are activated from
within regenerative nodules to promote the formation of new blood vessels,
allowing further nodular growth [101]. Hepatic blood vessels aremechanically
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Figure 2.7: A With the formation of bridging brous septa, portohepatic and
arteriovenous shunting occurs.e shunts bypass the hepatocytes and impoverish
the parenchyma of nutritive blood supply, leading to the formation of nodules.
e regenerative nodules promote the genesis of new blood vessels. Eventually,
the lobular architecture is completely replaced by structurally abnormal nodules
enveloped in dense brotic septa. Adapted from [203]. B Trichrome stained
brous septa (arrowheads) bridging portal triads (PTs) in hepatitis C cirrhosis.
C Immunohistochemistry for smooth-muscle actin in the same scar demonstrates
a low-resistance channel (arrow) embedded in brous tissue, connecting two PTs.
Adapted from [42].
compressed by the regenerative nodules, increasing the IHVR and impeding
the hepatic blood ow (see section 2.4.2) [67].e hepatic arterial system is
reported to be less aected by the compression as arterial vessel walls have a
thick muscle layer and higher intra-arterial blood pressure.
Cirrhosis can be classied as micronodular, macronodular, or mixed
cirrhosis (see Figure 2.8). Micronodular cirrhosis implies that almost
all regenerative nodules are less than 3mm in diameter [101]. It most
commonly originates fromdiseases in which a hepatotoxic agent ormetabolic
disorder uniformly aects the lobules, activating inammatory and brogenic
processes [208]. For instance, chronic high-dose ethanol exposure causes
the abnormal deposition of connective tissue along sinusoids, eventually
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leading to septa linking the PTs to CVs.ese brous septa constrain the
growing nodules and, as such, micronodules barely contain PTs or terminal
HV [226]. In contrast, macronodules usually comprise portal structures
and CVs that are not bound by septa. Diameters of nodules may vary
notably, ranging from 3 mm to several centimetres [101]. Macronodular
cirrhosis develops aer massive collapse of parenchyma (frequently observed
in chronic hepatitis B), thereby promoting hepatocellular regeneration of
the surrounding residual tissue [203, 226]. Regenerative nodules are initially
benign, however, it is not uncommon that some of them progress along a
carcinogenic pathway to become malignant or hepatocellular carcinomas
[101]. For liver diseases aecting the biliary system, nodular conversion is
usually not induced until the liver is extremely brotic. Cholestatic diseases
are more oen characterized by the rapid proliferation of ductules to provide
an alternative route for the obstructed bile [208].
Figure 2.8: A Micronodular cirrhosis due to chronic hepatitis C. Nodules of
regenerating hepatic parenchyma, separated and encapsulated by brous bands,
are rarely larger than 3 mm in dimension. e two green nodules are foci of
hepatocellular carcinoma. BMacronodular cirrhosis in chronic hepatitis B following
massive parenchymal necrosis. Nodules vary greatly in size, though most are bigger
than 3 mm in dimension. Adapted from [42].
2.4 Vascular pathobiology
For cirrhosis, it has long been considered that the main determinants,
increasing the resistance to hepatic blood ow, were solely mechanical of
nature. However, evidence has suggested that the distortion of the hepatic
architecture by brosis deposition and regenerative nodules merely accounts
for 70% of the total IHVR.e remaining 30% is attributed to an active
and potentially reversible component or intrahepatic vascular tone [23, 162].
Dynamic vascular changes that have been studied more recently include
sinusoidal remodelling and angiogenesis. Both phenomena contribute
actively to modulation of the vascular resistance and pressure within the
liver blood vessels.
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2.4.1 Sinusoidal remodelling
During chronic liver disease (CLD), the phenotype of sinusoidal endothelial
cells (SECs) is changed in response to soluble factors and mechanical
forces due to shear stress [123, 147].ese signals unbalance the synthesis
of vasoactive molecules in sinusoids, resulting in decreased release of
vasodilators (such as nitric oxide (NO)) and increased production of
vasoconstrictors (such as endothelin) [283]. Upon injury, SECs also stimulate
HSCs to migrate and attach to sinusoidal vessels [133, 283].
Reduced levels of NO also play a major role in the perpetuation of bro-
genesis, as NO usually maintains HSCs in a quiescent state. NO molecules
may even induce apoptosis or phenotopic reversal of activated HSCs. When
SECs switch phenotype and NO levels are reduced, the transformation of
HSCs into myobroblasts is signicantly facilitated [30]. As described earlier
in section 2.3.1.1, these myobroblasts secrete brillar ECM in the space of
Disse, thereby forming a basement membrane near the endothelium.is
newly-deposited basement membrane is accompanied by loss of SEC fen-
estrae and hepatocyte microvilli [123]. e fenestrated sinusoids are thus
remodelled into continuous and rigid capillaries, which is known as sinus-
oidal capillarization. Moreover, the myobroblasts enwrap and progressively
constrict the sinusoids due to increased contractile properties (see Figure 2.9).
e net eect of vasoconstriction, increased myobroblast coverage,
and sinusoidal capillarization contributes actively to the increased vascular
resistance to sinusoidal blood ow [147]. Moreover, sinusoidal capillarization
limits the permeability of sinusoids and perisinusoidal spaces, depriving
hepatocytes of nutrients and their ability to perform vital metabolic functions.
Sinusoidal capillarization is therefore considered to contribute to liver failure
regardless of the metabolic capacity of hepatocytes [117, 292, 298].
2.4.2 Angiogenesis
Angiogenesis is a dynamic and growth factor-dependent process, occurring
in physiologic and pathological conditions of the liver. It is essential for liver
regeneration and leads to the formation of new vessels from pre-existing
blood vessels [133]. Formation of new blood vessels can take place in two
distinct ways: i) through sprouting from or ii) splitting of the existing
vasculature (Figure 2.10). In sprouting angiogenesis, endothelial ‘tip cells’ are
assumed to instigate the sprouting mechanism.e vessel sprouts are further
elongated by endothelial ‘stalk cells’, proliferating behind the tip cells of the
growing branches [123]. New blood vessels are formed when the solid sprouts
bind to each other, to detached pericytes, and to the basement membrane.
Intussusceptive angiogenesis, on the other hand, is characterized by the
splitting of pre-existing vessels. Two opposing vessels walls approximate and
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Figure 2.9: Sinusoidal remodelling due to cirrhogenesis. Ae normal microana-
tomy of the liver. B Upon injury, quiescent stellate cells and portal broblasts are
triggered to proliferate and transform into myobroblasts. ese myobroblasts
enwrap and constrict sinusoids, whilst secreting high-density ECM.e latter con-
tributes to the development of abnormal arteriovenous and portohepatic shunts.
e fenestrated sinusoids are transformed into continuous and rigid capillaries.is
capillarization is characterized by formation of a basement membrane near the
endothelium and loss of endothelial fenestrae and hepatocyte microvilli. As the
sinusoidal permeability is reduced, hepatocytes are deprived of nutrients and their
ability to perform vital metabolic functions is aected.is may induce the localized
regeneration of hepatocytes leading to ‘twinning’ of hepatocyte plates. Adapted from
[42].
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Figure 2.10: Formation of new vessels via sprouting and intussusceptive angiogen-
esis. In sprouting angiogenesis, ‘tip cells’ instigate the sprouting mechanism.e
sprouts are further elongated by endothelial ‘stalk cells’, proliferating behind the tip
cells of the growing branches. New blood vessels are formed when the solid sprouts
bind to each other, to detached pericytes, and to the basement membrane. Intus-
susceptive angiogenesis is characterized by the splitting of pre-existing vessels. Two
opposing vessel walls approximate and form an intraluminal pillar. As the pillars
continue to grow, the capillary is divided into two new blood vessels. Sinusoidal
endothelial cell (SEC). Adapted from [123].
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form an intraluminal pillar. As the pillars continue to grow, the capillary is
divided into two new blood vessels [123].
Since angiogenesis plays a major role in the wound healing response, it is
stated that angiogenesis is intrinsically associatedwith the brosis progression
in CLD. Angiogenesis in pathological conditions is determined by two main
pathways, i.e. tissue hypoxia and inammation [167]. Hypoxia, being the
major stimulus, is an insucient oxygenation state for a particular tissue [133].
As such, pathological angiogenesis is observed to predominate in bridging
septa or postnecrotic brosis, where the sustained hypoxic environment
elicits the abnormal rapid proliferation of blood vessels to facilitate oxygen
delivery and adaptation to decreased oxygen levels [30, 102, 133]. During
brogenesis, hypoxia is also aggravated by angioarchitectural changes such
as sinusoidal capillarization and the generation of intrahepatic shunts, which
deprive hepatocyte of oxygenated blood. Fibrosis by itself is thus able to
promote angiogenesis [133].
e angiogenic mechanisms are orchestrated by a broad range of
hepatic cells (including SECs, HSCs, and hepatocytes) which respond to
inammation and reduced oxygen levels. ey upregulate the release of
proangiogenic mediators such as the vascular endothelial growth factor
(VEGF), thereby activating a cascade of events leading to an organized
branching of new vessels.ese newly-formed vessels, however, contribute
themselves to inammatory responses (and brogenesis), as they induce
recruitment of inammatory cells [133]. erefore, it is suggested that
angiogenesis plays an important role in sustaining and driving brogenesis
(see section 2.3.1) [30]. Angiogenesis and brosis progression may thus be
closely linked. In this regard, PMF (see section 2.3.1.2) are believed to be
critical cells in modulating the interplay between inammation, angiogenesis,
and brogenesis [167].
2.5 Complications
Clinically, cirrhosis can be staged as compensated or decompensated cirrhosis.
e compensated state represents the non-symptomatic phase, which may
deteriorate towards decompensation, i.e. the progressive stage with clinically
relevant complications (Figure 2.11).
2.5.1 Portal hypertension
Portal hypertension (PHT) is the earliest andmost prominent complication of
cirrhosis. It is characterized by an elevated portal pressure due to obstruction
of portal ow. e pathogenesis of PHT originates with distortion of the
hepatic architecture, increasing the IHVR to portal ow (see section 2.3). A
second contributing factor to PHT is the increased portal blood inow due to
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Figure 2.11:Many of the life-threatening complications, which are associated with
cirrhosis, commence in the setting of worsening PHT and vasodilation of the
splanchnic and peripheral vascular beds. Adapted from [67].
splanchnic arteriolar vasodilatation [37, 50].e vasodilatation results from
overproduction of vasodilators (NO is the most renowned) in the splanchnic
circulation.is contrasts the situation intrahepatically where the excess in
vasoconstrictors increases the vascular tone (see section 2.4.1) [315]. With the
splanchnic vascular resistance decreasing, an increase in splanchnic ow and
thus also portal ow is expected.e increased portal inow maintains and
worsens the PHT despite the presence of collaterals [162]. In advanced stages,
PHT is further aggravated by development of a hyperdynamic circulatory
state (see section 2.5.3).
Many of the complications related to cirrhosis commence in the setting
of worsening PHT. For clinically relevant complications of PHT to occur, it
is believed that the pressure gradient over the venous system should exceed
a critical threshold. In clinical trials, invasive techniques have been used
to measure the hepatic venous pressure gradient (HVPG), representing the
gradient between the portal pressure and the intraabdominal vena caval
pressure [94]. HVPG values ranging from 1 to 5 mmHg are considered
normal [4]. HVPG values exceeding 12 mmHg are mostly associated
with development of lethal complications, such as variceal bleeding (most
common in distal esophagus and proximal stomach), ascites (accumulation of
uid in the peritoneal cavity), spontaneous bacterial peritonitis (infection of
ascitic uid), and hyponatremia (low sodium level in the blood) (Figure 2.11)
[4]. e combined impact of these complications makes PHT the most
important cause of morbidity and mortality in patients with cirrhosis [84,
162, 302].
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2.5.2 Collateral formation
PHT may induce the formation of an extensive network of collaterals
(Figure 2.11). Collaterals are alternative blood ow channels that bypass
the liver, guiding a fraction of the portal blood ow directly into the systemic
venous system. In rare cases, patients suering from PHT may experience
the recanalization of the umbilical vein, which may act as a decompressive
portosystemic shunt (Figure 2.12). By reducing the blood ow to the portal
vein (PV), collaterals attempt to reduce the portal pressure, yet at the cost
of shunting large amounts of portal blood ow directly into the systemic
circulation without contact with hepatocytes, incapacitating as such synthetic
and detoxication liver functions [37, 301].
Figure 2.12: Dierent views of a 3D reconstructed cirrhotic macrocirculation
showing a recanalized umbilical vein (arrow). T= top, B= bottom, L= le, R=
right, A= anterior, and P= posterior.
2.5.3 Hyperdynamic circulatory state
e hyperdynamic circulation is typically observed in more advanced stages
of PHT. Its main characteristics are increased heart rate, cardiac output,
plasma volume, and decreased systemic vascular resistance and arterial blood
pressure [28]. ese haemodynamic changes result from vasodilation of
the splanchnic and later on peripheral vascular beds, reducing the overall
systemic vascular resistance leading to a relative underlling of the systemic
circulation. e abnormal blood volume and perfusion trigger several
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counter-regulatory systems, which produce vasoconstrictors and enhance
sodium and water retention to restore vascular homeostasis. However,
chronic activation of these regulatory systems is assumed to contribute to the
active component of the IHVR, as vasoconstrictors are released in the general
circulation.e paradox between vasoconstriction inside and vasodilation
outside the liver appears to be responsible for maintaining and worsening
the systemic dysfunction in spite of counter-regulatory systems. Eventually,
the hyperdynamic circulation may lead to development of a multi-organ
disturbance due to cirrhosis [28, 33, 162].
2.5.4 Other complications
Cardiopulmonary complications are commonly associated with cirrhosis
(and the hyperdynamic circulation). e hepatopulmonary syndrome
is estimated to develop in about a third of the patients suering from
decompensated cirrhosis. Symptoms include shortness of breath and
hypoxaemia (low concentration of oxygen in the blood). is syndrome
is caused by reduced arterial oxygen saturation due to pulmonary vascular
dilatation [67, 238].
Cirrhosis also deteriorates the renal function.e intrarenal circulation
may change and is oen characterized by blood owing away from the
cortex (the outer portion of the kidney).ese haemodynamic abnormalities
predispose the hepatorenal syndrome, which in turn may prelude acute renal
failure [67].
Several complications manifest due to collaterals allowing toxic sub-
stances to bypass the liver. In hepatic encephalopathy, unmetabolized sub-
stances reach and aect the brain. Symptoms include confusion, altered level
of consciousness, and potentially coma due to liver failure [67]. Portopul-
monary hypertension, dened as the coexistence of portal and pulmonary
hypertension, is caused by toxic or vasoconstrictor substances, bypassing the
liver via collaterals and subsequently entering and damaging the pulmonary
circulation. As a consequence, pulmonary arteries become brotic and hy-
pertrophic, which increases their stiness and resistance to ow leading to
pulmonary hypertension [67, 153].
2.6 Diagnosis and treatment
ere is no therapy to treat cirrhosis directly, except for aetiological treat-
ments and interventions to manage, stabilize, or recompensate complications
of the disease. In early stages, aetiological treatment (e.g. antiviral drugs,
healthy diet, abstinence from alcohol) may help to delay disease progression
and reduce complications to occur [67]. In some cases, a transjugular intra-
hepatic portosystemic shunt (TIPS) is surgically inserted to connect the PV
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to the systemic venous circulation.e immediate eect of this procedure
is lowering the portal pressure, yet at the cost of bypassing the remaining
functional hepatocytes thus bypassing the remnant liver functionality [197].
For advanced stages of cirrhosis, liver transplantation remains the only
available option when liver insuciency and/or complications occur [36,
219, 222]. e cost-eectiveness of this procedure remains questionable,
particularly in terms of the allocation of available livers [202]. Scoring systems
(e.g. MELD and Child-Pugh) are being used to assign the priority for liver
transplantation. ese systems predict the prognosis of cirrhotic patients
based on objective parameters, such as bilirubin levels [38]. Not surprisingly,
cirrhosis has become a global health issue associated with a substantial
economic burden, estimated to $3–5 billion per year in the USA alone [130].
Moreover, 31 million disability adjusted life years (DALYs), equivalent to 1.2%
of the global DALY burden, are attributed to this chronic condition [192,
288].
Early and accurate detection has thus become imperative for eective
treatment or reversal of the progressive liver disease. Traditionally, liver
biopsy was considered the golden standard to diagnose cirrhosis and
determine therapeutic treatment.e use in practice, however, has declined
due to its invasiveness and susceptibility to sampling errors (small sample
size) [32, 34, 42].
e recent progress in surrogate markers (e.g. FibroTest and ELF score)
and imaging technologies (computed tomography (CT), magnetic resonance
imaging (MRI), and ultrasonography (US)) has enabled clinicians to diagnose
and determine the prognosis of chronic liver diseases noninvasively [80, 228,
289].e diagnostic accuracy of the former relies on a number of serological
brosis markers, whereas the latter depends on its ability to detect and
visualize the nodular surface, parenchymal abnormalities, or morphological
changes of the liver. In this regard, MRI and CT are still considered superior
to US, though US is more likely to become a standard system in clinical
practice in spite of the lower accuracy.is is mainly attributed to its ease
of use and low costs. Nevertheless, further developments are required to
standardize and rene these non-invasive techniques [32, 34, 156, 228].
Elastography techniques involving US (e.g. FibroScan) and MRI also
show potential, especially to stage hepatic brosis noninvasively [74, 262].
Elastography is based on shear wave propagation and may provide real-
time information on the mechanical properties of liver tissue including
its stiness (Figure 2.13A-C) [46, 239, 242]. e liver generally stiens
with progression to cirrhosis owing to the abnormal deposition of high-
density ECM. Assessment of the stiness (brosis) over time may allow the
progression rate of the disease to be determined [34]. Several brosis staging
systems have been described, including the METAVIR scoring system [15].
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According to METAVIR (see Figure 2.13D-E), hepatic brosis can be divided
into ve stages: F0, no brosis; F1, mild brosis (portal brosis without
septa); F2, moderate brosis (portal brosis with rare septa); F3, bridging
brosis (numerous septa connecting portal and/or central areas); and F4,
cirrhosis (thick septa with well-formed regenerative nodules) [20]. Since
elastography does not involve radiation or contrast agents, it may be applied
not only to diagnose and monitor disease progression, but also to determine
the response to therapy [44].
Figure 2.13: Ae vibration source is placed on the surface of the body to generate
mechanical waves. Be mechanical waves propagate and cause micron-level cyclic
displacements, as shown in the wave image.e wavelength of the shear waves is
longer in stier tissues and shorter in soer tissues. C An inversion algorithm is
applied to produce the elastogram depicting the tissue stiness. D Elastograms of
four patients with hepatic brosis ranging from METAVIR stage 1 to 4.e liver
stiness increases progressively with severity of brosis. Adapted from [296].
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Techniques to model
cirrhosis
is chapter presents the state-of-the-art on cirrhosis modelling from an exper-
imental and numerical point of view. We will discuss animal models, in vivo
functional methods, and computational models, which enabled cirrhogenesis
to be revisited and novel insights in its pathophysiology to be gained. In the
following chapter, we will build upon and extend two of the presented tech-
niques (i.e. vascular corrosion casting and immunohistochemistry) to acquire
morphological data of the rat hepatic vasculature across multiple length scales.
3.1 Experimental techniques
In this section, the use of animal models as tool to study experimental
cirrhosis is addressed, followed by an overview of in vivo methods to
assess hepatic haemodynamic and/or functional parameters of (cirrhotic)
livers. Experimental data provides fundamental information to unravel the
pathological mechanisms of cirrhosis, but also supports the development of
quantitative computational models (section 3.2).
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3.1.1 Animal models
e genesis of cirrhosis in humans is very insidious and it can take up tomany
years to fully develop cirrhosis. During the progression, cirrhosis generally
remains unnoticed until reaching decompensation, in which complications,
such as ascites, variceal haemorrhage, jaundice, or encephalopathy, become
clinically present [258]. Hence, knowledge about the progression of the liver
towards cirrhosis in humans remains scanty.
In this context, animal models, mimicking the human (patho)physiology
as closely as possible, are valuable tools in ascertaining the pathological
process of varying liver diseases in an appropriate way. ey may lead to
the development of new human medicine and diagnostic or therapeutic
procedures. However, due to interspecies anatomical and physiological
dierences, caution is warranted when extrapolating results obtained in
animal models directly to the human setting. Since pigs and rodents have
proven indispensable to study a plethora of liver pathologies [161, 278,
309], we will rst compare their hepatic anatomy to the human liver and
subsequently discuss a number of established animal models of cirrhosis.
3.1.1.1 Interspecies hepatic anatomical similarities
Traditionally, the human liver is divided based on its external macroscopical
appearance into four anatomical lobes (see section 1.1.1). More functional
schematizations have been proposed, subdividing the liver based on its
internal (vascular) topography [25, 51, 97, 263, 279]. To date, the model
described by Couinaud in 1957 [52] remains the standard by which the
functional anatomy is understood. It divides the liver into eight segments,
each with its own arterial and portal blood supply and venous blood drainage
as well as biliary drainage (see Figure 3.1A) [51, 178].
More importantly, Couinaud’s division allows functional analogies to
be drawn between the hepatic anatomy of humans and other mammalian
species (e.g. pigs and rodents), even when their morphological appearances
do not resemble. For example, human livers count four anatomical lobes,
while pig livers merely have three main lobes. eir segmental anatomy
is however remarkably similar [53, 323]. Rodent livers, which are also
multilobed, comprise four major lobes (i.e. median lobe, le lobe, right
lobe, and caudate lobe) of which three can be further subdivided in two
sublobes (see Figure 3.1B) [57, 243]. Kogure et al. [143] demonstrated that
the hepatic lobes of the rat are equivalent to the segments of the human liver.
at is, the caudate lobe (superior caudate lobe (SCL) and inferior caudate
lobe (ICL)) is equivalent to segment I, the le lobe (le lateral lobe (LLL)) to
segment II, the median lobe (right medial lobe (RML) and le medial lobe
(LML)) to segments III, IV, V, and VIII, and the right lobe (right superior
lobe (RSL) and right inferior lobe (RIL)) to segments VI and VII.
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Figure 3.1: Illustration of the functional analogy between the segmental subdivision
of the human liver and the lobes of the rat liver. A Couinaud’s subdivision of the
human liver into eight segments. Each segment has its own blood supply. Adapted
from [269]. B Rat livers comprise four major lobes (i.e. median lobe, le lobe, right
lobe, and caudate lobe) of which three can be further subdivided in two sublobes.
It was demonstrated that the rat hepatic lobes are equivalent to the segments of
the human liver [143].at is, the caudate lobe (superior caudate lobe (SCL) and
inferior caudate lobe (ICL)) is equivalent to segment I, the le lobe (le lateral lobe
(LLL)) to segment II, the median lobe (right medial lobe (RML) and le medial lobe
(LML)) to segments III, IV, V, and VIII, and the right lobe (right superior lobe (RSL)
and right inferior lobe (RIL)) to segments VI and VII. Adapted from [6].
Interestingly, rats are assumed to relate more to humans than mice do,
especially in terms of various pathological aspects as they tend to develop
more liver brosis upon toxin-induced liver injury [225, 325]. Moreover,
Teutsch [281, 282] reported that the primary modules (see section 1.2.2) of
human and rat livers share similar structural elements to direct the blood
ow. For example, both primary modules comprise vascular septa, which
connect portal triads (PTs) and act as continuous vascular surfaces between
adjacent primary modules. ese PTs are located at the periphery of the
primary module, whereas the central veins (CVs) are situated in the centre,
draining the sinusoids.
3.1.1.2 Interspecies hepatic anatomical dierences
Despite the remarkable similarity between the fundamental structures of
pig, rat, and human livers, it remains imperative to account for the hepatic
anatomical (and physiological) dierences when transferring results from
animals to the human setting. Since rat livers will be used in this dissertation,
we will briey present the outspoken variations between the hepatic anatomy
of humans and rats.
Macroscopically, the absence of a gall bladder is a prominent feature of
the rat liver, apart from the more apparent dierences in size, weight, and
division in lobes (Figure 3.1B).e vena cava inferior (VCI) of rats is also
located intrahepatically as opposed to the human retroperitoneal location.
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Moreover, the portal vein (PV) of rats is known to trifurcate, whereas the PV
of humans merely bifurcates [182].
Microscopically, a number of morphological dierences have been
documented [281, 282]. Most notably, the shape of human primarymodules is
more complex and the arrangement of primarymodules within the secondary
module diers for human and rat livers.e branching pattern of the human
CV tree is also oriented along a horizontal main axis, while for the rat liver
the ramications are directed preferentially along a vertical axis. In addition,
Kline et al. [140] noted functional evidence for the existence of shunts
between the hepatic artery (HA) and PV in rats. ese arteriolo-portal
venular shunts have not been observed in (healthy) humans.
3.1.1.3 Models of experimental cirrhosis
Until now, a variety of animal models has been proposed to induce exper-
imental cirrhosis, although a model reecting all characteristics/stages of
human cirrhosis is yet to be developed [14, 161, 173, 223, 324]. Each animal
model has its advantages and disadvantages. Large animal models (e.g. pigs)
are favourable to test imaging tools or surgical interventions, such as liver
transplantation.ey are, however, costly (purchase of animals, housing and
facilities, etc.) and may require a long period of time to develop cirrhosis [14,
324]. On the other hand, rodentmodels have a substantial nancial advantage
compared to pigs and the faster development of disease leads to a more rapid
acquisition of results. Currently, three rodent models are extensively used
to induce cirrhosis: the carbon tetrachloride (CCl4) model, the chronic bile
duct ligation (CBDL) model, and the thioacetamide (TAA) model [88, 161,
292, 293].
• CCl4 is the most widely used hepatotoxin and is considered the ‘gold
standard’ to produce experimental cirrhosis. CCl4 impairs hepatocytes
by altering the permeability of plasma, lysosomal, and mitochondrial
membranes [173]. Aer 12–16 weeks of intoxication, rat livers mimic
nonbiliary cirrhosis, albeit with a low resemblance to human cirrhosis
as macronodular regeneration is lacking in the CCl4 model [161,
173, 292]. Consequently, the signicant disruption of the hepatic
architecture, as observed in human cirrhosis, remains relatively limited.
Additional drawbacks include low reproducibility due to highmortality
rates (about 30% of the animals die during induction) and poor
homogeneity [76].
• e CBDL model is a potential alternative for small-size laboratory an-
imals [149]. Experimental cirrhosis is obtained by surgical obstruction
of the common bile duct using ligatures. It leads to proliferation of bile
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ductules and brosis, thereby mimicking secondary biliary cirrhosis
aer 3–5 weeks [173]. A major drawback of the model is the high mor-
tality rate, as more than 40% of the animals die due to bile leakage or
sepsis [161].erefore, CBDL is mainly used to study the reversibility
of brosis in the earlier stages of liver disease [173].
• e TAA model of cirrhosis elicits less inconvenient complications.
Over the course of 18 weeks, the hepatotoxin TAA is administered
orally via the drinking water, while its dose is weekly adapted to the
body weight of the rat. TAA predominantly damages zone 1 and zone 3
hepatocytes (see section 1.2.2), leading to homogenous macronodular
cirrhosis with signs of high-grade hepatocellular dysplasia. Moreover,
the TAAmodel is supposed to resemble human cirrhosismore than the
CCl4 and CBDLmodels do [161]. A drawback is the long time required
to develop full-blown cirrhosis, increasing the risk of progression
to hepatocellular carcinoma [173]. We chose the TAA rat model to
revisit cirrhogenesis in this dissertation, because of its reliability and
homogeneous reproducibility. (Figure 3.2).
Figure 3.2: Progression of the rat liver towards cirrhosis aer thioacetamide (TAA)
intoxication.e macroscopic expression of the liver transforms from normal over
an irregular ‘salt & pepper’-like appearance at 6 weeks to an emerging nodular liver
at 12 weeks and ultimately macronodular liver at 18 weeks.
3.1.2 In vivo functional methods
Several experimental techniques have been adopted to measure the he-
patic haemodynamics or functional/mechanical parameters of the liver in
vivo. Functional data not only broadened our understanding of the patho-
physiology of varying liver diseases, but also provided fundamental informa-
tion to develop quantitative computational models (section 3.2.3). Below, an
overview is provided of invasive and non-invasive experimental techniques
to assess liver function in the case of cirrhosis.
For small laboratory animals, the microspheres technique is still re-
garded as the ‘gold standard’ to rapidly evaluate the nutritive perfusion of
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the liver [300]. It entails injecting a known number of radioactive (or col-
oured/uorescent) microspheres (3 µm to 200 µm in size) into the circulation
of the animal. e microspheres are captured by the body’s vascular beds
in proportion to the fraction of cardiac output (CO) that is being delivered
to each vascular bed individually. Hereaer, the radioactivity of the organ
is assessed by a gamma scintillation counter and compared to a reference
sample in order to calculate the blood ow through the organ [300]. Doing
so, the systemic, splanchnic, and hepatic haemodynamics have been quanti-
ed in cirrhotic rats [75, 93, 290, 301]. Results clearly showed that, in spite
of an increased splanchnic ow (4.3%), the portal inow was decreased in
some animals with CCl4-induced cirrhosis (13.7%), most likely due to portal-
systemic shunting [93]. Radioactive and gamma-labelled microspheres were
injected to measure the extent of portal-systemic shunting, indicating shunt-
ing values up to 80% of the portal blood ow in cirrhosis [49, 301]. Currently,
radioactive-labelled microspheres are also emerging as a treatment modality
to target and eradicate liver tumours eciently [2, 96].
e multiple-indicator dilution technique is another invasive method to
assess liver properties of the (cirrhotic) rat [294] or human [117, 298]. It does
not only allow for estimation of the extra- and intravascular volumes, but also
for the study of the kinetic behaviour of substrates, drugs, and metabolites in
cirrhosis [300]. In brief, multiple diusible tracers (e.g. labelled red blood
cell (RBC), albumin, and sucrose) are injected into the PV or HA, while
concomitantly measuring their hepatic outow concentrations as a function
of time (Figure 3.3). In physiological conditions, extravascular indicators,
such as albumin and sucrose, are able to diuse through sinusoidal fenestrae
into the extravascular space of Disse.e opposite stands for RBCs, which
remain in the lumen of sinusoids due to their large size.e RBCs typically
serve as the vascular reference substance.e extravascular indicators will
establish a ow-limited outow pattern as opposed to the barrier-limited
pattern of RBCs [300]. More importantly, the transport behaviour of tracers
across the sinusoidal vessel walls can be deduced from the peak heights and
downslope decay rates of the hepatic outow curves (see Figure 3.3). In
cirrhosis, for example, a high peak of one of the extravascular indicators
(relative to the peak of the vascular reference tracer) suggests that diusion
of that specic tracer may have been limited, most likely due to sinusoidal
collagenization. Bimodal outow curves (early + late peak), on the other
hand, indicate that a fraction of the tracer bypassed the liver via intrahepatic
shunts and, as such, appeared earlier in the hepatic outow curve [117, 298].
Dilution outow curves of multiple extravascular tracers are frequently used
to model the pharmacokinetic behaviour of livers [250, 310, 311].
Additional to invasive measurement methods, many non-invasive tech-
niques have been exploited over the years to provide quantitative in vivo
Techniques to model cirrhosis 43
Figure 3.3: A typical set of dilution curves for RBC, albumin, sucrose, and water in
a normal human liver (organ donor) and two cirrhotic human livers. In the organ
donor (le), RBC is detected rst in the outow curves, as indicated by the earliest
and highest peak.e extravascular indicators albumin and sucrose appear later in
the outow curve, showing a less steep downslope decay. In cirrhosis (middle and
right), the peak and decay of the RBC and albumin (also sucrose in cirrhosis no.2) is
nearly identical, indicating that the extravascular volume accessible to albumin (and
sucrose) was decreased, most likely due to sinusoidal collagenization. Source: [298].
information about liver function in the case of liver pathologies. An extensive
summary of available techniques to characterize the hepatic microcircula-
tion is documented by Vollmar et al. [300], including intravital uorescence
microscopy.e latter uses uorescent markers for in vivo staining of the
microcirculation, as such allowing its morphology, microhaemodynamics
(e.g. sinusoidal perfusion), and cellular/molecular aspects to be studied us-
ing a uorescent microscope. A few studies have applied this technique in
cirrhotic rodents to quantify the microvascular and cellular derangements
[293, 299] or to shed more light on the relationship between brosis and
angiogenesis [87, 292].
More recently, advanced methods of magnetic resonance imaging (MRI)
(e.g. diusion-weighted MRI, phase-contrast MRI, and 4D-MRI) and
ultrasonography (US) (e.g. Doppler US, contrast-enhanced US) have been
applied tomeasure haemodynamic changes (e.g. perfusion) of the PV andHA
in cirrhotic human [7, 213, 270–272] and rat livers [155, 244] (see Figure 3.4).
In addition, elastography techniques involving US andMRI have been widely
adopted to analyse the mechanical properties of liver tissue (such as its
stiness) and stage hepatic brosis in patients (see also section 2.6) [46, 239,
242, 284, 296]. However, further developments are required to standardize
and rene these non-invasive techniques for clinical settings [284, 296].
44 Chapter 3
Figure 3.4: Blood ow through the portal vein (PV) of a patient with cirrhosis,
depicted using time-resolved 3D particle traces (advancing from A to C).e grey
isosurface was calculated based on ow-sensitive 4D magnetic resonance imaging
(MRI) data.e detailed zoom of time stepC (right bottom panel) shows retrograde
ow in the superior mesenteric vein (SMV) and a vortex in the splenic-mesenteric
conuence. Source: [271].
3.2 Numerical modelling techniques
Computational models may provide an intriguing new approach towards
better understanding of liver pathologies. Since these models are dened in
a virtual setting, model parameters are readily adapted and perturbations
by unknown inuences can be avoided, which is nearly impossible in an
experimental environment. ough novel mechanisms are generally not
identied via in silico models, they do have potential to validate or invalidate
hypotheses at varying spatial and temporal scales [68]. Below, an overview
of the computational models on cirrhosis is provided, classied as models on
the hepatic vascular architecture, liver perfusion, and liver function.
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3.2.1 Hepatic vascular architecture
As many liver diseases lead to remodelling of the hepatic vasculature [68],
research has focused on quantifying and comparing the disease-induced
changes of the branching pattern and/or geometrical features for varying
species. While the hepatic angioarchitecture of patients can be imaged in
3D using computed tomography (CT) or MRI (angiography), an invasive
experimental approach was typically applied for lab animals (i.e. mice and
rats) to reconstruct the hepatic vascular network and generate input for the
computational models. Two experimental methods, i.e. vascular corrosion
casting (VCC) and immunohistochemistry (IHC), were established, using
resins and antibodies, respectively, to capture the animal-specic vasculature.
e resin-based models enabled multiple length scales of the hepatic vascular
trees to be covered [59], whereas antibody-based models primarily focused
on lobule-scale vascular networks [100, 111].
3.2.1.1 Resin-based models
Resin-based models applied the VCC technique to produce physical 3D rep-
licas of the vascular system. In short, VCC entails injecting a polymeric resin
into one or more cannulated blood vessels of the liver. Aer polymerization
and curing of the resin, the specimen is macerated in ±20–25% potassium
hydroxide (KOH) and successively rinsed in water to remove the liver tis-
sue. As such, an intact duplicate is produced of one or more vascular trees
(Figure 3.5).
Figure 3.5: A Cirrhotic human liver with cannulated hepatic artery (HA), portal
vein (PV), and vena cava inferior (VCI). Be corresponding vascular corrosion
cast.e HA tree was injected with red-pigmented resin, whereas blue-pigmented
resin was used for the PV tree. Resin outow was assured via the hepatic veins,
draining in the VCI. A small sample was dissected from the cast (white circle) to
analyse the microcirculation.
Commercially available resin kits include the Batson’s corrosion kit
(Polysciences, Florida, USA), Microl injection kits (Flow Tech. Inc., Carver,
MA, USA), and polyurethane-based casting kit (PU4ii; vasQtec, Zurich,
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Switzerland).ese resins have varying physical and imaging characteristics,
making certain resins more suitable for specic applications. In smaller
species, for example, the low viscosity, minimal shrinkage, and lack of
interaction with surrounding tissue of PU4ii is advantageous to ll even
the smallest capillaries [154, 188]. In this dissertation, we will use the PU4ii
resin kit to cast rat livers at dierent time points during TAA-induced
cirrhogenesis.
Conventionally, scanning electron microscopy (SEM) was adopted as the
main imaging tool to analyse the morphology of microvascular casts, thereby
producing astonishing 3D impressions (Figure 3.6)[154]. Doing so, Wack et
al. [304] investigated the sinusoidal ultrastructure of rat livers, regenerating
aer partial hepatectomy (PHX).e porosity and fenestral pore diameter
of sinusoidal endothelial cells (SECs) were clearly reduced in 72hr post-PHX
vascular casts, with some areas of the lobule even devoid of vascularization at
that time.ese voids had sinusoidal blind ends pointed inwards, suggesting
SEC growth and neovascularization during wound healing and angiogenesis.
Yamamoto et al. [320] used SEM-imaged microvascular casts to assess
the blood supply of regenerative nodules, which mainly comprised hepatic
arterial blood. More studies [85, 86, 107] have been conducted on the hepatic
microcirculation in the case of cirrhosis. However, the two-dimensionality
inherent to SEM images has precluded accuratemorphometricmeasurements
without destroying the casts [154].
e recent progress in high-resolution micro-computed tomography
(µCT) enabled researchers to overcome this 2D limitation and produce
geometric 3D models of the hepatic vascular trees. µCT scanners apply
the same X-ray imaging technique as conventional CT scanners, only on a
smaller scale resulting in higher resolutions.e latter is achieved by rotating
the sample instead of the scanner components (e.g. X-ray tube and at panel
detector), as is the case for medical CT scanners. A few studies applied
this µCT-imaging modality in combination with vascular casts of human
[58–60, 215] and rat livers [57, 140, 141, 184, 211, 291, 306]. For example,
Debbaut et al. [59] analysed the entire length scale of the hepatic vascular
trees of human livers, revealing the morphometric structure up to the level of
the microcirculation (Figure 3.7A). Op Den Buijs et al. [211] determined
the geometrical features of the PV tree in healthy rats, while Wan et al.
[306] studied their HA tree. Van Steenkiste et al. [291], on the other hand,
used portal hypertensive and cirrhotic rats to quantify the disease-induced
microvascular changes. Interestingly, Kline et al. [140] found anatomical
evidence of hepatic shunts between the HA and PV in rats (Figure 3.7B).
It was hypothesized that these arteriolo-portal venular shunts (occurring
between branches of approximately 50 µm diameter) function as a one-way
valve-like mechanism, i.e. allowing ow only from the HA to the PV and not
vice versa.
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Figure 3.6: Analysis of the human hepatic microvasculature under normal (top
panels) and cirrhotic circumstances (bottom panels). SEM images clearly show
A an organised sinusoidal network and B a smooth hepatic arteriole (HA) and
portal venule (PV) of the healthy liver [63]. C In cirrhosis, enlarged and irregularly
shaped intrahepatic vessels are detected (dashed circle), most likely representing
shunt vessels causing blood ow to bypass hepatocytes. D Cirrhosis also aects
and narrows larger blood vessels (arrow), leading to abnormal and bumpy-like
microscopic appearances.
As the hierarchical structure of vascular trees does not closely follow
a xed pattern and may remodel e.g. in response to pathological factors
[211, 306], dierent ordering systems were introduced to characterize the
branching topology. is led to the concept of blood vessel generations,
i.e. vessels belonging to the same generation are treated as parallel vessels.
One of the proposed classication systems is the top-down ordering method
(Figure 3.8A). It commences by assigning generation 1 to the trunk of the
vascular tree and consecutively allocates generation 2 to its daughter branches.
e method continues to travel downstream until reaching the terminal
vessel branches and assigns generation n+1 to daughter branches, with n
denoting the generation number of their respective parent vessel.e top-
down ordering system was previously applied to study the hepatic vascular
trees in a variety of species, including humans, dogs, and rats [57, 59, 141,
211].
An alternative ordering approach was proposed by Strahler [273].
e method starts by allocating order 1 to the terminal vessel branches
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Figure 3.7: A Reconstruction of the human hepatic vascular trees (hepatic artery
(HA), portal vein (PV), and hepatic veins (HV)) at themacro-, meso-, andmicrolevel.
Adapted from [59]. B Illustration of the hepatic arteriolo-portal venular shunts,
occurring between branches of approximately 50 µm diameter in rats. It was
hypothesized that these shunts functioned as a one-way valve-like mechanism:
during HA injection while casting, the shunt is open and resin ows into the PV.
e same shunt is closed when resin is injected via the PV. Adapted from [140].
Figure 3.8: Illustration of the principle of blood vessel generations and A top-down
ordering method, B the Strahler ordering, and C the diameter-dened Strahler
ordering (red numbers indicate the dierences with the original Strahler ordering).
Based on [125].
Techniques to model cirrhosis 49
(Figure 3.8B). When two daughter branches join, their parent vessel is
assigned n+1 provided that both daughter branches belong to the same
order n. If this condition is not met, the parent vessel is allocated to the
highest order number of the daughter branches. is versatile ordering
approach has been used to study the branching topology of vascular trees in
kidneys [206], lungs [125], and livers [98, 251].
Jiang et al. [125] adapted the Strahler ordering to account for three
shortcomings: i) the wide overlap of diameters of vessels in consecutive
orders, ii) the fact that vessels of the same generation are treated as parallel,
even though some may be connected in series, and iii) the “small-twigs-on-
large-trunks” phenomenon (Figure 3.8C). For this purpose, an additional
rule was introduced to reallocate a lower or higher generation number if the
vessel diameter was smaller than D′1(n) (Eq. 3.1) or bigger than D′2(n) (Eq. 3.2),
respectively, with Dn and SDn denoting the mean and standard deviation of
the diameters of vessels of order n.
D′1(n) = [(Dn−1 + SDn−1) + (Dn − SDn)]/2 (3.1)
D′2(n) = [(Dn + SDn) + (Dn+1 − SDn+1)]/2 (3.2)
Besides branch ordering systems, research on the hepatic angioarchitec-
ture also resulted in a number of novel algorithms with diverse applications,
ranging from automated extraction and representation of the 3D branching
morphology [82, 98, 141, 211, 264, 306, 307, 322] to the algorithmic generation
of realistic hepatic vascular trees [128, 152, 251, 254, 319] (Figure 3.9A-C).
For example, Kline et al. [141] applied fractal theory to quantitatively
describe the branching properties of the HA, PV, and biliary trees in rat
livers. Doing so, the hepatic trees were interpreted as self-similar structures
for which the geometrical features of each generation (i.e. radii, lengths, and
branching angles) were determined by the preceding generation (Figure 3.9A).
e results indicated some remarkable dierences between the vascular
and biliary branching geometries. Most notably, the vascular trees strongly
adhered to Murray’s law (Eq. 3.3, with r1 denoting the radius of the branch
that splits into two branches of radii r2 and r3), whereas the biliary trees
largely deviated from this law.
r31 = r32 + r33 (3.3)
More realistic 3D representations of the hepatic vascular trees were
generated by applying the constrained constructive optimisation algorithm,
which builds vascular networks based on a set of given requirements.
Schwen et al. [251, 254] rened and calibrated this algorithm to model
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Figure 3.9: A Self-similar fractal tree [98]. B–C Algorithmically rened vascular
structures of the human and rat liver, respectively. Red structures denote the portal
vein and hepatic artery, whereas blue represents the hepatic veins [253, 254]. D 3D
surgical planning model for tumour resection [103]. E–F Interactive augmented
reality on the Da Vinci robot for real-time guidance in liver resection [268].
the hepatic angioarchitecture of humans and rodents based on CT scans
(with contrast agent) and vascular casts, respectively (Figure 3.9B-C).e
algorithmic generation of vascular trees may help to bridge the gap between
the limited imaging resolution and the resolution required for modelling, as
in vivo measured data is easily extrapolated in 3D to the microlevel.is is
particularly useful for multiscale models of liver function, as will be shown
in section 3.2.3. Digitally constructed 3D vascular trees have also been used
as phantoms to study the performance of contrast-enhanced CT [21, 151] or
dynamic contrast-enhanced MRI [187].
In the clinical context, 3D models of the patient-specic hepatic angioar-
chitecture may be helpful for preoperative planning and real-time guidance
in (minimally invasive) liver surgery (Figure 3.9D-F). Dierent imaging mod-
alities (e.g. US, CT, and MRI) exist to acquire structural data on the hepatic
architecture of patients prior to surgical interventions (e.g. TIPS placement,
partial hepatectomy) [116]. Currently, CT and MRI angiographic techniques
are being used to image the hepatic vascular trees in 3D [220].e former
requires the injection of contrast agent to dierentiate blood vessels from
the surrounding so tissue on X-ray images.is injection of contrast agent
is not needed for MRI angiography.e resulting imaging datasets are sub-
sequently processed to generate 3D reconstructions as input for the surgical
models [104, 255, 267, 268]. For cirrhosis, angiography can also be used to
detect blood circulation disorders (e.g. extrahepatic shunts) or malignant
liver tumours in the case of progression to liver cancer.
Techniques to model cirrhosis 51
3.2.1.2 Antibody-based models
Antibody-based models combined uorescent IHC and confocal microscopy
to reconstruct 3D geometries, conned to the lobule-scale hepatic archi-
tecture. e methodology has been established as a well-proven method
to produce anatomically-correct structures of the hepatic microvasculature
down to a resolution of 0.2 µm [100, 111, 198, 295]. More importantly, it allows
information about structures other than the vascular network, such as the
biliary network or hepatocellular structures, to be retrieved concomitantly
(Figure 3.10).
Figure 3.10: A Image obtained aer immunohistochemistry and confocal micros-
copy, visualising the sinusoids, bile canaliculi, and hepatocyte shapes. Source: [111].
B 3D reconstruction of cell nuclei (blue), sinusoidal (red) and biliary network (green)
of a healthy mouse. Source: [100].
e principle of IHC relies on targeting one or more specic antigens
of cells using uorescent-labelled antibodies. A confocal microscope
allows these uorescent markers to be detected and localized in volumetric
geometries (Figure 3.10A). Fluorescent IHC is divided into 3 phases [229].
Phase 1 commences with sample acquisition and xation, and ends with
sectioning of the tissue on a microtome. Phase 2 entails incubation of
the tissue slices with primary antibody that will bind to the epitopes of
the antigen(s). is step is usually followed by labelling of the antigen-
antibody complex with uorescent secondary antibodies.e stained slices
are optically imaged in phase 3, most commonly by confocal laser scanning
microscopy. e latter generates a z-stack of 2D images by scanning the
sample in a horizontal plane (focal plane), one depth level at a time. e
uorescent-labelled complexes, located in the focal plane, are excited one
by one and their emitted photons are recorded. Hereaer, the focal plane is
moved to dierent tissue depths.is optical sectioning allows structures to
be visualized and rendered in 3D while the tissue’s microstructure is retained
(Figure 3.10B).
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With conventional IHC, 3D reconstructions of the hepatic microvascular
network in healthy mice have shown that anatomical geometries can be
achieved up to a maximal height of about 100 µm [111].is bottleneck is
primarily attributed to the limited penetration depth of antibodies and/or
photons being scattered at surfaces with changing refractive indices (RIs)
[235].
With the advent of chemical clearing technologies, various methods have
emerged to overcome both limits and allow for deep tissue imaging. Clearing
technologies (e.g. CUBIC [275, 276], ClearT2 [158], SeeDB [134], CLARITY
[285], iDisco [233], ACT-PRESTO [164]) attempt to equalize the RIs of the
tissue, thereby minimizing lateral light scattering and allowing virtually all
photon wavelengths to pass “through” the tissue [235]. Cleared samples may
become highly transparent, as illustrated for mice liver lobes in Figure 3.11.
In this dissertation, deep tissue imaging of liver tissue will be attained by
increasing the free diusion of antibodies, following a permeabilization
protocol adapted fromRenier et al. [233], and by applying theCUBICprotocol
of Susaki et al. [275, 276] to limit the obscuring eects of light scatter. Since
lipids form a major source of light scattering, the CUBIC protocol precedes
“matching of RIs” with a delipidation step [275]. We found that the latter
aected uorescent-labelled antigen-antibody complexes in liver tissue, and
therefore opted to discard this delipidation step (see chapter 4 for more
details).
Figure 3.11: Transmission images of mice liver lobes in A phosphate buered saline
(PBS), and aer tissue clearing with B ClearT2, C SeeDB, and D CUBIC. Source:
[81].
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Morales-Navarrete et al. [198] recently implemented a versatile pipeline
formultiscalemodelling of the hepaticmicroarchitecture inmice (Figure 3.12).
Even though tissue clearing was performed using the SeeDB protocol [134],
homogeneous staining of tissue slices remained conned to a thickness
of about 100 µm, most likely due to the high density of liver tissue. To
overcome the limited imaging depth, a workow for confocal imaging and
novel image processing algorithms were implemented to enable the hepatic
microarchitecture to be reconstructed across three orders of magnitude.e
methodology required liver tissue to be sectioned into serial slices of about
100 µm.ese slices were stained and imaged separately at a low-resolution
(1 µm × 1 µm × 1 µm) to gather the tissue-level information about PTs and
CVs. High-resolution images (0.3 µm × 0.3 µm × 0.3 µm) of the cellular- or
subcellular-level were recorded by zooming in on specic areas of the slices.
Assembling of the low-resolution images allowed for reconstruction of a
tissue-level model of the liver lobule, in which high-resolution models of the
cells, sinusoidal and biliary networks were integrated.
Figure 3.12: Multiscale modelling of the hepatic microarchitecture by Morales-
Navarrete et al. [198]. High-resolution 3D reconstructions of the cellular-level
(middle panel) and subcellular-level (right panel) are registered into a low-resolution
3D model of a liver lobule (le panel).e low-resolution model includes the tissue-
level information (i.e. portal veins (orange) and central veins (blue)), whereas the
cellular- and subcellular-level models provide detailed information about the main
components forming the tissue (i.e. sinusoidal network (magenta), biliary network
(green), and cells (random colours)), and the hepatocytes (i.e. apical (green), basal
(magenta), and lateral (grey) contacts), respectively.
3.2.2 Liver perfusion
To date, relatively little research has been conducted on numerical modelling
of the hepatic perfusion, especially in the case of cirrhosis. Few studies
accepted the challenge and developedmodels ranging from simple 0Dmodels
to detailed 3D computational uid dynamics (CFD) models. Here, we rst
present the available CFD models of the hepatic macro- and microperfusion,
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followed by reduced order models to bridge the gap between the hepatic
macro- and microlevel, before concluding with multiscale models of the
hepatic perfusion.
3.2.2.1 Computational uid dynamics (CFD) models
CFD is a powerful technique capable of simulating (blood) ow patterns
in complex 3D geometries. Since all uid systems have to obey the laws of
mass conservation, momentum conservation, and energy conservation, it
is virtually impossible to derive an analytical solution for any but simplied
geometries [260]. A numerical solution, however, can be attained when
properly discretizing the studied geometry in nite uid volumes using
CFD. Generally, several assumptions regarding the uid and/or geometry are
imposed to reduce the computational eort. For example, when assuming
an incompressible Newtonian uid and neglecting gravitational forces,
the mathematical formulation of the governing laws is reduced to the
Navier–Stokes and continuity equations (Eqs. 3.4–3.5, with ρ the uid density,
u⃗ the ow velocity eld, t the time, P the pressure, and τ¯ the shear stress
tensor [312]). is set of non-linear partial dierential equations can be
solved numerically with commercial CFD soware packages, such as Fluent
(Ansys, Pennsylvania, USA).
ρ ∂u⃗
∂t
+ ρ(u⃗ ⋅ ∇)u⃗ = −∇P +∇ ⋅ τ¯ (3.4)∇ ⋅ u⃗ = 0 (3.5)
3D CFD models not only allow pressure (up to an arbitrary constant)
and ow patterns to be estimated, but also provide information about the
distribution of biomechnical stressors such as wall shear stresses (WSS),
whose inuence on the endothelial cells has been frequently linked to bio-
logical/physiological events, such as ow-mediated vasodilation or vascular
remodelling [123, 291]. For instance, exposure of SECs to high uid shear
stresses has shown to increase the activity of the endothelial NO synthase
(eNOS), which leads to the release of nitric oxide (NO) and vasodilation of
blood vessels [259].
3.2.2.1.1 Macrocirculation. Macrolevel perfusion models have mainly fo-
cused on simulating the uid ow through one of the hepatic vascular trees,
without considering their interplay. Moreover, the 3D geometries were gener-
ally conned to the largest blood vessels, most likely due to the complexity of
hepatic vascular trees, limitations in imaging, and current CFD capabilities.
e majority of studies, aimed at assessing changes of the ow pattern in
cirrhosis, modelled the rst blood vessel generation of the PV, while some
Techniques to model cirrhosis 55
also included part of the splenic vein (SV) and superior mesenteric vein
(SMV) conuence. As such, George et al. [89] developed both idealized
and patient-specic MRI-based CFD models to calculate the contribution
of SMV blood being delivered to the right and le liver lobes (Figure 3.13).
Inlet velocities for the SMV and SV were computed based on phase-contrast
MRI derived ow rates and cross-sectional areas.e ow in the right PV
branch (RPV) was also measured using MRI to dene the PV outow split
to the RPV and le PV branch (LPV). While the bulk of SMV blood went
via the RPV in normal conditions, SMV ow was more uniformly divided
over both PV branches in cirrhotic patients.
Figure 3.13: Computational uid dynamics (CFD) simulations of blood ow through
the portal vein (PV) by George et al. [89]. Streamlines and velocity proles were
calculated for the ow in the PV, including part of the splenic vein (SV) (red lines)
and superior mesenteric vein (SMV) (blue lines), for two healthy subjects and two
patients diagnosed with cirrhosis. In the healthy liver, the bulk of SMV ow was
guided through the right PV branch (RPV), whereas in cirrhosis the SMV ow split
more evenly between the RPV and le PV branch (LPV).
Opposite ndings were reported by Li et al. [172] as to the lobar
distribution of blood coming from the SV. Patient-specic CFD geometries
of the PV system were generated based on CT scans of two cirrhotic and
four normal livers. Boundary conditions consisted of a constant at inlet
velocity prole for the SMV (healthy: 0.21 m ⋅ s−1; cirrhotic: 0.175 m ⋅ s−1) and
SV (healthy: 0.175 m ⋅ s−1; cirrhotic: 0.182 m ⋅ s−1), and ow rate weighting
for the RPV (0.6) and LPV (0.4) outow, following literature. In normal
conditions, results showed that the mass fraction of SV-derived blood to
the RPV was about 1.2–1.5 times larger than that of the LPV. However, in
cirrhosis, the mass fraction of SV blood to the le lobe was signicantly
increased, with the ratio reducing to 0.7–0.8. It was hypothesized that
- due to the changed SV ow distribution - more spleen and pancreas-
derived hepatotrophic growth factors were routed via the le PV and
less through the right PV, leading to hypertrophy and atrophy of the le
and right lobe, respectively. Wei et al. [308] continued this work and
investigated the WSS distributions in the CT-based models (Figure 3.14).
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e inlet velocities of the SMV and SV ows were measured individually for
each patient using Doppler US.e patient suering from cirrhosis clearly
showed lower WSS values (10.13 ± 1.34 dyn ⋅ cm−2) compared to the healthy
subject (19.06 ± 2.63 dyn ⋅ cm−2), which was hypothesized to increase the
potential for disturbed PV ows and thrombosis. Due to the heterogeneity
of the hepatic vasculature and haemodynamics amongst patients, we believe
that appropriate boundary conditions are as instrumental as accurate 3D
geometries to obtain ow simulation results, reecting physiological and/or
pathological conditions. erefore, dening boundary conditions based
on average measurements, or literature, remains suboptimal and caution is
warranted when interpreting these results, as they may not represent realistic
situations.
Figure 3.14: Computational uid dynamics (CFD) simulations of blood ow through
the portal vein (PV) by Wei et al. [308].e patient suering from cirrhosis clearly
showed lower wall shear stress (WSS) values near the conuence of the splenic vein
(SV) and superior mesenteric vein (SMV) compared to the healthy subject.
Van Steenkiste et al. [291] quantitatively analysed the spatial and temporal
WSS distribution in µCT scans of cast PV geometries of portal hypertensive
and cirrhotic rodents (Figure 3.15).e portal hypertension (PHT)model was
obtained by partial ligation of the PV (PPVL), whereas cirrhosis was induced
with CBDL. Before casting, haemodynamic parameters (e.g. blood pressure,
PV ow data) were measured in vivo to compute the time-dependent velocity
prole of the PV inow, imposed as boundary condition.e ow split at all
side branches was computed using Murray’s law, which estimates the ow to
each branch based on the third power of the ratio of the branch diameters
(Eq. 3.3). e CFD results indicated higher WSS values for the PPVL and
CBDL animals in comparison to sham animals. e highest WSS values
occurred in the PPVL model as a consequence of concomitant changes in
geometry (calibrated stenosis) and PV inow, which was increased due to
splanchnic hyperaemia (section 2.5.1).eWSS dierence between the CBDL
and sham animals was mainly attributed to the higher PV inow.
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Figure 3.15: Computational uid dynamics (CFD) simulations of blood ow through
the portal vein (PV) by Van Steenkiste et al. [291]. Time-averaged (over a cardiac
cycle) wall shear stress (WSS) distribution of the PV system of sham, cirrhotic (CBDL
model), and portal hypertensive (PPVL model) animals.e highest WSS values
were observed in the PPVL animal around the ligation.
A few studies also investigated the portal haemodynamic changes aer
partial hepatectomy (PHX) of the right liver lobe [108, 109]. C.-M. Ho et al.
[108] used patient-specic PV geometries based onmagnetic resonance (MR)
angiography and CT images, which were collected before, immediately aer,
and one month aer the PHX (Figure 3.16).e imposed PV velocities were
measured before (0.13 m ⋅s−1) and onemonth aer the operation (0.21 m ⋅s−1)
using Doppler US. A zero-pressure boundary condition was prescribed
at each vessel outlet. e CFD results indicated that the PV pressure
immediately increased aer the operation, however, its value decreased to
physiological pressures in the following month when the liver (and PV) was
regenerated. Other surgical interventions that have been studied include the
transjugular intrahepatic portosystemic shunt (TIPS) procedure (see also
section 2.6). Ho et al. [110] used a patient-specic CT-based TIPS geometry
to assess the internal ow patterns and WSS distribution.e simulations
clearly showed helical ow inside the TIPS stent, which was attributed to the
conuence of the SMV and SV ows.
Additional to PV CFD models, research recently focused on simulating
the blood ow through the HA tree, mainly in the setting of liver cancer.
Patients with unresectable tumours may be treated by radioembolization
with Yttrium-90 (90Y) microspheres being injected as close as possible to the
tumour. As the particles lodge in the tumour, radiation is emitted locally to
the surrounding cancer cells. To date, a number of CFD models have been
implemented to predict the particle trajectories in (idealized) geometries and
generate so-called particle release maps (Figure 3.17) [9, 16, 17, 47, 135, 148].
Particle release maps describe the relation between the injection location and
the trajectory followed by the microspheres.e models allow the inuence
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Figure 3.16: Computational uid dynamics (CFD) simulations of blood ow through
the portal vein (PV) by C.-M. Ho et al. [108]. Patient-specic PV geometries were
collected A before, B immediately aer, C and one month aer right lobe partial
hepatectomy (PHX).e results indicate that, even though the pressure increased
immediately aer PHX, normal pressure values were observed one month aer the
operation due to regeneration of the liver and PV.
of the particle characteristics and vessel geometries to be assessed on the
microsphere trajectories. In the future, development of patient-specic CFD
models may pave the way to improve the clinical outcome of these therapies.
Figure 3.17: Computational uid dynamics (CFD) simulation of blood ow (uid-
particle) through a simplied hepatic artery (HA) by Basciano et al. [16]. Illustration
of the principle of particle release maps, which allow particle trajectories to be
predicted based on the injection position of the particle.
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3.2.2.1.2 Microcirculation. Until now, most microlevel perfusion studies
focused on simulating the hepatic microvascular ow through idealized
geometries of healthy lobules [35, 61, 261]. Due to the complexity of the
microvasculature, a porous medium approach was oen applied to model
the architecture of the lobules. Doing so, sinusoidal vessels were interpreted
as the ‘pores’ of the structure.is approach was reasonable since sinusoids
are small, numerous, and interconnected [261].
Bonglio et al. [35] studied the ow patterns in a 2D transverse cross-
section of an idealized lobule based on porous media (Figure 3.18). e
eect of an anisotropic permeability and non-Newtonian uid was analysed.
However, pressure and velocity distributions barely changed in comparison
to simulations conducted with an isotropic permeability and Newtonian
uid.
Figure 3.18: Simulation result of blood ow through the 2D lobulemodel of Bonglio
et al. [35]. Ae non-dimensional sinusoidal pressure and B velocity elds in the
2D isotropic model of a hexagonal lobule.
Siggers et al. [261] extended this model to determine whether changes
in sinusoidal blood pressure aect the lymph production of the liver
(Figure 3.19). e model indicated that the lymph production was
signicantly increased in portal hypertensive conditions. Moreover, the rate
of interstitial uid leaving the liver through the surface instead of lymphatic
ducts was also increased. A build-up of this uid in the peritoneal cavity
may lead to the development of ascites.
Ricken et al. [236] generated a biphasic (solid- and uid-phase) model
to investigate sinusoidal remodelling events aer an outow obstruction
(Figure 3.20). e model was implemented in a 2D longitudinal cross-
section of the classic liver lobule and a transverse isotropic permeability
was introduced in the direction of the CV.e results suggested that the
local pressure gradient might act as the main eector of vascular remodelling
aer outow obstruction, since sinusoids reoriented themselves along the
direction of the local pressure gradient.
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Figure 3.19: Results of interstitial ow through the 2D lobule model of Siggers et al.
[261]. Ae interstitial pressures and B the interstitial ows in a 2D porous media
model of a hexagonal lobule.
Figure 3.20: Simulation results of the biphasic 2D lobule model of Ricken et al. [236].
e pressure distributions are shown for physiological conditions and conditions
aer an outow obstruction, indicated by a star (*). e sinusoids (white lines)
clearly reoriented themselves along the direction of the local pressure gradient aer
the outow was obstructed.
Debbaut et al. [61] were rst to develop a hexagonal 3D model of
the blood ow through a lobule using porous media (Figure 3.21). ey
investigated the role of vascular septa, dened as highly vascularized regions
in between lobules, as well as the eect of anisotropic permeability conditions
on the sinusoidal ow. Interestingly, the inclusion of vascular septa appeared
indispensable to obtain perfusion patterns reecting physiological conditions.
In addition, Debbaut et al. [60] determined the hydraulic conductivity
of the human hepatic microcirculation using image-based CFD simulations
(Figure 3.22A).e hydraulic conductivity was calculated based on Darcy’s
law (Eq. 3.6), which describes the ow through a porous medium with P the
pressure (Pa), µ the dynamic viscosity (Pa ⋅ s), k the permeability coecient
(m2), and q the Darcy ux (m ⋅ s−1).
∇P = − µ
k
q (3.6)
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Figure 3.21: Simulation results of blood ow through a 3Dporousmediamodel of the
liver lobule by Debbaut et al. [61]. A Pressure contours of the 3Dmodel with vascular
septa and anisotropic permeability. Be velocity-coloured streamlines in a 2D
cross-section for simulations without/with vascular septa and isotropic/anisotropic
permeability conditions.
Results indicated that the human sinusoidal network was character-
ized by a higher permeability along the direction parallel to the CV
(kz = 3.64 × 10−14 m2) compared to the radial (kr = 1.54 × 10−14 m2) and
circumferential (kθ = 1.75 × 10−14 m2) directions.
We conducted analogous CFD simulations to analyse ow patterns and
quantify the hydraulic conductivity of the hepatic microcirculation in the
case of human cirrhosis (Figure 3.22B) [215]. Similar to the healthy liver,
our results indicated that the cirrhotic microvasculature was characterized
by an anisotropic permeability showing the highest value along the CV
direction (kz = 1.68 × 10−13 m2 and kz = 7.79 × 10−13 m2 for sample 1 and
2, respectively) and lower values in the radial (kr = 9.87 × 10−14 m2 and
kr = 5.13 × 10−13 m2 for sample 1 and 2, respectively) and circumferential
(kθ = 5.78× 10−14m2 and kθ = 5.65× 10−13m2 for sample 1 and 2, respectively)
directions. Moreover, the observed permeabilities were markedly higher in
comparison to the healthy liver, implying a locally decreased intrahepatic
vascular resistance (IHVR) most likely due to compensatory mechanisms
at the microcirculatory level (e.g. dilated sinusoids and shunt vessels). We
hypothesized that these mechanisms attempted to alleviate the PHT and
counteract the IHVR increase caused by regenerative nodules and dynamic
contraction mechanisms (e.g. hepatic myobroblasts, NO-concentration).
Given that the studied cirrhotic liver only represented a single patient-
specic snapshot along the pathological pathway of cirrhosis, information
about the interplay between the progression of cirrhosis and the architectural
disarrangement could not be deduced.erefore, in this PhD dissertation,
we opted to revisit cirrhogenesis using the TAA rat model to study the
whole disease spectrum, going from a normal liver to a full-blown cirrhotic
liver. As such, a systematic approach could be followed to assess the spatial
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heterogeneity of the microangioarchitecture in a controlled way at dierent
time points during cirrhogenesis.
Hu et al. [113] developed CFD models, based on porous media theory
and our hydraulic conductivities, to analyse the microhaemodynamics (e.g.
pressure gradient, ow velocity) in normal, brotic, and cirrhotic ‘lobules’
(Figure 3.23). 3D models were adopted from [61] to simulate normal and
brotic conditions (Figure 3.21A). In the case of cirrhosis, the simulation
geometry was extended to include collateral vessels and highly resistive
PTs, resembling portal occlusion due to regenerative nodules and brous
tissue. Since the hepatic microarchitecture is severely remodelled during
cirrhogenesis, it is questionable whether the cirrhotic microcirculation can
still be represented as composed of repetitive anatomical units (e.g. lobules)
(see chapter 2). Moreover, the hydraulic conductivity used to implement
the brotic lobule was actually derived from the cirrhotic liver sample 1, as
mentioned above. In spite of these remarks, simulated pressure and ow
velocity proles were reported to correspond to experimental data found in
literature, assuming that the microhaemodynamics of mice and humans are
similar.
e bile ow through a murine liver lobule was modelled by Meyer et al.
[189]. Structural properties of the bile canalicular network, as determined by
high-resolution confocal microscopy, were complemented with functional
Figure 3.23: Simulation results of blood ow through 3D porous media models of
normal, brotic, and cirrhotic liver lobules by Hu et al. [113]. Pressure contours
are visualized in A longitudinal (Y=0) and B transverse (Z=0) cross-sections. In
the case of cirrhosis, the model was extended with collateral vessels between highly
resistive portal triads (PTs) and central vein (CV).
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properties of bile transport, as measured by intravital microscopy of a
uorescent bile tracer. e experimental data provided the necessary
parameters to model the bile ow through the biliary network based on
porous media (Figure 3.24). Regulating mechanisms of osmotic pressure and
contractility of the bile canaliculiwere also integrated into the model and both
features appeared key components to attain bile ow reecting physiological
conditions.e results indicated that the bile velocity gradually increased
from the centre of the lobule to the bile duct (± 12 µm ⋅ s−1), whereas the
pressure dropped by approximately one order of magnitude.
Figure 3.24: Simulation of bile ow through a 3D porous media model of the liver
lobule by Meyer et al. [189]. Results of A the bile velocity and B the bile pressure
obtained in an anisotropic hexagonal 3D model.
3.2.2.2 Reduced order models
Ideally, liver perfusion models should simulate the uid ow across the entire
length scale of the hepatic system, while simultaneously accounting for the
inuence of the systemic circulation. However, the spatial heterogeneity
of hepatic vascular trees and current technical capabilities (i.e. imaging
resolution, computational eort) have limited image-based CFD models to
either the hepatic macro- or microperfusion.e algorithmic generation of
vascular trees, as discussed earlier in section 3.2.1.1, may help to bridge the
gap between data obtained at dierent length scales. However, it may not
necessarily reduce the computational eort.
Reduced order models provide a neat way to analyse and couple
complex vascular systems, operating at separate length scales [260, 277].
In literature, electrical analog models have been proposed to simulate the
hepatic circulation. e idea behind this kind of modelling relies on the
analogy between the uid ow in a cylindrical tube (vessel) and the current
in an electrical circuit. As such, themathematical formulation of the uid ow
is simplied to the dierential equations governing the current and voltage in
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an electrical circuit [62]. Dierent basic units have been suggested to mimic
the blood ow in a single blood vessel, including the pi-lter of De Pater
(Figure 3.25A) [56]. is lter is composed of four electrical components
(serial resistance Rs, inductance L, conductance C, and parallel resistance
Rp), which solely depend on the geometry of the blood vessel (generation) it
represents (i.e. radius, length, and number of vessels), the pulse wave velocity,
and the physical properties of the uid [62].
Figure 3.25: Illustration of an electrical analog modelling approach for the hepatic
circulation. Ae pi-element, as proposed by De Pater [56], to model the blood ow
in a single blood vessel.e element includes a serial resistance Rs , inductance L,
conductance C, and parallel resistance Rp . B Schematic representation of the vessel
generations of the hepatic vascular trees (hepatic artery (HA), portal vein (PV), and
hepatic veins (HV)). C An electrical analog model of the liver by Debbaut et al. [58].
Adapted from [62].
Debbaut et al. [58] implemented a series of pi-lters to simulate the blood
ow through the dierent blood vessel generations of human hepatic vascular
trees (HA, PV, and hepatic veins (HV)) (Figure 3.25B-C). e electrical
components of the pi-lters were calibrated based on geometrical analyses of
vascular casts. Once initialised, the hepatic ow and pressure distributions
were simulated up to the level of the sinusoids. A similar methodology
was adopted to investigate the hepatic haemodynamics in rats, albeit using
single resistors instead of pi-lters to represent the blood vessels generations
(Figure 3.26). Moreover, the liver was modelled lobe-specically to study the
impact of PHX on the hepatic haemodynamics.
Audebert et al. [11] proposed a closed-loop 0D model of the entire
cardiovascular system to predict the haemodynamic changes aer partial
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Figure 3.26: A Block diagram of a pressure-regulated electrical analog model of
the rat liver by Debbaut et al. [57]. e vascular trees were modelled separately
and lobe-specically (see Figure 3.1B). Each building block represented a single
resistor, calculated based on the branching topology of the lobar vascular trees. B
Lobe-specic ow distributions of the simulated hepatic artery (HA), portal vein
(PV), and hepatic veins (HV) ows. Adapted from [62].
liver ablation surgery, as observed in pigs. e liver was modelled lobe-
specically and calibrated based on the lobe masses.e remaining organs,
except for the heart, were represented by three-element Windkessel (RCR)
models. For the heart, an elastance-based modelling approach was adopted
to account for the heart contraction [27] (see chapter 6 for more details).
During the in vivo experiments, waveform changes of the HA pressure and
ow were detected at the time of resection. Since 0D models cannot encode
wave propagation [260], it was opted to replace the main arteries of the
systemic circulation by 1D model connections to include and study this
phenomenon (Figure 3.27)[13]. By doing so, the 1D–0D model was able to
reproduce waveform changes measured for hepatectomies removing up to
90% of the total liver volume. Moreover, it was suggested that the altered
liver architecture may have caused the waveforms to change.
3.2.2.3 Multiscale models
As the spatial heterogeneity of vascular systems is compromised in 0D/1D
models, information on complex owelds while consideringmultiple length
scales cannot be acquired solely using reduced order models. With the
introduction of geometrical multiscale modelling, techniques have emerged
to link CFD models of the complex ow in specic regions to reduced order
models of the remaining (hepatic/systemic) circulation. Numerous studies
used this approach to investigate the uid mechanics in cardiovascular
diseases [277]. However, only few applied it to investigate the hepatic
perfusion.
Nishii et al. [205] integrated a tissue-scale 3D model of the microperfu-
sion into an organ-scale electrical analog model of liver haemodynamics to
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Figure 3.27: e 1D–0D closed-loop model of Audebert et al. [13]. A Schematic
representation of the 1D–0Dmodel, inwhich thin lines depict 0Dmodel components
and (red) thick lines represent 1D model components to study wave propagation. B
e carotid pressure, as measured over two cardiac cycles in four pigs (dashed lines),
is compared to the simulated carotid pressure of the 1D–0D closed-loop model
(solid line).
explore tissue engineering strategies. Tissue engineering techniques, such
as decellularization and recellularization, have the potential to regenerate
transplantable livers starting from cell-seeded scaolds, provided that the
appropriate biomechanical conditions (e.g. pressures, shear stresses, and ow
rates) are met. As such, they analysed the physical forces that are present in
decellularized scaolds during seed perfusion. Two poroviscoelastic mod-
els were generated for a native and decellularized liver and their microen-
vironments were compared for varying organ-scale perfusion conditions
(Figure 3.28).e results showed a 82% decrease of the vascular resistance
and vefold increase of the tissue permeability in the decellularized liver
lobule. Furthermore, the average pressure in the decellularized lobule was
clearly lower, whereas its pore uid velocity remained identical to the native
lobule for the dierent perfusion rates.
3.2.3 Liver function
Mathematical models representing liver function have been developed to
predict the dynamic hepatic response aer liver damage.emajority of these
models applied a multiscale modelling approach to integrate physiological
systems and cellular/molecular biological processes (e.g. regeneration,
metabolization, and detoxication), as liver (dys)function is not only linked
to the hepatic architecture, but also to the hepatic perfusion [111].
Hoehme et al. [111, 112] introduced an agent-based spatiotemporal model
to predict liver regeneration aer CCl4 intoxication at the lobular level in rats
(Figure 3.29).e basic unit of the model - the hepatocyte - was treated as a
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Figure 3.28: Finite element simulations of blood ow through native and decellu-
larized liver lobule models by Nishii et al. [205].e pressure in the decellularized
liver lobule is clearly lower than in the native liver lobule.
quasi-spherical particle. As CCl4 intoxication induced pericentral necrosis,
remnant hepatocytes commenced to proliferate and their daughter cells
reoriented along the direction of the nearest sinusoid. e proliferation
was instigated by hepatocytes close to the inner ring of dead cells and
subsequently spread wave-like to the midzonal and peripheral regions.e
model suggested that the coordinated reorientation of daughter cells played
an important role to restore the hepatic microarchitecture, characterized by
cords of hepatocytes aligning sinusoidal vessels.
Figure 3.29: Lobule model of liver regeneration aer carbon tetrachloride (CCl4)
intoxication in rats by Hoehme et al. [111].e CCl4 intoxication induces pericentral
necrosis (day 1), which instigates remnant hepatocytes to proliferate during the
following days.
is model was extended by Schliess et al. [247] to predict ammonia
detoxication and its zonal distribution in mice. A two-compartment model,
based on mass balancing and hepatic perfusion data, was developed to
simulate the hepatic metabolism of ammonia, urea, and glutamine. It was
coupled to the regeneration model of Hoehme et al. [111] to determine the
extent of impairment of the ammonia detoxication aer liver damage.e
integrated model allowed for visualization of the spatiotemporal distribution
of ammonia across multiple lobules and for the validation of hypotheses
during regeneration aer CCl4-induced hepatotoxicity (Figure 3.30). e
simulations agreed with corresponding experimental data and revealed
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an unidentied mechanism of ammonia consumption during regenerative
processes, i.e. increased extrahepatic ammonia detoxication.
Figure 3.30: Simulations of the detoxication and zonal distribution of ammonia
during liver regeneration aer CCl4-induced damage in mice by Schliess et al. [247].
Similarly, Dutta-Moscato et al. [69] applied an agent-based modelling
approach to investigate the consequences of liver inammation and predict
the progression of liver brosis (Figure 3.31). Hepatocytes were modelled as
the main agents within liver lobules, occupying most of the lobular space.
ey were able to regenerate e.g. to ll empty spaces aer necrosis. e
model simulated brosis development based on inammatory reactions and
cellular cross-talk between hepatocytes and various other agents (e.g. Kuper
cells (KCs), monocytes, portal broblasts, and hepatic stellate cells (HSCs)).
ese molecular mechanisms were implemented by above-threshold con-
centrations of produced cytokines (pro- and anti-inammatory) as well as
injury-associated molecules (aer inadequate clearance of dead cells). More
specically, injury near the periportal region initiated an inammatory cas-
cade, activating local KCs and recruiting monocytes. On the other hand, the
HSCs and portal broblasts transformed in myobroblasts, secreting space-
occupying collagen, mainly due to the release of inammation products.e
simulations were validated against the histological pattern of brosis develop-
ment in rats with CCl4-induced cirrhosis.e predicted collagen deposition
concurred with the biological observations and progressed from periportal
brosis to bona de brous bridges, eventually leading to regenerative nod-
ules and lobular deformation. Also, the simulated liver tissue became less
pliable, hence more stier, during the exorbitant formation of high-density
scar tissue.
Ricken et al. [237] focused on the glucose regulation within liver lobules.
ey developed a two-scale (sinusoidal and cellular level) multicomponent
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Figure 3.31: Simulations of the brosis progression in liver lobules by Dutta-
Moscato et al. [69].e histological sections (Masson’s trichrome stain) of carbon
tetrachloride (CCl4)-intoxicated rats (le) and the corresponding simulation (right)
forA healthy liver (initial state), B aer 4 weeks of CCl4 intoxication (100 simulation
steps), C aer 12 weeks of CCl4 intoxication (200 simulation steps), and D aer
24 weeks of CCl4 intoxication (400 simulation steps).e collagen structures are
blue-coloured in the stained sections and the agent-based model.
model for description of the blood ow and the cell metabolism of glucose,
glycogen, and lactate (Figure 3.32).e component simulating the sinusoidal
blood ow was modelled using a biphasic (solid- and uid-phase) approach
based on porous media. It was coupled to a metabolic component (cell
level) describing the uptake or release of glucose, as regulated by the blood
glucose concentration.e simulations highlighted the important role of liver
lobules as ‘glucostat’, i.e. taking up excess glucose from the blood circulation
(aer eating) and releasing it when the blood glucose levels decline (between
meals).
Since the metabolization and detoxication of xenobiotics (foreign
chemical substances) is also identied with the liver, research on liver
function recently shied towards modelling the spatiotemporal distribution
of environmental pollutants in order to estimate the (long-term) risk of liver
injury in silico [207, 234, 245, 252, 253, 265, 305, 313].
For instance, Wambaugh et al. [305] developed a microdosimetric model
to predict the cell-scale distribution of chemical substances (e.g. caeine and
propranolol) aer environmental exposure. Distinct graphical models were
generated to approximate the discrete topology of heterogeneous liver lobules
(Figure 3.33). e mass transport through the microvessels was modelled
using a connectivity graph. is graph was complemented with a whole-
body physiology-based pharmacokinetic (PBPK) model, in which the liver is
considered awell-stirred compartment, to determine the hepatic blood inow
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Figure 3.32: Simulations of the glucose regulation in liver lobules by Ricken et al.
[237]. A Pressure contour and B velocity distribution in the case of anisotropic
permeability conditions. Streamlines depict the preferred ow direction. Ce
predicted spatial distribution of glucose in the lobule aer 2 h of food intake followed
by 22 h of fasting.
Figure 3.33: Five graphical models generated by Wambaugh et al. [305] to
approximate the topology of liver lobules and simulate the mass transport of
chemicals. Adapted from [62].
and as such predict the chemical concentration across the microvascular
network.
Ochoa et al. [207] simulated cell viability aer acute toxicity (Figure 3.34).
Cellular and organ models were integrated into a whole-body environment
to simulate the metabolism and transport of toxic metabolites across the
body.e model was able to correlate the concentration of various drugs to
the onset of hepatotoxicity at the microlevel. Sluka et al. [265] exploited this
modelling approach and built a multiscale framework centred around the
liver.e framework was developed in a shareable way and linked to existing
models, among which the PBPK model of Wambaugh et al. [305]. e
integrated model predicted the temporal distribution of various xenobiotics
at three biological levels: whole-body, tissue, and cellular level.
Interestingly, Schwen et al. [252] were pioneers to implement a spatially
resolved model suitable for simulating the xenobiotic distribution and
metabolization in a mouse liver. Instead of modelling the liver as consisting
of well-stirred subcompartments, hepatic vascular trees were algorithmically
constructed based on µCT data (see Figure 3.35). e model was used to
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Figure 3.34:Model of cell viability in the liver lobule aer acute hepatotoxicity by
Ochoa et al. [207].e viable cells are coloured in orange, whereas dead cells are
depicted in black. e cell viability is shown for two dierent CYP3A4 activities
aer acetaminophen-induced toxicity (single dose of 393 mg ⋅ kg−1). CYP3A4 is an
important enzyme that contributes to the removal of xenobiotics in the body and is
mainly found in the liver and intestines.
analyse the spatiotemporal distribution aer drug injection as well as the
eect of steatosis and CCl4-induced necrosis on the pathophysiological state
of the liver. In a follow-up study, Schwen et al. [253] presented a generic
methodology to integrate such detailed liver models into a whole-body
pharmacokinetic model.
Figure 3.35: Hepatic perfusion simulations of a tracer dye (CFDA SE) by Schwen et
al. [252].e volume renderings depict the spatiotemporal distribution of CFDA
SE in a healthy mouse liver during the perfusion (t≤2s), distribution (1s≤t≤5s), and
wash out (t≥3s) phases.
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3.3 Conclusion
As illustrated throughout this chapter, modelling of cirrhosis has been con-
ducted from dierent perspectives (e.g. animal models, CFD models, and
multiscale models) and with varying objectives, thereby elucidating some
pieces of the puzzle. However, more information is necessary, especially at
the microlevel, to reveal the complete picture and understand the complex
pathophysiology of cirrhogenesis. In particular, the intricate relation between
the progression of the disease, the hepatic (angio)architectural disarrange-
ment, and the impaired vascular perfusion remains largely understudied.
Fundamental insight into these aspects may help to unravel specic patho-
logical mechanisms and determine the “point-of-no-return”, beyond which
the progressive disease can no longer be reversed.
In the following chapters, we will address the latter and adopt the TAA
rat model to revisit cirrhogenesis in a controlled way. Two experimental
techniques, i.e. vascular corrosion casting and immunohistochemistry, will
be revised and tailored specically to the rat liver.e combination of these
techniques will allow us to generate animal-specic 3D geometries of the
hepatic vasculature, ranging from the macro- down to the microlevel. At four
predened time points (0, 6, 12, and 18 weeks) during cirrhosis development,
a group of rats will be sacriced and their hepatic vascular trees will be
reconstructed and analysed across multiple length scales.e morphological
data will subsequently serve as input to develop a computational model of
the rat circulation, allowing us to predict the haemodynamic consequences
of the hepatic architectural disarrangement in the case of cirrhosis.

II
Modelling cirrhogenesis in rats
Chapters
4 3D reconstruction of the rat hepatic vasculature 77
5 Vascular remodelling of the rat liver during cirrhogenesis 99
6 Modelling rat haemodynamics during cirrhogenesis 119

C
h
a
p
t
e
r 4
3D reconstruction of the
rat hepatic vasculature
In this chapter, we will present a methodological framework to generate
anatomical 3D geometries of the rat hepatic vasculature, ranging from the
macro- down to the microlevel. It includes dedicated soware to analyse
the morphology of the hepatic vascular trees and determine their branching
topology. In the following chapter, the methodological framework will form
the basis to quantify the vascular pathology during cirrhogenesis.
is chapter is based on: “A multilevel framework to reconstruct anatomical
3D models of the hepatic vasculature in rat livers”, as published in Journal
of Anatomy, vol. 230, no. 3, pp. 471-483, 2017 [217]. However, the results of
the macrocirculation, here reported, are slightly dierent due to more rened
algorithms and increased computational capabilities.
4.1 Introduction
e liver represents the largest internal organ of the human body [191]. It has
a unique macro- and microvascular system, profoundly determining blood
ow distribution and regulation. In contrast to other organs, it comprises two
aerent vessels, namely the hepatic artery (HA) and the valveless portal vein
(PV).is dual blood supply ramies throughout the liver into consecutive
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blood vessel generations and nally merges into sinusoids, the liver-specic
fenestrated capillaries. Aer passing this capillary bed, blood drains into the
systemic circulation via the hepatic venous tree [3, 41, 42, 61].
At the macrolevel, previous research on liver angioarchitecture focused
on automated segmentation, branching pattern analysis, and visualization of
the hepatic vascular trees.is resulted in a number of novel algorithms with
various applications, ranging from automated extraction and representation
of the 3D branching morphology [82, 98, 211, 264, 306, 307, 322], the
algorithmic generation of realistic hepatic vascular trees [128, 152, 251, 254,
319], preoperative planning and real-time guidance in liver surgery [104,
255, 267, 268] to modelling the impact of partial hepatectomy (PHX) [11,
57]. However, algorithms for automated extraction were typically optimised
solely for the venous systems of the liver, as the HA required higher
imaging resolutions [211, 251, 255, 267]. Moreover, branching patterns of
algorithmically generated vascular trees were assumed to consist merely of
bifurcations [211, 255].is assumption is rather imprecise in the case of rats,
whose PV has been shown to trifurcate [182] (see also section 3.2.1.1).
At the microanatomical level, the prevailing theory concerning the
hepatic substructure is the classic hexagonal lobule, established by Kiernan
[137].is model describes hexagonally shaped lobules which are presumed
to be organised in a tessellated pattern (see also section 1.2.2).e central
vein (CV), a terminal tributary of the hepatic veins (HV), constitutes the
central axis of the lobule.e portal triads (PTs) are situated at the periphery,
between the corners of adjacent liver lobules. Each triad contains a bile
ductule, portal venule, and hepatic arteriole. e blood ow through the
lobule is thus oriented centripetally [61]. However, this blood ow cascade
remains a simplication of the complex reality [60, 129, 186].
In addition to the hexagonal lobule model, several other functional liver
units have been published in the literature (e.g. the primary and secondary
lobule ofMatsumoto et al. [185] and the hepatic acinus of Rappaport et al. [230,
231]). Characteristic for all these models is that they represent a simplication
of the true complexity of the 3D structure of the liver microcirculation, as
demonstrated by Debbaut et al. [60]. Detailed 3D anatomical knowledge
of the liver vasculature across dierent length scales is therefore essential
to understand its function, its haemodynamics, and its role in various liver
pathologies (e.g. liver cirrhosis).
Previously, vascular corrosion casting (VCC) in combination with high-
resolution micro-computed tomography (µCT) provided unique insight
into the hepatic vasculature, covering both macro- and microcirculation.
Detailed 3D reconstructions of human and rat livers allowed for accurate
morphological and geometrical analysis down to a resolution of 1–2 µm [57–
59, 215, 291]. Current limitations of the casting technique include perfusion
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diculties, especially for microcirculatory perfusion, and the reactivity of
casting resins with other chemical compounds and surrounding tissue [154,
297]. Moreover, Debbaut et al. [57] experienced technical diculties while
dual casting rat livers, and geometrical data on the hepatic vascular trees (HA,
PV, and HV) could only be gathered by splitting the protocol over two rat
livers (one to obtain the PV and HV systems, and one to retrieve the HA and
HV systems). In addition, Kline et al. [140] noted functional evidence for
the existence of shunts between the HA and PV in rats. It was hypothesized
that these arteriolo-portal venular shunts (occurring between branches of
approximately 50 µm diameter) function as a one-way valve-like mechanism,
i.e. allowing ow only from the HA to the PV and not vice versa. Due to
these shunts, dual liver casting of rodents (i.e. simultaneous casting of HA
and PV) may be problematic when contrast-based dierentiation between
the supplying blood vessels is desired.
Confocal microscopy of immunostained liver tissue has proven to be
applicable for imaging 3D geometries at the microlevel down to a resolution
of 0.2 µm [65, 111, 314]. is method may also provide information about
structures other than the microvascular network, such as connective tissue
and the biliary network [100]. 3D reconstructions of the hepatic microvascu-
lar network in mice have shown that anatomical geometries can be achieved
up to a maximal height of about 100 µm using immunohistochemistry (IHC)
[111]. Hence, a bottleneck of conventional IHC and confocal microscopy is
the limited penetration depth of antibodies and photons. With the advent
of chemical clearing technologies and advanced 3D IHC, various methods
emerged to overcome both limits and allow for deep tissue imaging [235].
As both VCC (with µCT scanning) and IHC (with confocal imaging)
still face a number of challenges and more detailed morphological data on
the liver vasculature is needed, the aim of this study was to optimise and
combine the VCC and IHC protocols in a rat liver model.e VCC protocol
was revised to allow for dual casting of rodents, thereby retrieving all the
required geometrical data from a single rat liver. Dierences with previous
work [57] included usage of another casting resin (PU4ii) and contrast agent
(Lipiodol), adapting the casting sequence (sequentially), and increasing the
reproducibility of the VCC protocol.e IHC method, on the other hand,
was tailored specically to the rat vascular system and supplemented with a
chemical clearing technology to increase the visualization depth. Combining
the complementarity of both techniques enabled us to set up multilevel
models, which allowed the macro- as well as the microvasculature of the
rat liver to be examined accurately in 3D. Such detailed 3D models are
fundamental to a better understanding of the angioarchitecture in normal
liver conditions, but can also be extended to study liver diseases (e.g. cirrhosis
and hepatocellular carcinoma).
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In addition, we implemented an alternative 3D ordering algorithm, based
on the diameter-dened Strahler system of Jiang et al. [125] (see Figure 3.8C),
to analyse and quantify the branching topology of hepatic vascular trees in a
logical manner.
4.2 Materials and methods
4.2.1 Animals
MaleWistar rats (N = 5) with a body weight ranging between 250–400 g were
kept in cages at a constant temperature and humidity in a 12 h controlled
light/dark cycle, with food and water provided ad libitum. All the procedures
were approved by the Ethical Committee of the University Hospitals Ghent
and Leuven (Belgium).
4.2.2 Vascular corrosion casting and µCT imaging
Animals (N = 2) were anaesthetized by intraperitoneal injection of
130 µl ⋅ 100 g−1 pentobarbital (Nembutal, Ceva Sante Animale, Brussels,
Belgium). Next, the upper thorax and abdomen were shaved, and a
combined midline thoracotomy and laparotomy was performed to expose
the liver. Heparin (0.3 ml; 5000 U ⋅ ml−1) (Heparine Leo, Leo Pharma,
Lier, Belgium) was injected intrasplenically with a 26-G needle (Terumo,
Leuven, Belgium) to prevent clotting. e PV and abdominal aorta (AA)
were cannulated with a 14-G and 22-G catheter (Terumo, Leuven, Belgium),
respectively. Additional measures to support precise catheterization included
ligatures, tissue glue, and clamping of the PV proximal to the inserted
catheter. Aer cannulation, the thoracic aorta (TA) and renal arteries (RAs)
were clamped to force the arterially injected resin to ow into the HA.
Several interventions were made to the procedure to reduce the amount of
air bubbles in the vascular replicas, including the introduction of a three-way
stopcock (Discox; B.Braun, Melsungen, Germany), vacuuming the resin
solution before injection (4 min), and priming the syringe with resin
solution.e casting resin was prepared just before injection. It consisted of
PU4ii and hardener (VasQtec, Zurich, Switzerland), 27% ethyl methyl ketone
(EMK) (Merckx, Darmstadt, Germany), colour dyes (yellow and blue for the
HA and PV system, respectively), and 15% Lipiodol (Guerbet, Roissy-CdG,
France).e contrast agent Lipiodol was only added to the HA casting resin
to enhance the contrast between the HA and venous systems on the µCT
images.
e AA and PV were injected sequentially (AA followed by PV) and
manually with approximately 20 and 30 ml of the HA and PV resin mixtures,
respectively. To avoid bloating of the microcirculation, a probe (portex
polythene tubing, internal diameter 1.67 mm and outer diameter 2.42 mm;
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Fischer scientic, Loughborough, UK) was inserted into the caudal vena
cava (CVC) via the right atrium to facilitate outow drainage. Following
the injection, the thoracic CVC, AA, and PV were clamped to prevent
resin leakage during polymerization. Special attention was paid to avoid
manipulation of the specimen during polymerization.
e specimen was le undisturbed for approximately 72 h to allow poly-
merization and curing of the resin at room temperature (RT). Subsequently,
the cast liver was macerated using a 25% potassium hydroxide (KOH) bath
for about 5 days. Aer maceration, the vascular replica was ushed with
distilled water and laid to dry under a vented hood for about 5 days.
X-ray imaging was performed using a high-resolution µCT scanner
developed in-house (HECTOR) (Centre for X-Ray Tomography (UGCT),
Ghent University, Belgium)[183].
e resulting µCT dataset (resolution of 40 µm) was processed using
Mimics soware (Materialise, Leuven, Belgium) to obtain segmentations
and 3D reconstructions of the macrocirculation [59]. Algorithms including
dynamic region growing and smart expand were supplemented with mor-
phological (closing, opening) operations to obtain the hepatic vascular trees.
Several manual adjustments (e.g. multislice editing) were additionally car-
ried out to optimise the segmentations and calculate the 3D reconstructions
(Figure 4.1). A geometrical analysis was performed to quantify the branching
topology of the hepatic vascular trees (see section 4.2.4.1).
Dynamic region growing Closing Smart expanding Original VCC image
HV
PV
HA
Figure 4.1: Segmentation pipeline of the macrocirculation aer vascular corrosion
casting (VCC) and µCT imaging: (i) the original image with separate grey value
ranges for the hepatic artery (HA), the portal vein (PV), and the hepatic veins
(HV) is exposed to (ii) a dynamic region growing algorithm; (iii) subsequently a
closing operation is performed, (iv) which is nally followed by smart expand (of
the borders) and slight manual operations.
Aerwards, a smaller sample (approximate dimensions 2.5 × 2.5 ×
2.5 mm3) was dissected from the right medial lobe (RML) of the cast to
investigate the microcirculation. Scanning electron microscopy (SEM)
(JEOL JSM-5600LV, Jeol, Zaventem, Belgium) and microscope imaging
(Olympus SZ Stereo microscope with Colorview 1 camera and CellˆD
soware, Olympus, Hamburg, Germany) were performed to assess the lling
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of the microcirculation. Subsequently, the microcirculation sample was re-
scanned at a resolution of 1.89 µm.resholding of the µCT datasets – using
Mimics – enabled accurate 3D reconstructions of the microvascular network.
To quantify the microcirculation (see section 4.2.4.1), an even smaller sample
with dimensions of 350 × 350 × 200 µm3 was virtually dissected in between
PTs. Special care was taken to exclude blood vessels other than sinusoids.
4.2.3 Immunohistochemistry and deep tissue microscopy
Animals (N = 3) were anaesthetized by intraperitoneal injection of
130 µl ⋅ 100 g−1 pentobarbital (Nembutal, Ceva Sante Animale, Brussels,
Belgium). e chest and abdomen were shaved, and a combined midline
thoracotomy and laparotomy was performed.e pericardium was incised
and the heart was exposed. Central arterial access was obtained by inserting
a ushed 22-G buttery needle (Medicare, Gent, Belgium) in the apex of the
le ventricle. To allow exsanguination of the animal, the right atrium was
opened by a small incision in the right auricle. To avoid occlusion of the
vasculature by clots or vasospasm, the animal was rst perfused with the
physiological saline Krebs (37 ○C) at 100 mmHg. Aer 10 min, the perfusate
was switched to 4% phosphate-buered paraformaldehyde for 20 min.
Aer perfusion xation, a hepatectomy was performed.e lobes of the
excised liver were separated and immersed in the same xative for 2 h on an
orbital shaker (100 RPM) at RT. Subsequently, the liver lobes were washed
in phosphate buered saline (PBS) (0.01 M, pH 7.4) and stored in PBS with
0.01% sodium azide (NaN3).
e rightmedial lobe (RML)was cut with a vibratome (MicromHM650V;
ermo Scientic, Massachusetts, USA) to 350 µm-thick slices. e other
dimensions were adjusted by means of a razorblade to create slices of
approximately 5 × 5 × 0.35 mm3. e samples were washed in PBS/0.2%
Triton X-100 (3 × 10 min) and permeabilized in PBS/0.2% Triton X-100/20%
dimethyl sulfoxide (DMSO) at 37 ○C for 2 h, following a protocol adapted
from Renier et al. [233].ereaer, the samples were washed in PBS/0.2%
tween-20 with 10 µg/ml heparin (PTwH) (3 × 10 min), and incubated in a
blocking buer, containing bovine serum albumin (Sigma-Aldrich, St. Louis,
Missouri, USA) and normal horse serum (Nodia, Boom, Belgium) at 37 ○C
for 3 h. Following a sample wash in PTwH (3 × 10 min), immunostaining
was initiated by incubating with primary antibody to stain viable endothelial
cells (1/40 RECA-1; Serotec, Kidlington, UK) for 24 h at 37 ○C.e samples
were then washed in PTwH (4 × 15 min and 2 × 30 min) and incubated with
secondary antibody (1/150 Donkey anti-mouse CY3; West Grove, PA, USA)
at 37 ○C for another 24 h. ereaer, the samples were washed in PTwH
(4 × 15 min and 2 × 30 min).
To resolve the limited imaging depth of samples encountered with
traditional IHC, part of the CUBIC (clear, unobstructed brain imaging
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cocktails and computational analysis) clearingmethod [275, 276] was adapted
to optimise IHC for rat liver samples (Figure 4.2).e samples were incubated
overnight in ScaleCUBIC-2 at RT, which is a mixture of sucrose, urea,
water, 2,2,2-triethanolamine, and Triton X-100. ScaleCUBIC-2 increases
the transparency of the tissue and minimizes light scattering by matching the
refracting index, while preserving uorescent signals. Control samples were
not cleared using CUBIC and were stored in PBS + sodium azide (NaN3)
aer IHC.
Figure 4.2: Tissue clearing of a rat liver lobe following the CUBIC protocol: A the
original liver lobe, B aer 3 days, and C aer 9 days of CUBIC clearing.
Aer the IHC protocol, the samples were imaged using a Nikon A1R
confocal laser scanning microscope (Nikon; Tokyo, Japan) at a voxel
resolution of 0.63 × 0.63 × 1.4 µm3 using a 40 × Plan Fluor air lens with
extra-long working distance (numerical aperture (NA) 0.6; working distance
(WD) 3.6–2.8 mm; Nikon Instruments, Paris, France) or a resolution of
1.28 × 1.28 × 1.3 µm3 using a 20 × Plan Apo air lens (NA 0.75; WD 1 mm;
Nikon Instruments, Paris, France). During acquisition, a linear Z intensity
correction was applied to adjust the laser intensity with increasing imaging
depth. Preprocessing of the image datasets included correcting the intensity
decay due to photo-bleaching with histogram matching (Bleach correction;
Fiji), denoising the images for Poisson andGaussian noise (PureDenoise [175];
Fiji plugin), executing a blind 3D deconvolution (point spread function (PSF)
generator [139], 3D iterative deconvolution; Fiji plugins), and enhancing local
contrast by applying the 3D contrast limited adaptive histogram equalization
(CLAHE) algorithm.
Automated segmentation of the vascular network was achieved with
the soware DeLiver developed in-house, which links to the open-source
libraries VTK [248] and ITK [126].e soware builds on the principles of
the TiQuant soware developed at the Multicellular Systems Biology Group
(IZBI, University Leipzig, Leipzig, Germany) and MAMBA group (INRIA-
Rocquencourt, Paris, France) [78, 100]. However, it was expanded to detect
and remove background noise more accurately to cope with the variable
quality of our confocal images, to improve the automated segmentation
pipeline (especially near imaging borders), and to adjust and tune graph
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settings for better visualization and statistical interpretation (see appendix A
for more details).
Basically, segmentation entailed binarizing the images using adaptive
Otsu thresholding, ltering noise, and executing a morphological cavity
lling algorithm to restore vessel discontinuities and close holes of the sinus-
oidal lumina (Figure 4.3). Additional morphological operations (opening
and closing) were performed to smooth structures and remove small dis-
connected objects. A geometrical analysis was carried out to quantify the
morphological parameters of the sinusoidal network (see section 4.2.4.1).
e 3D reconstruction of the segmented datasets was performed using the
commercial soware package Mimics.
Figure 4.3: Segmentation pipeline of the microcirculation aer immunohistochem-
istry (IHC) and confocal laser microscopy: (i) the original image is (ii) preprocessed,
(iii) thereaer binarized and despeckled, and nally (iv) a morphological cavity
lling algorithm and several morphological operations (opening, closing, remove
small objects) are performed.
4.2.4 Morphological analysis of the hepatic vasculature
4.2.4.1 Macrocirculation
e morphological analysis of the macrocirculation (VCC datasets) was
performed in DeLiver by applying graph theory (appendix A). By means
of a 3D thinning algorithm, the skeleton of the segmented vasculature
tree (HA, PV, and HV) was acquired and converted to a graph structure
(Figure 4.4). Such a graph is composed of several interconnected branches.
A branch consists of multiple nodes and edges connecting adjacent nodes.
For each node, the radius was measured using a best-t diameter approach.
is was implemented by calculating the normal plane for every node and
subsequently measuring the radius in this plane in eight radially evenly
distributed directions. e best-t radius was then obtained by averaging
over the eight radii.
e resulting graph allowed the mean radius for each branch to be
extracted. We implemented a diameter-dened top-down ordering method
to assign generation numbers to the branches (Figure 4.5), partially based on
the method used by Jiang et al. [125] (Figure 3.8C).
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Figure 4.4: Schematic illustration of the skeletonization and conversion to graph
structure. A Voxel-based shape representation aer segmentation. Be skeleton of
the shape is obtained using a 3D thinning algorithm, which iteratively deletes voxels
- without shortening or fragmentizing the shape - until only 1-voxel wide lines remain,
i.e. the centre lines. C Identication of voxels representing intersection (yellow) or
dead-end (red) points. De resulting graph consists of several connected branches.
A branch is dened as a collection of nodes and edges in-between two adjacent
intersection nodes or in-between one dead-end node and its adjacent intersection
node. Adapted from [98].
First, the inlet (= root) was selected and branches were combined into
coupled branches based on radius tapering and angle deviations. Branches
(starting at the root) were linkable if the following two conditions were met:
1. e ratio of the mean radius of the daughter branch to the mean radius
of the parent branch was larger than 0.7.
2. e angle between the last segment (last 5 nodes) of the parent branch
and the rst segment (rst 5 nodes) of the daughter branch (α; see
Figure 4.5A) was larger than 160○.
At each intersection node, only the most suitable daughter branch (least
tapering and largest angle) was coupled to the parent branch. From then
onwards, it was considered part of the parent branch. e tapering ratio
and branching angle were manually calibrated based on the 3D branching
topology of the largest vessels. Secondly, generation numbers (n) were
assigned to the coupled branches. It commenced by assigning generation 1 to
the inlet (= root) of the vascular tree and consecutively allocated generation
2 to its daughter branches. e method continued to travel downstream
until reaching the terminal vessel branches and assigned generation n+1 to
daughter branches, with n denoting the generation number of their respective
parent vessel. irdly, the assigned generation numbers were iteratively
reordered based on the mean radius of the branches. For each iteration, the
mean radius (Rn) and standard deviation (SRn) were calculated for every
generation (n). One iteration entailed comparing themean radius of a branch,
initially belonging to generation n, with the range [Rn – SRn; Rn + SRn]. If its
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value did not lie within that range, but instead was lower than (Rn+1 + SDn+1)
or higher than (Rn-1 – SDn-1), its generation number was increased to n + 1 or
decreased to n − 1, respectively.is process was repeated – always starting
at the inlet (= generation number 1) – until the generation numbers of the
branches converged and remained unchanged.
Figure 4.5: Schematic illustration of the morphological analysis approach. A
Example of a converged diameter-dened top-down ordering method for the
macrocirculation (black structures). e analysis is applied to the graph of the
macrocirculation (white lines), whereby intersection nodes are indicated as yellow
circles. Branches are connected to at least one intersection node. For the ordering
method, branches (e.g. 3 branches belonging to the inlet) are rst combined into one
coupled branch if the tapering of the radius is not lower than 0.7 and the angle (α)
between the last segment (last give nodes) of the parent branch and the rst segment
(rst ve nodes) of the daughter branch is larger than 160○.e generation numbers
are then iteratively reordered based on the mean radius of the coupled branches and
the mean radii (Rn) and standard deviations (SRn) of the generations. B Simplied
2D sinusoidal network (black) with its skeleton (white). Intersection branches (1) are
found in-between adjacent intersection nodes (yellow circles). Dead-end branches
(2) are connected to at least one dead-end node (red circles) and one intersection
node. Composite branches (3) are located between two intersection nodes, which
are not part of a dead-end branch, and typically comprise multiple intersection
branches.
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4.2.4.2 Microcirculation
e morphological analysis of the microcirculation (VCC and IHC datasets)
was performed using DeLiver (appendix A). Similar to the macrocirculatory
analysis, a 3D thinning algorithm was used to obtain the skeleton of the
segmented microvasculature, which was converted to a graph structure (see
Figure 4.5B).e resulting graph allowed several morphological parameters
to be extracted, including the average radius of the sinusoidal vessels, branch
lengths, the tortuosity, and the porosity of the vascular network.e radius
was measured using the best-t diameter approach. Branch lengths were
measured as the cumulative Euclidian distance between successive nodes
belonging to the branch.e tortuosity of a branch was dened as the ratio
of the total branch length to the Euclidian distance between the rst and last
node of the branch.e 3D porosity of the vascular network was calculated
as the total sinusoidal volume divided by the volume of its envelope. To limit
the impact of outliers, dead-end branches and branches within a 5-µm range
of the imaging borders were automatically excluded from the morphological
analysis.
4.3 Results
4.3.1 Vascular corrosion casting reveals the hepatic angioarchitecture
at multiple scales
e resulting vascular replicas, including all seven rat liver lobes, were densely
lled (Figure 4.6A-B). A smaller sample was dissected from the RML to
visualize the branching topology at the microlevel (see Figure 4.6C). Near
the liver surface, hepatic lobules could be visualized using stereomicroscopy
(1.2 ×; Figure 4.6D), and sinusoids using SEM (Figure 4.6E), indicating
complete lling of the microcirculation.
As a result of the arterially added contrast agent (Lipiodol), segmentations
and 3D reconstructions of the dierent hepatic trees (HA, PV, andHV) based
on the µCT-images could be carried out semi-automatically. Sequential
casting – HA followed by PV – was of utmost importance to achieve this, as
the contrast agent that entered the PV through the arteriolo-portal shunts
was ushed aerwards. Hence, the contrast agent not only allowed the PV to
be distinguished from the HA system, but additionally assigned a dierent
grey value range to the HV system due to mixing of the injected AA (with
contrast agent) and PV resin. Because the grey value ranges of the hepatic
trees did not overlap, all morphological data could be gathered from a single
rat liver (Figure 4.7).
Each of the vascular trees was classied according to its diameter-dened
branching topology (Figure 4.8), resulting in ve, eight, and nine generations
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Figure 4.6: Vascular corrosion cast of a rat liver showing the liver lobes.e median
lobe is formed by the right medial lobe (RML) and le medial lobe (LML), the right
liver lobe is formed by the right superior lobe (RSL) and right inferior lobe (RIL), the
le liver lobe is formed by the le lateral lobe (LLL), and the caudate lobe is formed
by the superior caudate lobe (SCL), inferior caudate lobe (ICL) and caudate process
(CP). Ae portal venous (and part of the hepatic venous) system is coloured blue,
whereas the hepatic arterial (and part of the hepatic venous) system is pigmented
with a yellow colouring dye. A smaller sample was dissected from the RML to study
the microcirculation. B Yellow-coloured parts of the arterial system of the intestines
are also included (see black arrow) as well as the PV catheter (see dashed arrow). C
Dissected microvascular sample of a rat liver. DMicroscopic image of the surface of
the cast, illustrating the liver lobules (i.e. cloud-like structures in the image; black
contours). E Scanning electron microscopy (SEM)-image of the sinusoidal network.
for the HA, PV, and HV tree (including CVC), respectively. In contrast to the
HV and PV system, fewer blood vessel generations could be segmented for
the HA system because of the limited µCT scanning resolution and the fact
that HA vessels typically have smaller diameters than PV andHV vessels.e
HV mean radii dropped from 2.73 (CVC) to 4.47 ± 0.21 × 10−2 mm, the PV
radii from 1.28 to 5.00 ± 0.31 × 10−2 mm, and the HA radii from 1.74 × 10−1
to 4.54 ± 0.33 × 10−2 mm.
Following 3D reconstruction of the high-resolution µCT images of the
microvascular sample, 3D cubes with dimensions of 350 × 350 × 200 µm3
were virtually dissected only containing sinusoids (Figure 4.7C).e aerent
and eerent microvessels were omitted from the morphological analysis.
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Figure 4.7: 3D reconstructions of a rat liver. A e three vascular trees. B 3D
reconstruction of the microcirculation containing sinusoids (red), aerent (yellow)
and eerent (blue) microvessels. C A virtually dissected and reconstructed 3D cube
containing only sinusoids with dimensions 350 × 350 × 200 µm3. De hepatic
venous system. Ee portal venous system. Fe hepatic arterial system.
According to the VCC data (N = 3), the mean radius measured 7.3 ± 0.93 µm,
the mean branch length was 27.3 ± 2.7 µm, and the mean tortuosity amounted
1.2± 0.01 for 6603 composite branches.e porosity of the sinusoidal network
in the virtually dissected samples was 31.9 ± 6.7%.
4.3.2 Immunohistochemistry reveals the hepatic
microangioarchitecture
When imaging 350 µm-thick non-cleared liver slices using confocal micros-
copy (with air lenses), the imaging depth is generally limited to a maximum
of 50–60 µm (Figure 4.9A). By clearing the tissue using the CUBIC pro-
tocol, the imaging depth was increased by approximately a factor of 5 (300–
350 µm). However, at imaging depths of 150–200 µm, the stained blood
vessels were no longer unambiguously identiable on the recorded confocal
images of the cleared tissue (later referred to as the information retrieval
depth; Figure 4.9B). Furthermore, uniform image intensity can bemaintained
over the entire information retrieval depth (about 150 µm) in cleared liver
tissue, whereas the intensity decay is already noticeable at about 40–50 µm
in non-cleared liver slices.
Automated segmentation of the sinusoidal network was executed for
the cleared datasets (Figure 4.10A). A 3D reconstruction of the segmented
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Figure 4.8: Diameter-dened top-down ordering method for the hepatic vascular
trees, resulting in nine, eight, and ve generations for A the hepatic veins (HV)
including the caudal vena cava (CVC), B the portal vein (PV), and C the hepatic
artery (HA), respectively. e HV mean radii dropped from 2.73 (CVC) to
4.47 ± 0.21 × 10−2 mm, the PV radii from 1.28 to 5.00 ± 0.31 × 10−2 mm, and
the HA radii from 1.74 × 10−1 to 4.54 ± 0.33 × 10−2 mm.
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Figure 4.9: Example of intensity decay in Z stacks acquired through confocal
microscopy. A Non-cleared sample versus B cleared liver tissue sample at imaging
depths z = 14, 78, and 144 µm. For cleared liver tissue, uniform image intensity can
be maintained over the entire information retrieval depth, whereas the intensity
decay is clearly noticeable for non-cleared liver samples.
microcirculation is depicted in Figure 4.10B. By means of graph theory
(Figure 4.10C-F), a morphological analysis - similar to the segmented µCT
dataset - was carried out to quantify the microcirculation in the case of non-
cleared (NC; N = 3) and cleared (C; N = 3) liver samples.e mean radius
measured 3.9 ± 0.3 µm (NC) and 4.6 ± 0.2 µm (C), the mean branch length
was 20.2 ± 0.4 µm (NC) and 20.1 ± 1.4 µm (C), and the mean tortuosity
was 1.3 ± 0.1 (NC) and 1.3 ± 0.02 (C) for 1183 (NC) and 8436 (C) composite
branches, respectively.e porosity of the sinusoidal network in the virtually
dissected samples equalled 21.2 ± 0.7% (NC) and 21.2 ± 0.6% (C), respectively.
An overview of the geometrical parameters of the sinusoidal network,
obtained by IHC and VCC, is depicted in Figure 4.11.
4.4 Discussion
In this study, a methodological framework was presented to study the hepatic
vasculature in rats. We optimised the VCC protocol and IHC technique
to setup detailed multilevel models. With dual VCC, we were able to semi-
automatically obtain accurate 3D macrocirculatory models of all vascular
trees (HA, PV, and HV) from a single rat liver. is was accomplished
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Figure 4.10:e morphological graph analysis pipeline for microsamples obtained
by immunohistochemistry (IHC) and vascular corrosion casting (VCC). A Segmen-
ted 2D image stack of a cleared IHC sample. B 3D reconstruction of the segmented
structures (dimensions: 322 × 322 × 170 µm3). C Visualization of the network graph,
where the edges are coloured according to their branch length. DHistogram of the
branch length. E Visualization of the network graph, where the nodes are coloured
according to their branch mean radius. FHistogram of the branch mean radius.
by sequential casting (PV followed by HA) with arterially added contrast
agent, allowing the three vascular trees to be distinguished one from another
on the µCT images. By implementation of a novel 3D ordering algorithm,
partially based on the diameter-dened Strahler system of Jiang et al. [125],
we were able to classify these vascular trees according to their diameter-
dened branching topology. Furthermore, it was shown that reconstructing
3D geometries of the microvasculature is feasible using both VCC and IHC.
To enhance the limited imaging depth of conventional IHC (< 50–100 µm),
we adapted the CUBIC clearing protocol, thereby reaching unprecedented
information retrieval depths of 150–200 µm in (rat) liver tissue.
Our data clearly highlights the strengths, weaknesses, and complemen-
tarity of both techniques. Submicron resolution can be achieved with IHC,
thereby allowing the visualization of smaller vessels which are harder to
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Figure 4.11: Overview of the morphological parameters in the case of non-cleared
(N = 3), cleared (N = 3), and micro-CT (N = 3) samples. Measured parameters
include (i) the mean composite branch radius; (ii) the mean composite branch
length; (iii) the mean composite branch tortuosity; (iv) the number of composite
branches for each sample; (v) the mean sinusoidal porosity; and (vi) the maximal
information retrieval depth.
detect with VCC. However, the information retrieval depth (150–200 µm)
– even aer clearing – remains restricted to the microvasculature level. VCC,
on the other hand, is not limited in depth resolution, and scales from the
macro- down to the microlevel.
A quantitative comparison of relevant morphological parameters of the
microcirculatory data obtained from rats and mice is provided in Table 4.1.
Most data are available on radii. Our values are within the same range but
on the higher end for rats. is is most likely due to the applied imaging
technique (3D confocal microscopy), as our values are in excellent agreement
with recent data imaged using the same technique in mice.is suggests that
quantitative analyses of the microcirculation can be carried out by combining
IHC and CUBIC clearing.
e slight variation between the mean radius of the cleared and not-
cleared IHC samples can be attributed to tissue heterogeneity or the reported
marginal expansion of tissue due to the CUBIC protocol [235, 275, 276].
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Comparing the mean radii of the IHC and VCC morphological analyses
of the microcirculation (see Figure 4.11), on the other hand, suggests bloating
of the rat liver capillaries in the case of VCC. Even though special care was
taken to avoid this phenomenon, manually injecting the resin always resulted
in a minor expansion of the sinusoids. Absolute quantitative measurements
of the microcirculation are thus recommended with IHC, while VCC can
be used for relative measurements. e VCC samples may still provide
valuable information on the branching topology as larger samples of the
microcirculation – compared with IHC – can be examined. Especially in the
case of liver pathologies, this VCC feature may be relevant, for example, for
recognizing shunting vessels at both the macro- and micro-level.
e radii of the macrocirculation, which were reported in this paper as a
function of their generation number, were compared with the literature and
appeared to be in agreement [57, 182, 217]. A strict one-on-one comparison
between the radii of the generation numbers and literature values was
impossible due to our novel classication system and the lack of anatomical
knowledge about the branching topology of the hepatic vasculature in rats.
erefore, we chose to compare the diameters of the 1st generation with the
available literature (see Table 4.2).
We measured the radii using the best-t diameter approach. Generally,
radii are estimated using the maximum inscribed sphere principle. However,
venous blood vessels and sinusoids may have an ellipsoidal shape. Measuring
the radius using the maximum inscribed sphere principle would – in that
case – result in an underestimation. Our best-t calculation attempts to
account for this ellipsoidal character, as radii are measured by averaging over
eight uniformly spaced directions.
A number of noteworthy pitfalls were encountered when optimising the
techniques.
For VCC, removal of air bubbles in the resin and setting up the dual
casting sequence appeared the most troublesome.e former was resolved
by subjecting the nal mixture to vacuum for at least 4 min and using an air
buer in the injecting syringe. Optimising the dual casting sequence was
hampered by the apparent existence of arteriolo-portal venular shunts with
a one-way valve mechanism between the rat HA and PV [140]. We believe
that the presence of these shunts – which are extensively described by Kline
et al. [140] – prevented us from simultaneous casting of the PV and HA.
When casting simultaneously, contrast agent (injected in the HA) always
ended up in the PV, thereby preventing a contrast-based dierentiation
between the supplying blood vessels. We hypothesize that the contrast agent
from the HA was able to ow through arteriolo-portal shunts to the PV.
However, our analysis did not allow these shunts to be identied, possibly
due to low imaging resolutions of the macrocirculation. Sequential casting
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– HA followed by PV – resolved this issue, as contrast agent entering the PV
during the HA injection was ushed out by the subsequent PV injection.
For IHC, next to CUBIC, two other clearing methods were found
potentially eligible during a feasibility study: CLARITY [285] and iDISCO
[233]. However, we found that passive CLARITY had limited compatibility
with immunostaining due to impairment of epitope recognition, as the
clearing step inherently precedes the immunostaining process.e long time
required to complete the clearing process (2 weeks) is another disadvantage.
e iDISCO protocol proved to be a very potent clearing method, enabling
deep antibody visualization (200–300 µm), however, the main impediment
was considerable tissue shrinkage and deformation (approximately 80%
shrinkage for a normal hepatic lobe). e tissue deformation resulted
in severe undulation of the tissue slices, severely hampering confocal
microscopy.
Several challenges were identied while setting up the presented frame-
work. Regarding the IHC technique, one major diculty remains the limited
free diusion of (primary) antibody. Using CUBIC, we reached unprec-
edented imaging depths of about 300–350 µm of a nuclear counterstain
(TO-PRO3;ermo Fisher Scientic, Waltham, MA USA).e information
retrieval depth (depth at which the antibody staining could be visualized)
was, however, restricted to 150–200 µm. It is hypothesized that the high
extracellular matrix content, which is on the whole not aected by clearing,
is responsible for impeding the free diusion of macromolecules. is is
particularly present in dense hepatic tissue, as opposed to other organs such
as the brain or spleen [164], despite prolonged incubation times and high
antibody concentrations.e explanation for the discrepancy between ima-
ging and information retrieval depths is that antibodies can use the lumen
of the large vessels to penetrate more deeply into the tissue. We hypothesize
that greater information retrieval depths may be attained by either actively
injecting antibodies or by using electro-induced antibody diusion systems
[138, 164, 170]. Additionally, we estimate that - with readjustments to the
applied settings and hardware (the use of more high-end confocal micro-
scopes, e.g. two-photon excitation microscopy) - an even greater imaging
and information depth (> 500 µm) may be achieved in liver tissue.
ConcerningVCC, the hypothesis that the casting resins caused signicant
shrinkage, was refuted [59, 150, 154]. We hypothesize that the known
shrinkage of the cast resinwas compensated for by the pressure exerted during
the injection of the polymer. Although we did not measure the injection
pressure, we ensured that the livers were cast in a consistent way according
to a standardized protocol.e resin was injected manually by a continuous
pressure, assured through an air buer in the syringe, until resin emerged
from the vena cava inferior (VCI). In this way, all liver lobes were adequately
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perfused and cast. At the microlevel, however, bloating of the sinusoids
was observed most likely due to the injection pressure, even though resin
outow was ensured. Pressure-regulated resin injection, particularly in the
PV, may help to resolve this issue when focusing on absolute quantitative
measurements of the cast microcirculation.
4.5 Conclusion
Two complementary protocols were presented, optimised for application to
the rat liver. As such, we were able to reconstruct detailed 3D geometries
of the hepatic circulation, allowing the quantication of the entire length
scale of the vasculature. e protocols were applied to the liver, an organ
that is unique in many respects and thus posed organ-specic challenges (e.g.
dual blood supply). However, we are convinced that the presented protocols
will have value beyond the study of the liver (and its pathology) and will
impact the study of parenchymal organs in general in both physiologic and
pathologic circumstances.
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Vascular remodelling of
the rat liver during
cirrhogenesis
In this chapter, we will use the methodological framework presented in
chapter 4 to visualize and quantify themorphological changes of the rat hepatic
vasculature during TAA cirrhogenesis. In the next chapter, this temporal
morphological data will be used to develop a computational model of rat
haemodynamics during the progression of the liver towards cirrhosis.
is chapter is based on: “Quantitative analysis of hepatic macro- and
microvascular alterations during cirrhogenesis in the rat”, submitted for
publication [216].
5.1 Introduction
Cirrhosis is the common end-point of any given progressive chronic active
liver disease and can evolve to liver insuciency and clinically signicant
portal hypertension (PHT) [222]. PHT is responsible for the more severe
and oen lethal complications of cirrhosis, such as bleeding oesophageal
varices, ascites, renal dysfunction, and hepatic encephalopathy. Because of the
combined impact of these complications, PHT remains the most important
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cause of morbidity and mortality in patients with cirrhosis. Not surprisingly,
cirrhosis therefore accounts for approximately 1.03 million deaths per year
worldwide [288]. Moreover, 31 million disability adjusted life years (DALYs),
equivalent to 1.2% of the global DALY burden, are attributed to this chronic
condition [192].
As the common pathway to cirrhosis entails repetitive destruction and
regeneration of liver tissue, morphological characteristics of cirrhosis com-
prise diuse brogenesis and the conversion of the normal liver architecture
into structural abnormal regenerative nodules [8].
e morphological remodelling exerts a mechanical impact on each of
the large hepatic venous vessels, as these pliant veins, i.e. the portal vein (PV),
intrahepatic inferior vena cava, and hepatic veins (HV), are highly amenable
for mechanical compression [122, 168, 320]. is architectural distortion
contributes to an increased intrahepatic vascular resistance (IHVR) and is
generally accountable for approximately 70% of the increase in portal pressure
in liver cirrhosis, potentially leading to PHT [114, 160].
e morphological impact of cirrhosis is also conspicuous at the level
of the hepatic microcirculation [283]. e microvascular phenotype is
transformed from highly specialized porous sinusoids into continuous, more
rigid capillaries. is process is termed sinusoidal capillarization and is
characterized by the uniform defenestration of the endothelial cells and the
development of subendothelial basal membranes [41, 117]. Furthermore,
cirrhosis causes numerous microscopic vessel aberrations, as hepatic arteries
(HAs), PVs, and HVmay tangle with each other. Various distorted spatial
arrangements have been reported for blood vessels of cirrhotic livers, such
as sharp bends, anomalous branching patterns, abnormal branching angles
and tortuosity. Severe damage (characterised by bridging brosis) results in
stenosis and eventually loss of vessels. In contrast, new vessels may originate
to support the blood supply and venous drainage of the regenerative nodules.
e resulting neovasculature is primarily located in the brotic regions and
bypasses functional liver tissue, thereby aggravating the liver insuciency
[62, 102, 140, 291, 292]. In addition, cirrhosis is considered the principal
cause of intrahepatic portosystemic shunts [176], although the majority of
portosystemic shunts observed in PHT are extrahepatic.ese portosystemic
shunts develop in an attempt to alleviate the elevated portal pressure [5, 31,
199]. Non-tumorous arterioportal shunts have been described in cirrhosis,
as have portal-to-portal venous shunts, though the latter are considered rare
[22, 31, 132].
Despite the irrefutable contribution of the aforementioned research,
knowledge on the pathological alterations of the hepatic (micro)vasculature
during the genesis of cirrhosis remains scanty. In this context, animal models
are valuable tools to analyse the disease process in the most appropriate way.
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More specically, the thioacetamide (TAA) model [161] is a reproducible
model of homogeneous and macronodular cirrhosis and is associated with
typical features of cirrhosis, including PHT and a hyperdynamic circulatory
state.
We aimed at quantifying the morphological changes of the hepatic
vasculature at dierent time points during the TAA-induced cirrhogenesis.
Detailed anatomical data of rat livers were obtained using two complementary
techniques: (i) micro-computed tomography (µCT) imaging aer vascular
corrosion casting (VCC) and (ii) deep tissue microscopy (DTM) aer
immunouorescence staining (see chapter 4). A quantitative description
of the spatiotemporal impact of cirrhosis on the hepatic vasculature may
broaden our understanding of the underlying mechanisms contributing to
the progressive IHVR, which eventually leads to complications such as PHT
[162].
5.2 Materials and methods
5.2.1 Rat model of TAA-induced cirrhosis
Cirrhogenesis was induced by oral administration of thioacetamide (TAA)
(Sigma-Aldrich, Bornem, Belgium). Prolonged TAA intoxication causes
the stepwise process towards compensated cirrhosis [161]. At the start of
the protocol, 0.03% TAA concentration was added to the drinking water.
Hereaer, TAA concentrations were weekly adapted to keep individual body
weights within the limits of 250–300 g.e study protocol was approved by
the Ethical Committee of the University Hospital Leuven (Belgium).
Male Wistar rats (N = 38) were randomly divided into four groups.
Each group consisted of nine animals, except for the fourth group where
two extra animals were allocated to accommodate potential mortality.e
animals were kept in cages at a constant temperature and humidity in a 12 h
controlled light/dark cycle, with food and water provided ad libitum. Group 1
served as control group, allowing the baseline description of normal hepatic
characteristics. Groups 2 to 4 underwent TAA intoxication for 6, 12, and
18 weeks, respectively. Aer 6 weeks of administration, histopathological
characteristics corresponded to hepatitis. At 12 weeks, the advanced brotic
stage was attained and eventually, aer 18 weeks of intoxication, animals
showed homogeneous macronodular cirrhosis [161].
At dierent time points (0, 6, 12, and 18 weeks), the corresponding
group (1–4, respectively) was sacriced. Five animals of each group (six
in the case of group 4) were assigned to µCT imaging aer VCC to study
the macrocirculation. Four animals (ve in the case of group 4) were
allocated to DTM aer immunouorescence staining to analyse the lobule-
scale microcirculation (Figure 5.1).
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Figure 5.1:Male Wistar rats were randomly divided into four groups. Each group
consisted of nine animals, except for the cirrhosis group, where two extra animals
were allocated to accommodate potential mortality. Five animals of each group (six
in the case of cirrhosis) were assigned to the combination of vascular corrosion
casting (VCC) and micro-CT imaging to study the macrocirculation. Four animals
(ve in the case of cirrhosis) were allocated to deep tissue microscopy (DTM) aer
immunouorescence staining to capture the microcirculation.
5.2.2 µCT imaging aer vascular corrosion casting
e procedure started with anaesthesia by intraperitoneal injection of
130 µl ⋅ 100 g−1 pentobarbital (Nembutal, Ceva Sante Animale, Brussels,
Belgium) and careful exposure of the liver and surrounding vessels.
Anticoagulation was performed through intrasplenic administration of
heparin (0.3 ml; 5000 U ⋅ml−1) (Heparine Leo, Leo Pharma, Lier, Belgium).
e PV and abdominal aorta (AA) were injected sequentially and manually
with 30 and 20ml of polyurethane-based casting resin, respectively.e resin
mixture consisted of PU4ii and hardener (VasQtec, Zurich, Switzerland),
ethyl methyl ketone (EMK) (Merckx, Darmstadt, Germany), and colour dyes
(yellow and blue for the HA and PV system, respectively).e radiocontrast
agent Lipiodol (Guerbet, Roissy-CdG, France) was added to the AA resin
to allow for clear distinction between the venous and arterial vascular
trees on the µCT images.e thoracic aorta (TA) and renal arteries (RAs)
were clamped prior to infusion to direct the resin ow. Immediately aer
injection, the thoracic caudal vena cava (CVC) and both inlet vessels were
clamped to prevent resin leakage.e specimen was allowed to polymerize
for 72 h. Aerwards, the liver tissue was macerated in 25% potassium
hydroxide (KOH) for approximately 5 days.e resulting cast was scanned
with X-ray imaging at a resolution of 40 µm using a high-resolution µCT
scanner developed in-house (HECTOR, Centre for X-ray Tomography
(UGCT), Ghent University, Belgium) [183]. A more elaborated description
of the VCC and µCT protocol is described in section 4.2.2.
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5.2.3 Deep tissue microscopy aer immunohistochemistry
Animals were anaesthetized by intraperitoneal injection of 130 µl ⋅ 100 g−1
pentobarbital (Nembutal, Ceva Sante Animale, Brussels, Belgium) and
subsequently underwent a perfusion xation with 4% phosphate-buered
paraformaldehyde.e liver was excised and cut into 350 µm-thick slices by
means of a vibratome (Microm HM650V;ermo Scientic, Massachusetts,
USA). Slices from the top (up to 2 mm from the surface) and mid (4–6 mm
from the surface) region of the right medial lobe (RML) were selected for
further processing.
e slices were permeabilized following a protocol adapted from Renier
et al. [233]. Aer permeabilization, the samples were immunostained using a
generic endothelial marker antibody (RECA-1; Serotec, Kidlington, UK), as
illustrated in Figure 5.2.e limited antibody penetration and imaging depth
inherent to traditional immunohistochemistry (IHC) was tackled by applying
an adapted version of the CUBIC clearing protocol aer IHC [275, 276] (see
section 4.2.3 for more details). Subsequent confocal laser scanning (Nikon
A1R; Nikon, Tokyo, Japan) using a 40 × Plan Fluor air lens with extra-long
working distance (numerical aperture (NA) 0.6; working distance (WD) 3.6–
2.8 mm; Nikon Instruments, Paris, France) provided detailed volumetric
datasets of the microcirculation (voxel resolution of 0.63 × 0.63 × 1.4 µm3).
e datasets were further processed and analysed using the soware DeLiver
(appendix A).
Figure 5.2: e sinusoidal network (red) immunostained using the generic en-
dothelial marker antibody RECA-1 in A healthy liver tissue, B a regenerative nodule,
and C near a thin vascularized brotic septa (green), which was stained for collagen
type I using anti-collagen I antibody (Abcam, Cambridge, UK).e cell nuclei (blue)
were coloured with the uorescent dye DAPI (ermo Fisher Scientic, Waltham,
MA USA).
5.2.4 Data analysis of the hepatic vascular architecture
5.2.4.1 Macrocirculation
e µCT datasets were processed using the commercial soware package
Mimics (Materialise, Leuven, Belgium). e hepatic vascular trees (HA,
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PV, and HV) were semi-automatically segmented, as their grey value ranges
diered from one another on the µCT images.e arterially added contrast
agent allowed the PV to be distinguished from the HA system, and also
assigned a dierent grey value range to the HV system due to mixing of the
injected AA (with contrast agent) and PV resin.
Aer segmentation, centrelines of the vascular trees were calculated
and converted to graphs using the soware DeLiver (see section 4.2.4.1
and appendix A).ese graphs were used to characterize the branching
topology and quantify the geometrical attributes (i.e. branch radius, length,
and number of vessels). A diameter-dened top-down ordering method
was implemented, partially based on the method used by Jiang et al. [125]
(Figure 3.8C), to assign generation numbers to the branches. As opposed
to Jiang et al., the inlet of each hepatic vascular tree (HA, PV, and HV) was
assigned generation “1” and daughter branches were allocated generation
numbers higher than (or equal) to their parent vessel (see section 4.2.4.1).
Aer data classication, exponential trend lines (Eq. 6.1) were tted to
the morphological features y (i.e. radius, length, and number of vessels) as
a function of their generation number n, with a and b the coecients to
be tted.e tting principle was similar to previous studies [57, 59], and
allowed the cirrhogenic evolution of the parameters studied to be quantied.
y(n) = ae−bn (5.1)
5.2.4.2 Microcirculation
Prior to microvascular segmentation, DTM datasets were post-processed to
reduce lipofuscin-like autouorescence, which was abundantly present from
12 weeks of TAA administration onwards.e autouorescence was recorded
separately for every sample.is autouorescence signal was subsequently
subtracted from the signal of the vasculature. Additionally, we applied
contrast enhancement, eliminated imaging noise, and reattributed out-of-
focus components [175, 246].
Segmentation of the microcirculation was executed automatically using
the soware DeLiver (appendix A).e segmented datasets allowed for
accurate 3D reconstructions of the intertwined and interconnected blood
vessels.e centrelines were calculated for each blood vessel to extract and
quantify various morphological parameters.e radius was measured using
a best-t diameter approach.is was achieved by measuring the radius in
eight radially evenly distributed directions. By averaging over the eight radii,
the best-t radius was able to account for the ellipsoidal character of blood
vessels. Branch lengths were calculated as the cumulative distance between
vessel intersections.e tortuosity of a branch was dened as the ratio of the
total branch length to the distance between the start and end point of the
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branch.e 3D porosity of the vascular network was calculated as the total
vascular volume divided by the volume of its envelope. More information
about the segmentation and analysis pipeline of the microcirculation can be
found in section 4.2.4.2.
Statistical analyses were performed in RStudio (open source soware)
[240]. Non-parametric Kruskal–Wallis tests were executed with Holm–
Bonferroni adjustment to assess the sinusoidal remodelling during cirrho-
genesis. Dierences with a p-value below 0.05 were considered statistically
signicant. Post hoc pairwise multiple comparison used the Conover–Iman
test, which is robust for small sample sizes.
5.3 Results
Rat livers were excised and cast at dierent time points during cirrhogenesis,
as depicted in Figure 5.3A-B.e macroscopic expression of the liver clearly
evolved from normal over an irregular ‘salt & pepper’-like appearance
(6 weeks) to an emerging nodular (12 weeks) and eventually macronodular
liver at 18 weeks.ese changing appearances were accurately captured by
the casting procedure, as nodules appeared at the liver surface from 12 weeks
onwards.
5.3.1 Macrocirculation
Cirrhosis mainly aects the hepatic venous vessels
For each time point, two liver casts were processed down to a 3D reconstruc-
tion of all vascular trees (HA, PV, and HV) (Figure 5.3C-E). From 12-week
intoxication onwards, the continuously growing regenerative nodules star-
ted to compress their surroundings mechanically.e pliant HV branches
were largely aected by this mechanical compression, and even appeared to
collapse, as evidenced from the scanned casts (Figure 5.4A). In the cirrhotic
stage, the PV system was also aected by the nodular compression, albeit to a
lesser extent, and several portosystemic shunt vessels were detected, connect-
ing the trunk of PV with the CVC (Figure 5.4B, colour-coded in magenta).
Furthermore, we observed that HA branches became more tortuous due
to cirrhosis, as sudden sharp bends appeared which were not observed in
the control group (Figure 5.4C). However, the HA cross-sections remained
unaected by the nodular compression, most likely because arterial vessel
walls include a thick muscle layer.
Regenerative nodules mechanically compress the hepatic venous trees
e vascular trees were classied according to their diameter-dened
branching topology. Due to the restricted µCT resolution (40 µm), fewer
blood vessel generations were measured for the HA system, as HA branches
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Figure 5.3: A Rat livers were excised at dierent time points during the genesis of
cirrhosis.e macroscopic expression of the liver transformed from normal over an
irregular ‘salt & pepper’-like appearance at 6 weeks to an emerging nodular liver at
12 weeks and eventually macronodular cirrhotic liver at 18 weeks. BVascular replicas
obtained using vascular corrosion casting. Blue pigmented resin was injected via the
portal vein (PV) and yellow dye was added to the arterial resin. C–EMacroscopic
3D reconstructions of the hepatic veins, the PV, and the hepatic artery, respectively.
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Figure 5.4: 3D reconstruction of the macrocirculation of a cirrhotic rat liver
(18 weeks). Ae amendable hepatic veins (HV) in the middle medial lobe were
signicantly compressed by regenerative nodules and some branches even appeared
to collapse. B Portosystemic shunts were detected (arrows), shunting directly from
the trunk of the portal vein (PV) into the HV (caudal vena cava). Branching trees
from the PV and HV were cut to provide a better view of the shunts. C Due to
cirrhosis, arterial branches became more tortuous, resulting in sudden sharp bends
(arrows).
normally have smaller diameters than venous branches. For each generation,
the mean radius, length, and number of vessels were measured (see Figure 5.5
and Tables 5.1 to 5.3).
At the 6-week time point, all vascular trees (HA, PV, and HV) appeared
unaected, as their morphological parameters (i.e. radii, length, and number
vessels) were comparable to control values. From the 12-week time point,
when regenerative nodules began to grow in expansive manner and due to
an excessive amount of brous connective tissue deposited, radii of the HV
gradually decreased. Illustrative is the signicant decline of the CVC radius,
dropping from 3.01 (healthy) to 1.39 mm (most severe case of cirrhosis; see
Table 5.1).
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Figure 5.5: e hepatic macrovascular trees – hepatic veins (HV), portal vein
(PV), and hepatic artery (HA) – were classied according to their diameter-dened
branching topology. For each liver intoxicated with thioacetamide during dierent
weeks (0, 6, 12, and 18 weeks), A the mean radius, B the mean length, and C
the number of vessels were measured as function of the generation number and
exponential trend lines were tted. For the number of vessels, trend lines were tted
based on the rst four generations of the PV and HV (and three for the HA). In
this way, an inaccuracy of the number of vessels due to under-segmentation was
limited. e trend lines clearly illustrate the impact of cirrhosis on the HV, with
mean diameters nearly halving across the rst generations due to the mechanical
compression of regenerative nodules and brous tissue.e HA, on the other hand,
dilated with increasing intoxication time. We did not observe any trends during
cirrhogenesis for the number of vessels and length as function of the generation
number.
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e PV system was less aected by cirrhosis. e PV inlet radius
marginally dilated from 1.28 (rat 1 and 2) to 1.71 mm (rat 7) with increasing
intoxication time. However, in rat 8 (presumably a more advanced cirrhotic
stage), the PV inlet radius narrowed to 1.01 mm (shown in Table 5.3).
Furthermore, a clear widening of the arterial tree was measured during
cirrhogenesis, as the HA inlet radius dilated from 1.71 × 10−1 (rat 2) to
3.01 × 10−1 mm (rat 7; see Table 5.3).
We did not observe any trends during cirrhogenesis for the number of
vessels and length as a function of the generation number.e mean lengths
did not even show clear-cut declining trends in the rst generation(s), but
did start to decrease in later generations. Moreover, the length of the rst
generation was underestimated, as it was partially cut during resection of
the liver. Hence, the length of the rst generation was not considered when
tting the trend lines in Figure 5.5B.
5.3.2 Microcirculation
Cirrhogenesis instigates remodelling of the microcirculation
For each time point, 10 to maximally 13 DTM samples (randomly
selected from four livers with a minimum of two samples per liver) were
post-processed, 3D reconstructed, and subjected to pairwise comparison
(Figure 5.6A-B). For the 12-week and 18-week samples, we dierentiated
between sinusoids in regenerative nodules and shunt vessels in the brotic
septa, both constituting the microcirculation. is was achieved by
pre-imaging the slices at a lower resolution (2.48 µm; ×10 magnication),
allowing the visual recognition of nodules and vascularized septa. Samples
of their respective microcirculation were subsequently gathered by
imaging both structures separately at a higher resolution (0.63 µm; ×40
magnication).
Histograms of the sinusoidal radii during disease progression are depicted
in Figure 5.6C.emean radius decreased from 4.41± 0.23 in control animals
to 3.91 ± 0.47 µm at week 18 (p = 0.0006). In addition, the porosity (i.e. the
sinusoidal volume per unit of volume) steadily declined from 20.45 ± 1.92%
(control) to 11.33 ± 3.06% (week 18; p < 10−5; see Figure 5.6D).e sinusoidal
tortuosity and length increased slightly but signicantly (p < 10−4) during
cirrhogenesis, going from 1.12 ± 0.01 to 1.19 ± 0.05 and 18.71 ± 0.83 to
24.52 ± 4.39 µm, respectively from week 0 to week 18 (see Figure 5.7).
Cirrhosis aects the sinusoidal network zone-specically
Samples sectioned near the top (N ≥ 5) were compared with samples located
in the middle of the RML (N ≥ 5). We found that sinusoids situated in
the core of the lobe typically had larger radii and appeared less aected by
the cirrhogenic process compared with those near the surface (Figure 5.8).
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Figure 5.6: A Example of a stack of 2D images acquired through deep tissue
microscopy (DTM) aer immunohistochemistry. Be dataset was automatically
processed to segment the sinusoidal network and convert it to a graph. Here, the
network graph is coloured according to the mean radius of the branches. e
graph allowed other morphological parameters to be extracted, including the length,
tortuosity, and porosity. CHistograms of the sinusoidal radii during the dierent
cirrhogenic stages. e values visibly shi to the le, when progressing from a
normal to cirrhotic liver. At 12 weeks and 18 weeks, we dierentiated between the
sinusoids in regenerative nodules and the microvascular vessels in the vascular septa.
ese vascular septa comprised a substantial number of smaller vessels, but also a
considerable number of large shunt vessels (diameter > 10 µm). D 3D reconstructions
of the intricate sinusoidal network obtained with DTM (140 µm-thick samples) for
the dierent time points.e porosity (= volume of blood vessels per volume unit)
of the depicted samples steadily declined from 19% (healthy) to 16% (hepatitis) to
9% (advanced brosis) to 7% (cirrhosis).
Pairwise comparison of the 18-week samples demonstrated signicantly
dierent radii in these two zones (p = 0.048). Variations between the porosity
of mid- and top-located samples existed but did not vary signicantly. Similar
observations were made for the branch length and tortuosity.
Cirrhosis is characterized by the formation of highly vascularizedbrous
septa
We analysed several samples consisting primarily of vascular septa in the
case of cirrhosis (N = 3) and compared their radius histogram with those of
cirrhotic sinusoids (Figure 5.6D).e skewed distribution of the vascular
septa indicated the presence of very large blood vessels (radius > 10 µm)
acting as intrahepatic shunts.e septa also comprised a substantial amount
of smaller intertwined blood vessels, which probably originated to support
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Figure 5.7: Boxplots forA the radius, B the porosity, C the branch length, andD the
tortuosity of the microcirculation as function of TAA intoxication time.e radius
and porosity diered signicantly between healthy (week 0) and cirrhotic livers
(week 18; (p < 0.05). Both parameters decreased gradually during the cirrhogenic
progression, and as such contributed to the increased intrahepatic vascular resistance.
On the other hand, the sinusoidal tortuosity and length increased only slightly,
though still signicant, when going from healthy to cirrhotic livers.
blood supply. Both vessel types were embedded in brotic tissue and thus
separated from the hepatocytes.ey acted as bypasses guiding the blood
ow directly from the portal triad (PT) into the central vein (CV).
5.4 Discussion
To the best of our knowledge, the present study is the rst to analyse the
main remodelling events of the hepatic vascular architecture during TAA
cirrhogenesis in rats. Solely using static techniques (VCC and DTM), we
were able to study and quantify the dynamic transition of this pathological
process. At four discrete time points during the progression towards cirrhosis,
VCC and DTM were used to capture, 3D reconstruct, and morphologically
analyse the intricate hepatic vasculature across multiple length scales. Our
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Figure 5.8: Boxplots for A the radius, B the porosity, C the branch length, and D
the tortuosity of the microcirculation as function of TAA intoxication time and
location within the lobe. Slices (350 µm) were taken near the top (up to 2 mm from
the surface) and mid (4–6 mm from the surface) region of the right medial lobe
(RML). Sinusoids situated in the core of the lobe appeared to be less aected by the
cirrhogenic process, as their mean radii and porosity were typically larger than those
near the surface. When comparing the 18-week intoxicated samples pairwise, the
radii diered signicantly between the top and mid region (p = 0.048).
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data demonstrated various anatomical abnormalities attributable to cirrhosis,
which are likely to underlie the increase of total IHVR as previously
characterized haemodynamically in this model and at the same given time
points [161].
With VCC, we examined the circulatory changes at the macrolevel. From
12 weeks of TAA intoxication onwards, regenerative nodules started to grow
in an expansive manner. It is commonly assumed that this tissue growth
exerts a compressive force on the surrounding blood vessels (Figure 5.4).is
compression narrowed the pliant venous systems (PV and HV); we found
that HV were especially impacted by this compression, with collapsed vessel
segments severely impeding hepatic outow (Figure 5.5).emean diameters
of the HV across the rst generations nearly halved. As resistance of a vessel
scales inversely with its radius to the fourth power following Poiseuille’s law, it
is not surprising that an increase of the total IHVR was documented in TAA-
induced cirrhotic livers [161]. Furthermore, the HA dilated with increasing
intoxication time.e diameter of the PV most likely increased up until the
moment the mechanical impact of the regenerative nodules outweighed the
internal portal pressure and forced the PV to narrow, as observed in rat 8
(more advanced stage of cirrhosis). While the morphology of the PV system
appeared only slightly aected by cirrhosis, the progressive narrowing of the
HV vasculature most likely increased the overall IHVR and, hence, impeded
portal ow.is impediment may have retrogradely increased the pressure
in the PV through congestion, leading to PHT [161]. PHT is the earliest and
most prominent complication observed in patients with cirrhosis. Many
of the lethal complications related to cirrhosis commence in the setting of
worsening PHT [222].
At the microscopic level, sinusoidal remodelling was abundantly present.
Capillarization and the impaired intrahepatic balance between vasodilators
and vasoconstrictors presumably caused the diameters and number of
sinusoids to decrease [283]. We observed that from 12 weeks onwards,
the microvascular porosity and sinusoidal radii signicantly diered from
control data at week 0 (Figure 5.6D and Figure 5.7A-B). Even though
macrocirculatory changes were still limited, PHT was already measured
at 12 weeks as documented earlier in the animal model [161].is suggests
that the increase of the IHVR is initiated at the microlevel and is further
aggravated by alterations at themacroscale later on. At 18 weeks, PHT became
associated with a hyperdynamic circulatory state (another pathophysiological
hallmark of cirrhosis), which may have further contributed to the increasing
portal pressure [161].
At 18 weeks of TAA intoxication, the presence of complete brous
vascularized septa, encapsulating the growing regenerative nodules, has been
reported [161]. In the present work, we observed that these portal-portal and
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portal-central septa comprised a considerable amount of small vessels as well
as larger intrahepatic shunt vessels (Figure 5.6C). Additionally, intrahepatic
portosystemic shunts were detected between the trunk of the PV and CVC
(Figure 5.4C). Although these shunts may represent anatomical variations, we
hypothesize that they spontaneously developed in an attempt to alleviate the
elevated portal pressures. Consequently, large amounts of blood are shunted
directly into the systemic circulation without contact with the hepatocytes,
incapacitating, as such, synthetic and detoxication liver functions. We only
observed these portosystemic shunts in cirrhotic rat livers, most likely due
to the presence of severe PHT.e formation of abnormal portosystemic
collaterals is not uncommon in patients with cirrhosis [318]. In rare cases,
cirrhotic patients may even experience the recanalization of the umbilical
vein, acting as a decompressive portosystemic shunt [1, 218].
Our microcirculatory ndings concur with the results of Vanheule et
al. [292]. Using intravital uorescence microscopy (IVM), they studied
the hepatic microcirculation of mice during the genesis of carbon tetra-
chloride (CCl4) and chronic bile duct ligation (CBDL) cirrhosis. In both
models, sinusoidal diameters also decreased signicantly from 4.15 ± 0.03
(control) to 2.84 ± 0.03 µm (16-week CCl4) and 4.35 ± 0.09 (sham-operated)
to 3.7 ± 0.03 µm (6-week CBDL), while large shunts developed, reaching
diameters up to 22.2 ± 0.03 µm (16-week CCl4). ese diameter measure-
ments are clearly on the lower end compared to our morphological data.is
discrepancy may be attributed to the use of dierent animal models (TAA vs.
CCl4 and CBDL) and/or species (mouse vs. rat). However, it is more likely
due to the applied imaging technique (2D IVM vs. 3D confocal microscopy),
as our data of healthy rat livers is in excellent agreement with recent data
imaged using the same confocal technique in mice (Table 4.1).
Although the workow of this study is straightforward, some aspects are
very labour-intensive and time-consuming.is is particularly the case for
the segmentation of the µCT datasets of the vascular corrosion casts, which
is the reason only two liver casts were fully segmented for each cirrhogenic
stage. erefore, the reported numerical data must be considered only
to be indicative. Moreover, liver casts should ideally be µCT-imaged at a
suciently high resolution to allow the HA to be reconstructed accurately
up to the same generation as the PV. As diameters of HA branches are
typically smaller than PV branches, this was technically impossible with the
current computational capabilities. Consequently, the number of HA vessels
for higher generations was probably underestimated, as smaller ramifying
branches remained undetected. Because the HA runs in parallel with the PV,
we can only assume that the number of vessels should be at least equal to or
even higher (due to PV being anked by more than one parallel HA vessels)
than the PV [59].
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e hypothesis that the casting resin caused signicant shrinkage was
discredited [59, 154, 188]. We presumed that the known shrinkage of the cast
resin was compensated by the pressure exerted during the injection of the
polymer. Althoughwe did notmeasure the injection pressure, we ensured that
all livers were cast in a consistent way according to a standardized protocol.
Moreover, as the intrahepatic vascular resistance progressively increased
during cirrhogenesis and livers were of varying sizes, maintaining a uniform
injection pressure for all livers would most likely not have suced to perfuse
all liver lobes adequately, or could have even destroyed others. For this reason,
the resin was injected manually by a continuous pressure, which was assured
through the air buer in the syringe, until resin emerged from the vena cava
inferior (VCI). In addition, the heat generated during PU4ii polymerization
was negligible.
5.5 Conclusion
e degenerative adaptation of the rat hepatic vasculature was assessed and
quantied during the genesis of TAA-induced cirrhosis. At four predened
time points, two experimental techniques (i.e. VCC and DTM) were used to
capture and reconstruct the rat-specic hepatic vasculature across dierent
scales, ranging from the largest blood vessels down to the sinusoids. e
complementarity of both techniques provided a comprehensive overview of
the detrimental impact of cirrhosis on the vasculature. Moreover, our data
shed light on the irreversible component behind the progressive increase of
the IHVR, which was haemodynamically characterized earlier at similar time
points and in the same model [161].e combined impact of this work, both
haemodynamically and angioarchitecturally, might be of interest for targeted
liver interventions pharmaceutically, surgically, and angiographically.
116 Chapter 5
5.6 Morphological data of hepatic vascular trees
Table 5.1:e macroscopic hepatic veins were classied according to their diameter-
dened branching topology at dierent time points during cirrhogenesis.e mean
radius, the mean length, and the number of vessels were measured based on the
assigned generation numbers.
Hepatic veins Generation Mean radius (mm) Mean length (mm) # Vessels
Healthy
liver
0 weeks
rat 1 rat 2 rat 1 rat 2 rat 1 rat 2
1 2.73 3.01 27.87 21.43 1 1
2 1.75±0.34 1.87±0.36 3.92±0.26 3.73±0.39 10 11
3 9.31±1.39 × 10−1 1.04±0.18 5.69±1.52 4.65±2.03 19 18
4 5.35±0.88 × 10−1 5.95±1.02 × 10−1 3.53±1.20 4.66±1.64 66 55
5 2.91±0.48 × 10−1 3.13±0.60 × 10−1 2.62±0.70 2.59±0.77 224 178
6 1.64±0.30 × 10−1 1.71±0.30 × 10−1 1.78±0.43 2.18±0.50 486 451
7 8.93±1.55 × 10−2 1.04±0.15 × 10−1 1.50±0.29 1.69±0.33 709 795
8 5.76±0.58 × 10−2 7.00±0.78 × 10−2 1.16±0.18 1.37±0.23 356 672
9 4.47±0.21 × 10−2 5.17±0.33 × 10−2 0.82±0.11 1.02±0.15 56 138
Hepatitis
6 weeks
rat 3 rat 4 rat 3 rat 4 rat 3 rat 4
1 3.41 3.07 36.58 23.73 1 1
2 1.92±0.57 1.78±0.20 6.41±1.98 3.74±0.58 15 15
3 8.22±1.36 × 10−1 8.75±1.50 × 10−1 4.99±1.72 6.16±2.28 31 25
4 4.11±0.89 × 10−1 4.66±0.90 × 10−1 3.25±1.02 3.41±1.27 134 105
5 2.08±0.40 × 10−1 2.37±0.48 × 10−1 2.58±0.58 2.65±0.62 377 280
6 1.17±0.20 × 10−1 1.35±0.22 × 10−1 2.25±0.41 2.21±0.44 741 561
7 7.52±0.91 × 10−2 9.10±0.92 × 10−2 1.71±0.26 1.55±0.27 679 517
8 5.40±0.27 × 10−2 6.63±0.70 × 10−2 1.34±0.14 1.14±0.21 135 208
9 4.64±0.19 × 10−2 5.12±0.21 × 10−2 1.20±0.13 1.26±0.16 29 28
Advanced
brosis
12 weeks
rat 5 rat 6 rat 5 rat 6 rat 5 rat 6
1 3.12 3.04 35.48 32.82 1 1
2 1.65±0.29 1.35±0.40 6.88±1.62 5.46±0.61 9 7
3 8.56±1.60 × 10−1 8.29±1.83 × 10−1 4.62±1.53 8.08±2.63 30 18
4 4.72±0.72 × 10−1 4.31±0.92 × 10−1 3.84±1.29 4.39±1.28 63 78
5 2.68±0.48 × 10−1 2.10±0.50 × 10−1 2.53±0.67 3.30±0.78 211 221
6 1.53±0.24 × 10−1 1.16±0.17 × 10−1 2.36±0.50 2.18±0.48 417 324
7 9.63±1.28 × 10−2 7.78±0.91 × 10−2 1.80±0.35 1.42±0.28 521 197
8 6.64±0.73 × 10−2 5.38±0.33 × 10−2 1.44±0.24 1.06±0.12 277 7
9 4.57±0.19 × 10−2 1.37±0.15 6
Cirrhosis
18 weeks
rat 7 rat 8 rat 7 rat 8 rat 7 rat 8
1 2.77 1.39 23.39 19.26 1 1
2 1.19±0.21 6.09±1.37 × 10−1 5.87±0.92 7.84±2.53 10 14
3 6.38±0.87 × 10−1 3.26±0.49 × 10−1 7.59±2.43 6.56±1.67 20 20
4 3.51±0.75 × 10−1 1.77±0.31 × 10−1 4.51±1.40 4.66±1.49 60 93
5 1.85±0.33 × 10−1 1.08±0.14 × 10−1 3.53±0.94 3.51±0.81 148 138
6 1.12±0.14 × 10−1 7.69±0.58 × 10−2 2.47±0.58 3.08±0.63 213 108
7 7.96±0.75 × 10−2 6.27±0.15 × 10−2 2.22±0.48 2.36±0.59 179 21
8 5.79±0.49 × 10−2 5.37±0.44 × 10−2 1.44±0.22 1.67±0.21 80 24
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Table 5.2:e macroscopic portal veins were classied according to their diameter-
dened branching topology at dierent time points during cirrhogenesis.e mean
radius, the mean length, and the number of vessels were measured based on the
assigned generation numbers.
Portal veins Generation Mean radius (mm) Mean length (mm) # Vessels
Healthy
liver
0 weeks
rat 1 rat 2 rat 1 rat 2 rat 1 rat 2
1 1.28 1.28 13.41 15.96 1 1
2 8.07±1.13 × 10−1 8.05±1.17 × 10−1 7.90±1.52 8.14±2.19 6 8
3 4.97±0.65 × 10−1 4.47±0.62 × 10−1 6.06±1.71 7.04±1.49 22 25
4 2.91±0.45 × 10−1 2.60±0.41 × 10−1 4.02±0.99 3.84±1.05 98 103
5 1.71±0.29 × 10−1 1.52±0.23 × 10−1 2.41±0.61 2.86±0.62 293 259
6 1.03±0.15 × 10−1 9.69±1.24 × 10−2 1.98±0.41 1.84±0.38 446 378
7 6.80±0.77 × 10−2 6.80±0.71 × 10−2 1.47±0.26 1.32±0.22 384 243
8 5.00±0.31 × 10−2 4.96±0.25 × 10−2 1.07±0.17 0.98±0.13 96 26
Hepatitis
6 weeks
rat 3 rat 4 rat 3 rat 4 rat 3 rat 4
1 1.55 1.40 16.80 15.98 1 1
2 9.01±1.32 × 10−1 8.16±0.61 × 10−1 11.20±2.78 14.82±2.47 8 6
3 4.63±0.75 × 10−1 4.72±0.94 × 10−1 7.29±1.84 7.02±1.78 40 36
4 2.67±0.44 × 10−1 2.54±0.45 × 10−1 3.88±0.89 4.13±0.86 159 147
5 1.57±0.25 × 10−1 1.44±0.23 × 10−1 2.92±0.61 2.97±0.62 427 387
6 1.01±0.12 × 10−1 9.46±1.09 × 10−2 1.14±0.33 1.80±0.32 596 419
7 7.24±0.67 × 10−2 6.96±0.42 × 10−2 1.57±0.22 1.30±0.22 364 121
8 5.29±0.37 × 10−2 5.57±0.41 × 10−2 1.22±0.14 0.97±0.18 56 36
Advanced
brosis
12 weeks
rat 5 rat 6 rat 5 rat 6 rat 5 rat 6
1 1.37 1.58 17.40 13.11 1 1
2 8.40±0.59 × 10−1 8.61±1.11 × 10−1 10.62±1.85 16.16±2.36 7 6
3 5.03±0.74 × 10−1 4.56±0.66 × 10−1 6.42±1.64 7.02±1.66 31 45
4 2.86±0.47 × 10−1 2.44±0.73 × 10−1 3.61±0.92 3.56±0.85 130 166
5 1.68±0.27 × 10−1 1.40±0.21 × 10−1 2.81±0.63 2.28±0.50 287 296
6 1.06±0.15 × 10−1 9.45±0.92 × 10−2 2.09±0.40 1.45±0.27 380 170
7 7.10±0.84 × 10−2 6.64±0.78 × 10−2 1.52±0.27 1.18±0.21 203 83
8 4.70±0.21 × 10−2 1.12±0.11 10
Cirrhosis
18 weeks
rat 7 rat 8 rat 7 rat 8 rat 7 rat 8
1 1.71 1.01 18.21 17.64 1 1
2 9.35±0.69 × 10−1 6.73±0.60 × 10−1 13.50±2.92 11.80±1.75 5 6
3 5.53±0.85 × 10−1 4.05±0.59 × 10−1 9.47±1.90 5.93±1.21 19 23
4 3.25±0.54 × 10−1 2.50±0.41 × 10−1 4.11±1.13 4.57±1.06 93 67
5 1.96±0.31 × 10−1 1.55±0.22 × 10−1 2.70±0.69 3.43±0.75 215 121
6 1.21±0.17 × 10−1 1.02±0.11 × 10−1 2.35±0.52 2.00±0.49 360 127
7 8.62±0.72 × 10−2 7.64±0.64 × 10−2 1.78±0.34 1.51±0.40 163 53
8 6.61±0.55 × 10−2 5.78±0.39 × 10−2 1.20±0.23 1.02±0.13 75 20
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Table 5.3: e macroscopic hepatic arteries were classied according to their
diameter-dened branching topology at dierent time points during cirrhogenesis.
e mean radius, the mean length, and the number of vessels were measured based
on the assigned generation numbers.
Hepatic arteries Generation Mean radius (mm) Mean length (mm) # Vessels
Healthy
liver
0 weeks
rat 1 rat 2 rat 1 rat 2 rat 1 rat 2
1 1.74 × 10−1 1.71 × 10−1 4.97 9.04 1 1
2 1.11±0.13 × 10−1 9.60±0.86 × 10−2 11.69±1.79 7.16±2.59 4 3
3 7.74±0.86 × 10−2 7.34±0.65 × 10−2 7.75±1.78 10.45±2.24 9 6
4 5.91±0.43 × 10−2 5.73±0.34 × 10−2 6.98±1.20 6.58±1.48 13 7
5 4.54±0.33 × 10−2 4.81±0.19 × 10−2 2.59±0.61 8.08±2.27 20 17
Hepatitis
6 weeks
rat 3 rat 4 rat 3 rat 4 rat 3 rat 4
1 1.82 × 10−1 1.82 × 10−1 6.23 15.49 1 1
2 1.10±0.12 × 10−1 1.35±0.81 × 10−1 11.68±2.73 3.83±0.76 5 3
3 6.92±0.95 × 10−2 7.98±1.24 × 10−2 12.10±2.59 11.45±2.47 9 13
4 5.13±0.29 × 10−2 5.26±0.47 × 10−2 5.58±1.11 5.05±1.17 12 21
5 4.46±0.08 × 10−2 4.20±0.16 × 10−2 6.28±1.94 2.94±0.79 12 7
Advanced
brosis
12 weeks
rat 5 rat 6 rat 5 rat 6 rat 5 rat 6
1 2.06 × 10−1 2.35 × 10−1 2.90 3.99 1 1
2 1.37±0.02 × 10−1 1.78±0.18 × 10−1 4.85±1.41 9.11±0.79 2 2
3 8.20±0.74 × 10−2 1.16±0.11 × 10−1 11.38±2.31 13.94±2.53 7 10
4 6.04±0.38 × 10−2 9.04±0.69 × 10−2 9.93±2.17 7.68±0.48 11 16
5 4.7±0.27 × 10−2 6.53±0.56 × 10−2 4.08±0.88 3.30±0.96 7 14
Cirrhosis
18 weeks
rat 7 rat 8 rat 7 rat 8 rat 7 rat 8
1 3.01 × 10−1 2.69 × 10−1 20.40 14.04 1 1
2 1.85±0.13 × 10−1 1.87±0.15 × 10−1 6.47±1.30 13.30±2.53 5 4
3 1.37±0.16 × 10−1 1.30±0.12 × 10−1 8.63±2.21 7.25±1.79 11 16
4 9.87±0.73 × 10−2 9.79±1.21 × 10−2 6.15±1.52 5.23±1.29 18 32
5 7.27±0.66 × 10−2 7.23±0.62 × 10−2 3.14±0.96 2.92±1.07 31 24
6 5.38±0.56 × 10−2 5.52±0.58 × 10−2 1.73±0.60 1.83±0.44 12 25
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Modelling rat
haemodynamics during
cirrhogenesis
In this chapter, we will present a closed-loop model of the rat circulation to
simulate the systemic and hepatic haemodynamics at various time points
during the genesis of cirrhosis.e liver building block is calibrated based on
the morphological data from chapter 5 and modelled lobe-specically to assess
the intrahepatic ow distribution.
is chapter is based on: “Closed-loop lumped parameter modelling of
haemodynamics during cirrhogenesis in rats”, submitted for publication [12].
6.1 Introduction
Cirrhosis is the common end-stage of any chronically active liver disease.
It develops aer persistent destruction and regeneration of parenchymal
liver cells, initiating necro-inammation and brogenesis [222]. Eventually,
normal liver tissue is replaced by diuse brosis, vascularized brotic
septa, and regenerative nodules [249]. Previous studies have shown that
the associated morphological reorganization of the hepatic architecture
contributes to an increase of the intrahepatic vascular resistance (IHVR),
dysregulating liver perfusion [166, 283].
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Cirrhosis is clinically divided into two stages: compensated and decom-
pensated cirrhosis.e compensated stage represents the non-symptomatic
phase, which may deteriorate towards decompensation characterized by clin-
ical signs usually leading to hospitalization. Portal hypertension (PHT) is
the earliest and most common clinical complication of liver cirrhosis. Ag-
gravation of PHT leads to variceal haemorrhage, hepatic encephalopathy,
hepatopulmonary syndrome, and hepatorenal syndrome, which are major
causes of morbidity and mortality in cirrhotic patients [33].
e pathogenesis of PHT originates from an increased IHVR (70%) and
is further aggravated by dynamic vascular changes (30%) [288].e dynamic
(and reversible) component is primarily established by local imbalances
between vasoconstrictor and vasodilator compounds [283]. Production of
the vasodilatory nitric oxide (NO) molecule is reduced in the portal vein
(PV), thereby increasing its resistance to ow. Paradoxically, extrahepatic
vascular beds (including the mesenteric and peripheral beds) are subjected
to an upregulation of vasodilators, leading to a hyperdynamic circulation
characterized by low systemic vascular resistance, and increased cardiac
output (CO), heart rate (HR), and plasma volume [123, 194].
e progressive IHVR promotes the formation of an extensive network
of hepatic collateral vessels (shunts) that may divert up to 80% of the PV
blood ow, partially but insuciently alleviating the raised portal pressure
[301].
To date, little research has focused on modelling liver haemodynamics
in pathological conditions (e.g. cirrhosis). Li et al. [172] developed 3D
computational uid dynamics (CFD) models of healthy and cirrhotic human
livers to study blood ow through the PV and mesenteric vein. Geometries
were based on CT-scans and results indicated that – in the case of cirrhosis –
right-lobe atrophy was signicantly inuenced by the distribution of the
splenic venous blood. Van Steenkiste et al. [291] used vascular corrosion
casting (VCC) to study vascularmorphological changes and CFD simulations
to compute the PV wall shear stress (WSS) in portal hypertensive and
cirrhotic rodents. Additional to the macroscale models, only few studies have
focused on modelling of the hepatic microcirculation, especially in cirrhotic
livers. Debbaut et al. [60] performed image-based CFD simulations of the
human sinusoidal 3D network, thereby characterizing the permeability tensor
of healthy liver lobules.e permeability tensor was subsequently used to
develop a generic 3D liver lobule model based on porous media [61]. Similar
simulations were conducted to quantify the permeability tensor of the human
hepatic microcirculation in the case of cirrhosis [215].e results suggested
the presence of local compensationmechanisms (e.g. dilated sinusoids) at the
microcirculatory level to alleviate PHT in cirrhotic livers. Altogether, most
liver cirrhosis modelling research has focused on PV or microcirculatory
haemodynamics of the liver.
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To our knowledge, the impact of cirrhogenesis on the entire blood circu-
lation has never been addressed from a modelling perspective.erefore, the
aim of this study is to simulate the hepatic haemodynamics, constituted by
ow through the hepatic artery (HA), the PV, and the hepatic veins (HV), as
well as the systemic haemodynamics throughout the genesis of cirrhosis (in-
cluding systemic circulatory disorders in late stage cirrhosis). Compensated
cirrhosis was chemically induced using the established thioacetamide (TAA)
rat model [161]. At predened time points during cirrhogenesis, 3D ge-
ometries of the hepatic vasculature were generated by combining VCC and
micro-computed tomography (µCT) imaging. Detailed morphological data
of the 3D geometries served as input for a lobe-specic resistive lumped para-
meter model of the liver [57], which was coupled to a closed-loop lumped
parameter model of the entire blood circulation [11]. Our setup allowed both
hepatic and systemic haemodynamics to be simulated in physiological and
pathological circumstances (e.g. cirrhosis).
6.2 Materials and methods
6.2.1 Rat model of TAA-induced cirrhosis
Cirrhogenesis was mimicked by prolonged administration of TAA (Sigma-
Aldrich, Bornem, Belgium) as described by Laleman et al. [161].e study
protocol was approved by the Ethical Committee of the University Hospital
Leuven (Belgium). Male Wistar rats (N = 20), weighing 250–300 g, were
randomly divided into four groups (N = 5).e animals were kept in cages
at a constant temperature and humidity in a 12 h controlled light/dark cycle,
with food and water provided ad libitum. Group 1 served as control group,
providing normal hepatic characteristics. Groups 2 to 4 were intoxicated for
6, 12, and 18 weeks, respectively. Initially, a concentration of 0.03 % TAA was
added to the drinking water. Hereaer, body weights were monitored weekly
and concentrations were adapted accordingly to keep individual bodyweights
within the limits of 250 and 300 g. With increasing TAA intoxication, rat livers
developed – from a histological perspective – hepatitis at 6 weeks, advanced
hepatic brosis at 12 weeks, and eventually homogeneous macronodular
cirrhosis at 18 weeks [161]. In the following sections, these time points will
be indicated by control (0 week), hepatitis (6 weeks), advanced brosis (12
weeks), and cirrhosis (18 weeks).
6.2.2 Data acquisition and processing
6.2.2.1 Vascular corrosion casting and µCT imaging
Aer their respective intoxication time (0, 6, 12, and 18 weeks), each group
of rats was subjected to VCC to generate accurate 3D replicas of their hepatic
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vascular system.e procedure began by carefully exposing the liver of the
anaesthetized rats. Heparin was administered intrasplenically to prevent
coagulation (Heparine Leo, Leo Pharma, Lier, Belgium).e casting resin
was sequentially injected, rst in the abdominal aorta (AA) and then in
the PV. To direct the resin ow into the liver, clamps were mounted on the
thoracic aorta (TA) and renal arteries (RAs).e polyurethane-based resin
contained PU4ii and hardener (VasQtec, Zurich, Switzerland), ethyl methyl
ketone (EMK) (Merckx, Darmstadt, Germany) and colour dyes (yellow and
blue for the HA and PV, respectively).e contrast agent Lipiodol (Guerbet,
Roissy-CdG, France) was added to the HA mixture to ensure a clear contrast
enhancement of the arterial tree on the µCT images. Shortly aer injection,
both aerent vessels and the thoracic caudal vena cava (CVC) were clamped
to prevent resin leakage.e resin was allowed to polymerize intrahepatically
for 72 h, before being macerated for about 5 days in 25% potassium hydroxide
(KOH).e vascular replicas were µCT-imaged at a resolution of 40 µmusing
a high-resolution µCT scanner (HECTOR, Centre for X-ray Tomography
(UGCT), Ghent University, Belgium) to acquire detailed 3D datasets of the
hepatic vasculature [183]. A more elaborate description of the VCC and µCT
protocol was described earlier in chapter 4.
6.2.2.2 Image processing
e µCTdatasets were processedwithMimics (Materialise, Leuven, Belgium)
to segment the hepatic vascular trees. Segmentations were carried out semi-
automatically. Due to the added contrast agent, dierent grey value ranges
were assigned to the arterial and venous systems [217].e grey value range
of HV also diered from the one of PV due to mixing of the injected HA
(with contrast agent) and PV resin. For each time point (0, 6, 12, and 18
weeks), two liver casts were processed to obtain 3D reconstructions of their
hepatic vascular trees (HA, PV, and HV).
Aer segmentation, these vascular trees were subdivided according to
their liver lobes. Typically, rat livers comprise four separate major lobes
(median lobe, le lateral lobe, right lobe, and caudate lobe), of which three
can be further subdivided in two sublobes [57]. For the PV and HA, the
vascular branching scheme starts at the trunk (Figure 6.1) and subsequently
branches towards the right medial lobe (RML), le medial lobe (LML), le
lateral lobe (LLL), right superior lobe (RSL), right inferior lobe (RIL), superior
caudate lobe (SCL), and inferior caudate lobe (ICL).e small paracaval liver
lobe (2% of total liver tissue), also called the caudate process and typically
nourished by two dierent PV branches, remained undetected. Its impact
on the perfusion, however, appears to be very limited as it only becomes
important in the case of extended liver resection (90% partial hepatectomy
(PHX)) [243]. A similar branching scheme was observed for the HV.e
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only dierence was that the RML is subdivided in two separate sublobes by
two anatomically well-dened HV trees (the RML-HV and middle medial
lobe (MML)-HV) (Figure 6.1).
6.2.2.3 Analysis of the lobe-specic vascular architecture
e 3D reconstructions of the lobe-specic vascular trees were individually
skeletonized and converted to graphs using the dedicated soware Deliver
(appendix A). By applying a diameter-dened top-down ordering algorithm
presented earlier in section 4.2.4.1, we were able to classify the trees according
to their branching topology and extract relevant morphological features (i.e.
radius, length, and number of vessels). To gather data across the entire
length scale, ranging from the major blood vessels down to the smallest liver-
specic capillaries (sinusoids), exponential trend lines (Eq. 6.1) were tted to
the geometrical attributes y as a function of the generation number n using
a lobe-specic exponential tting algorithm [57].
y = ae−bn (6.1)
A cost function c - based on the least squares method - was implemented in
Matlab and minimized to determine the optimal exponential power b and
y-intercept a of the exponential functions (see Eq. 6.2) [57]. We assumed that
b values were similar for all lobes of a liver and that these lobes only diered
in their initial starting value, as dened by the a value.
c = g∑
j=1
⎛⎝ x j∑n=1 (ln(a j) + b ⋅ n − ln(y j,n))2⎞⎠ (6.2)
where j is the lobe number, g the total number of lobes, x j the total number
of generations of lobe j, and y j,n the average of the geometrical measure for
the nth generation of lobe j.
e total number of generations for each PV and HV lobar vascular
tree was estimated by extrapolating the radius until reaching mean values
representing sinusoids (as reported in chapter 5). For 0, 6, 12, and 18 weeks of
TAA intoxication, mean sinusoidal radii were measured to be 4.41 ± 0.23 µm,
4.33 ± 0.36 µm, 3.83 ± 0.24 µm, and 3.91 ± 0.47 µm, respectively. As HA and
PV trees typically run in parallel aer the rst generations, we assumed that
the total number of generations for each HA lobar vascular tree was equal
to its PV counterpart. Furthermore, sinusoids were considered terminal
HV branches, hence the nal (extrapolated) generation of the HA and PV
trees was removed. Trend lines of the radius, length, and number of vessels
for a cirrhotic liver are presented in (Figure 6.2). Since rat liver lobes vary
widely in size, variations were also observed in the total number of vessel
generations for the vascular trees of dierent lobes.
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Figure 6.1: Lobar branching scheme of the rat hepatic vascular trees (hepatic veins
(HV), portal vein (PV), and hepatic artery (HA)) at dierent time points during
cirrhogenesis. Rat livers comprise four separate major lobes (median lobe, le lateral
lobe, right lobe, and caudate lobe), of which three were further subdivided in two
sublobes. For the PV and HA vascular trees, the branching scheme starts at the
trunk (grey), which subsequently branches towards the right medial lobe (RML), le
medial lobe (LML), le lateral lobe (LLL), right superior lobe (RSL), right inferior
lobe (RIL), superior caudate lobe (SCL), and inferior caudate lobe (ICL). A similar
branching scheme was observed for the HV.e only dierence (indicated by a
star) entails subdividing the median lobe based on three anatomically well-dened
HVs, draining the RML, middle medial lobe (MML), and LML.
Modelling rat haemodynamics during cirrhogenesis 125
Figure 6.2: Analysis of the lobe-specic vasculature (hepatic veins, portal veins, and
hepatic arteries) in the case of cirrhosis (cirrhosis 2). Exponential trend lines were
tted to the geometrical attributes (i.e. radius, length, and number of vessels) as a
function of the generation number using a lobe-specic tting algorithm [57].e
lobe-specic exponential trend lines start at generation 2, as the rst generation
depicts the attributes of themain trunk. Le lateral lobe (LLL), lemedial lobe (LML),
right medial lobe (RML), right superior lobe (RSL), right inferior lobe (RIL), inferior
caudate lobe (ICL), and superior caudate lobe (SCL).
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6.2.3 Lumped-parameter model
6.2.3.1 Closed-loop model
To simulate hepatic and systemic haemodynamics, we developed a closed-
loop model of the rat blood circulation (Figure 6.3) based on a lumped-
parameter model for porcine applications [11]. e model was adapted
to the rat by adjusting the model parameters using literature [54, 75, 161,
204] and previously acquired haemodynamic values via microspheres in
rats [287]. e building blocks of the model include the heart, the lungs,
the liver, the digestive organs (including the spleen), and other organs (see
Figures 1.1 and 6.3).e heart model (Eq. 6.3) was adopted from [27, 274] and
is presented in more detail in [13]. Briey, it consists of four heart chambers
(i.e. the right atrium, right ventricle, le atrium, and le ventricle) and four
heart valves.e heart chambers are described following an elastance-based
modelling approach to account for the heart contraction⎧⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎩
Pi = Ei(t) (Vi − V0,i)
∂Vi
∂t = Qin,i − Qout,i
Qout,i = G(∆Pi)∆Pi (6.3)
where Vi and V0,i refer to the volume and unloaded volume of heart
chamber i, Qin,i and Qout,i denote the incoming and outgoing ows, Pi
is the heart chamber pressure, and ∆Pi is the pressure drop across the heart
valve. Ei(t) is the elastance function
Ei(t) = EA,ie(t)α i + EB,i (6.4)
where EA,i and EB,i are the amplitude and baseline values of the elastance,
respectively. Also, αi = 1 for atria and αi = 0.5 for ventricles. e(t) is a
normalized time-varying function of the elastance, which is dened for
ventricles as
ev(t) =
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎪⎪⎪⎩
1
2 [1 − cos (pi tTvc )] 0 ≤ t ≤ Tvc
1
2 [1 + cos (pi t−TvcTvr )] Tvc < t ≤ Tvc + Tvr
0 Tvc + Tvr < t ≤ T
(6.5)
and for atria as
ea(t) =
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎩
1
2 [1 + cos (pi t+T−tarTar )] 0 ≤ t ≤ tar + Tar − T
0 tar + Tar − T < t ≤ tac
1
2 [1 − cos (pi t−tacTac )] tac < t ≤ tac + Tac
1
2 [1 + cos (pi t−tarTar )] tac + Tac < t ≤ T
(6.6)
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Here, T refers to the duration of the cardiac cycle, Tvc , Tac , Tvr , and Tar
denote the durations of the ventricular/atrial contraction/relaxation, and tac
and tar are the times when the atria begin to contract and relax, respectively
[27].
e heart valves are implemented by logistic functions to allow for
smooth yet sharp transitions between open and closed states (see Eq. 6.7).
G(∆Pi) represents the valve conductance with G0 = 0.1 × 10−5 m3 ⋅ Pa−1 ⋅ s−1
and d = 0.01 Pa.
G(∆Pi) = G01 + e−(∆Pi−d) (6.7)
e other building blocks (lungs, digestive organs, and other organs)
were implemented by three-element Windkessel models (Eq. 6.8; see also the
RCR-block of Figure 6.3)⎧⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎩
C ∂Pk∂t = Qin − Qout
RpQin = Pp − Pk
RdQout = Pk − Pd (6.8)
where Qin and Qout denote the incoming and outgoing ows, Rp and Rd are
the proximal and distal resistances, C is the capacitance, Pp and Pk represent
the pressures proximal and distal to Rp, and Pd is the pressure distal to Rd ,
respectively.
e closed-loop model was further modied to integrate a lobe-specic
model of the rat liver, comprising seven lobes [182]. e liver lobes were
modelled to include three vascular trees (HA, PV, and HV), each represented
by a separate resistance (Figure 6.3). Noteworthy, the HV equivalent
resistance of the RML was calculated based on both draining HV vascular
trees (MML-HV and RML-HV). HA, PV, and HV branches common to
several lobes were modelled by separate resistances and computed based
on the VCC data. Furthermore, an extrahepatic shunt was implemented to
model the collateral network in the case of cirrhosis (Figure 6.3). Unless
stated otherwise, the resistance of this shunt was set to a high value, allowing
virtually no ow through the blood vessel (see Table 6.2).
For each time point (0, 6, 12, and 18 weeks), we computed the equivalent
vascular resistances Req (Pa ⋅ s ⋅m−3) of the lobar vascular trees (HA, PV, and
HV) of two cast rat livers, assuming Poiseuille ow (Eq. 6.9). In this way, the
resistance solely depends on the dynamic viscosity of blood µ (3.5× 10−3 Pa⋅s)
and geometrical features, including the mean length ln, the number of vessels
mn, and the mean radius rn of each blood vessel generation n, with x the
total number of generations.
Req = x∑
n=1
8µln
mnpirn4
(6.9)
128 Chapter 6
Figure 6.3: Schematic representation of the closed-loop lumped model for the rat
circulation. e model is based on [11, 57] and includes a resistive liver model,
comprising seven lobes and common branches of the hepatic artery (HA) and portal
vein (PV). Extra-hepatic shunts were also included and are represented by a single
vascular resistor. e vascular resistances of the lobes were computed based on
geometrical analyses of µCT-imaged liver casts.e remaining model parameters,
used to mimic the heart, digestive and other organs, are documented in Table 6.2.
e model equations, a nonlinear dierential-algebraic system, were
solvedwith the IDApackage from SUNDIAL [106].e dierential equations
were integrated with a Backward Dierentiation Formula and the obtained
non-linear system was solved with a Newton method.e solver provided
by IDA includes an adaptive time step method [106]. For each simulation,
the maximal time step was set to 10−4 s. For error control (at various levels),
IDA introduces a mixed relative and absolute tolerance criterion.e relative
and absolute tolerances for all simulations of this work were set to 10−6 for
each variable. Seven pressures were imposed as initial conditions (proximal
pressures of the three RCRWindkessel components as well as the four heart
chamber pressures).e simulated time was 2 s (10 cardiac cycles of 0.2 s).
For this simulation time, the average computation time on a quad-core laptop
computer was 5 s.
6.2.3.2 Model calibration
e closed-loop model was calibrated to baseline haemodynamics based on
the hepatic vascular data of two control rats (0-week TAA intoxication). We
calculated the equivalent vascular resistances of the liver lobes (Eq. 6.9) to
dene the lobe-specic liver model for each rat individually. Hereaer, model
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parameters of the rat heart were adjusted to provide mean arterial pressure
(MAP), CO, and HR values reported in literature (Table 6.1) [54, 75, 161, 204,
212]. More precisely, the heart parameters were manually calibrated based on
a simpler model, including four heart chambers, the pulmonary circulation,
and the systemic circulation.e resistance of the systemic circulation was
estimated byMAP/CO and the resistance of the pulmonary circulation by
∆P/CO with ∆P = 10 mmHg.e heart rate determined the contraction and
relaxation time of the heart chamber [27]. Unloaded volumes of the heart
chambers were estimated assuming proportionality to the body weight as
follows
V0,i = VH0,i WrWH (6.10)
where VH0,i is the unloaded volume of a human heart model [27], and
Wr = 250 g, WH = 70 kg are the average rat and human weights. Hence,
only the elastance baseline and amplitude of the heart chamber remained
to be calibrated.ese parameters were initially estimated based on values
for humans (reported in [27]) and subsequently tuned to match systole,
diastole and central venous pressures, reported in literature [54, 75, 161, 204,
212]. is resulted in Eri = αiEHi , where Eri and EHi are the rat and human
heart elastances, respectively, and αi ∈ [6.10−4, 5.10−3] is the scaling factor.
All heart parameters are listed in Table 6.2. Subsequently, the resistance of
the digestive organs Rdo was estimated based on PV pressures and ows
reported in literature (Rdo = (MAP–PPV)/QPV , with PPV and QPV the
pressure and ow of the PV, respectively). Hereaer, the resistance of the
other organs Roo was estimated based on the resistances of the HA (averaged
over both control rats), the digestive organs, and the systemic circulation
(Roo = 1/(1/Rsyst–1/RHA–1/Rdo)). Lastly, resistances and capacitances were
ne-tuned to simulate hepatic and systemic rat haemodynamics, reecting
physiological conditions (see Table 6.1).e model parameters - except for
the hepatic lobe resistances - remained the same for each simulation (i.e. for
each animal and cirrhogenic time point), unless mentioned otherwise. An
overview is presented in Table 6.2.
6.2.3.3 Systemic circulatory disorders
Cirrhogenesis (and PHT in particular) is postulated to induce pathological
mechanisms that dysregulate the systemic circulation, and may eventually
lead to a hyperdynamic circulatory state. Hence, the most relevant haemo-
dynamic consequences were added to the cirrhotic model (18-week TAA
intoxicated simulations) and tested by means of three cases [28, 90, 123]:
Case I: decreased MAP
Cirrhosismay induce a decrease of theMAP,mainly due to vasodilation of the
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Table 6.2: Model parameters dening the circulation of rats in physiological
conditions (control) and in the case of a hyperdynamic circulation (cirrhosis). Heart:
the heart rate was used to dene the duration of the ventricular and atrial contraction
and the relaxation in the elastance function; Ea and Eb stand for the amplitude
and baseline of elastance function E(t) = Eae(t) + Eb , with e(t) a normalized time-
varying function of the elastance [27, 274] for each cardiac chamber (right atrium,
right ventricle, le atrium, and le ventricle); V0 denotes the unloaded volume of
the heart chamber. Digestive organs and other organs are represented by three-
element Windkessel models where Rp and Rd are the proximal and distal resistance,
respectively, and C is the capacitance.
Model parameter Control Cirrhosis
Heart Heart rate (min−1) 300 300
Right atrium Ea (Pa ⋅m−3) 2.61 × 109 2.61 × 109
Eb (Pa ⋅m−3) 1.87 × 109 1.87 × 109
V0 (ml) 0.012 0.012
Right ventricle Ea (Pa ⋅m−3) 4.34 × 1010 4.34 × 1010
Eb (Pa ⋅m−3) 1.30 × 109 1.30 × 109
V0 (ml) 0.03 0.03
Le atrium Ea (Pa ⋅m−3) 1.47 × 1010 1.47 × 1010
Eb (Pa ⋅m−3) 3.93 × 109 3.93 × 109
V0 (ml) 0.012 0.012
Le ventricle Ea (Pa ⋅m−3) 3.66 × 1011 3.66 × 1011
Eb (Pa ⋅m−3) 7.80 × 109 7.80 × 109
V0 (ml) 0.015 0.015
Added venous return volume (ml) 0 0.5
Digestive organs Rdo ,p (Pa ⋅ s ⋅m−3) 9.51 × 109 4.76 × 109
Rdo ,d (Pa ⋅ s ⋅m−3) 8.56 × 1010 4.28 × 1010
C (Pa−1 ⋅ s−1 ⋅m3) 10−11 10−11
Other organs Roo ,p (Pa ⋅ s ⋅m−3) 107 107
Roo ,d (Pa ⋅ s ⋅m−3) 1.8 × 1010 9.0 × 109
Coo (Pa−1 ⋅ s−1 ⋅m3) 2.0 × 10−11 2.0 × 10−11
Extra-hepatic shunt R (Pa ⋅ s ⋅m−3) 1017 3.1 × 1010
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splanchnic and peripheral vascular beds (see section 2.5.3). Niederberger et al.
[204] reported a halving of the systemic vascular resistance aer 9–10 weeks
of carbon tetrachloride (CCl4) intoxication in rats. At that time, the rats had
already developed cirrhotic ascites. Similar observations were documented
for CCl4-induced cirrhotic rats without ascites by Fernández-Muñoz et al.
[75]. From a modelling perspective, vasodilation of the mesenteric and
peripheral vascular beds was achieved by reducing the total resistances of
the digestive and other organs by a factor of two (see Table 6.2).
Case II: increased CO
In the case of cirrhosis, an abnormal circulatory volume has been reported
[28].is is characterized by an increased venous blood return, consecutively
leading to an increased CO and PV ow. In the model, we implemented
this phenomenon by articially adding extra venous blood ow to the right
atrium.e venous volume was increased by 0.5 ml, which is about 10% of
the returned venous volume per heartbeat. As such, the overall blood volume
and CO were increased [75, 204].
Case III: collaterals development
An extensive network of collaterals (mainly portosystemic and splenorenal
shunts) may develop in cirrhosis. In this way, blood can bypass the liver,
leading to a decreased PV inow. Our morphological analysis had revealed
two portosystemic shunts in one of the cirrhotic rats (cirrhosis 2), shunting
blood directly from the portal trunk into the caudal vena cava (illustrated
in Figure 5.4C). In addition, previous research reported that blood ow
through the splenorenal shunt was multiplied by 3.5 in the case of TAA-
induced cirrhotic rats [161]. Hence, an extrahepatic shunt was added to the
model by means of a vascular resistance to guide part of the blood from the
digestive organs directly into the systemic venous system (see Figure 6.3) [45,
99, 161]. As the combined eect of portosystemic and splenorenal shunts
was embodied by this single vascular resistance, the extrahepatic shunt was
calibrated to divert about 30% of the PV ow (see Table 6.2). is value
was arbitrarily chosen as it is highly rat dependent, but it concurred with
literature [301].
6.3 Results
e hepatic and systemic haemodynamics for the dierent time points were
obtained by averaging the simulations over the last cardiac cycles aer
periodic convergence of the solution. As haemodynamics diered between
rats belonging to the same group, we will report the resulting values using
the following notation m [r1, r2], with m, r1, and r2 the mean value and the
value of the rst and second rat, respectively.
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6.3.1 Baseline haemodynamic state
e simulated total PV and HA inows of the control rats were
0.17 [0.17, 0.17] ml ⋅ s−1 and 0.025 [0.036, 0.014] ml ⋅ s−1, respectively.
e hepatic venous pressure gradient (HVPG), dened as the dierence
between the PV (PPV ) and venous pressure (PV ), and the MAP were equal
to 3.6 [3.0, 4.1] mmHg and 127 [126, 128] mmHg, respectively. e CO
was 1.1 [1.1, 1.1] ml ⋅ s−1. ese haemodynamic parameters, resembling
physiological conditions, were in agreement with literature values (see
Table 6.1).
6.3.2 Hepatic haemodynamics during cirrhogenesis
To assess the global impact of the adaptive morphology on the hepatic
vascular resistance, equivalent resistances of the hepatic vascular trees
(HA, PV, and HV) were calculated for two animals of each time point
(see Table 6.3). At 6 weeks, the equivalent resistances were still close to
the control values. From 12 weeks onwards, the HA resistances gradually
decreased with development of cirrhosis, dropping from 7.94 [4.25, 11.6]× 1011
(control) to 1.12 [1.27, 0.98] × 1011 Pa ⋅ s ⋅ m−3 (cirrhosis). e equivalent
resistances of the PV did not show any unambiguous temporal pattern
between the groups. Moreover, one of the cirrhotic animals (cirrhosis 2,
probably with more advanced cirrhosis) demonstrated an increased PV
resistance (1.84 × 109 Pa ⋅ s ⋅m−3), while the other cirrhotic animal (cirrhosis 1)
indicated a decreased PV resistance (0.62 × 109 Pa ⋅ s ⋅m−3) compared to
control animals (1.09 [0.97, 1.22] × 109 Pa ⋅ s ⋅m−3). Most strikingly, however,
was the signicant increase of the HV resistances for the cirrhotic stage
(7.03 [5.97, 8.08] × 109 Pa ⋅ s ⋅m−3), reaching resistive values which were 7 to
9 times higher than the control values (0.85 [0.72, 0.97] × 109 Pa ⋅ s ⋅m−3).
e haemodynamic consequence of these cirrhosis-induced vascular
changes was determined via our closed-loop model, using lobe-specic
hepatic vascular resistances. Figure 6.4 presents an overview of the simulated
hepatic haemodynamics for the dierent time points and animals.
At 6 weeks (hepatitis), the HA and PV ows (0.03 [0.02, 0.03] and
0.17 [0.17, 0.17] ml ⋅ s−1, respectively) as well as the PV pressure (4.6 [4.6, 4.6]
mmHg)were comparable to control values. From 12weeks (advanced brosis)
onwards, the HA ow increased from 0.05 [0.02, 0.07] to 0.13 [0.11, 0.14]
ml ⋅ s−1 in cirrhosis and the PV ow slightly decreased from 0.17 [0.17, 0.16]
to 0.15 [0.15, 0.14] ml ⋅ s−1 in cirrhosis. An increase of the PV pressure was
observed going from 7.4 [5.4, 9.4] (advanced brosis) to 18.2 [14.3, 22.1]mmHg
(cirrhosis). Simultaneously, the HVPG also increased from 5.2 [3.2, 7.2]
(advanced brosis) to 16.0 [12.1, 19.8] mmHg (cirrhosis).e MAP slightly
decreased for cirrhotic animals (121 [122, 121] mmHg) compared to control
rats (127 [126, 128] mmHg).
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Table 6.3: e equivalent resistances (in Pa ⋅ s ⋅m−3) of the hepatic vascular trees
(hepatic artery (HA), portal vein (PV), and hepatic veins (HV)) calculated for two
animals for dierent time points of cirrhogenesis.
HA resistance PV resistance HV resistance
(× 1011 Pa ⋅ s ⋅m−3) (× 109 Pa ⋅ s ⋅m−3) (× 109 Pa ⋅ s ⋅m−3)
Control 1 4.25 0.97 0.72
Control 2 11.6 1.22 0.98
Hepatitis 1 6.67 0.82 0.82
Hepatitis 2 5.91 0.97 0.61
Advanced brosis 1 7.76 0.79 1.34
Advanced brosis 2 2.06 1.25 3.10
Cirrhosis 1 1.27 0.62 5.97
Cirrhosis 2 0.98 1.84 8.08
Purely looking from a haemodynamic modelling perspective, we ob-
served that rat livers – intoxicated for 12 weeks – appeared to be in a transi-
tional phase: while one liver (advanced brosis 1) yielded normal haemody-
namics, the simulation of the other liver (advanced brosis 2) already showed
impaired hepatic haemodynamics with developing PHT.
6.3.3 Interlobar ow distribution
Intrahepatically, we noticed that ow distributions varied between lobes, i.e.
dierent lobes received dierent percentages of the total HA and PV ows.
Self-evidently, larger lobes (e.g. LLL and RML) received relatively high inow
(Figure 6.5), whereas smaller lobes (RIL and SCL) received smaller inow
[182].e lobes also received more PV than HA blood, though the HA ow
appeared to increase for virtually every lobe during cirrhosis development
with the opposite being true for the lobar PV ow. Moreover, lobes receiving
smaller PV ow (e.g. RML in control; RSL and SCL in advanced brosis;
LML, RSL, RIL, and ICL in cirrhosis) were mostly perfused by higher HA
ow (or vice versa), probably attempting to maintain constant inow of the
lobes. In both animals of the cirrhotic stage and animal 1 of the advanced
brotic stage, lobes (e.g. LML, RSL, ICL, and SCL) even showed reversed PV
ows, accompanied by atypically high HA ows.
6.3.4 Sinusoidal pressure
At the microlevel, simulated sinusoidal pressures also varied between the
dierent lobes, ranging from 3.1 (ICL; control 1) to 5.0 mmHg (RIL; control 2)
under physiological conditions (Figure 6.6). Sinusoidal pressures remained
stable during the rst phases of cirrhogenesis until reaching the advanced
136 Chapter 6
Figure6.5:Lobe-specicdistributionsofthehepaticarterial(H
A
;top
panel)and
portalvenous(PV;bottom
panel)ow
sfordierenttim
epoints
ofcirrhogenesis.In
anim
alsofthecirrhoticstage(and
advanced
broticstage),an
abnorm
alow
pattern
w
asdetected
asPV
ow
w
asreversed
in
severallobes(e.g.LM
L,RSL,ICL,and
SCL).
oselobesreceived
an
atypically
high
percentageofH
A
ow.Le
laterallobe(LLL),le
m
ediallobe
(LM
L),rightm
ediallobe(RM
L),rightsuperiorlobe(RSL),rightinferiorlobe(RIL),inferiorcaudatelobe(ICL),and
superiorcaudatelobe(SCL).
Modelling rat haemodynamics during cirrhogenesis 137
brotic stage (12 weeks), at which they started to increase steadily up to values
of 11.4 (SCL; cirrhosis 1) and 25.0 mmHg (RSL; cirrhosis 2) aer 18 weeks of
TAA administration.
6.3.5 Systemic circulatory disorders in cirrhosis
Figures 6.7 and 6.8 depict the impact of the circulatory disorders on the
systemic and hepatic haemodynamics. In the absence of any systemic
disorder, the 18-week simulations showed that the CO, the splanchnic ow,
the HA ow, and the PV ow were equal to 1.2 [1.1, 1.2], 0.15 [0.14, 0.15],
0.13 [0.11, 0.14], and 0.15 [0.15, 0.14] ml ⋅ s−1, respectively. e MAP and
PV pressure were simulated to be 122 [122, 121] and 18.2 [14.3, 22.1] mmHg,
respectively.
Modelling systemic vasodilation (case I) led to an increase of the CO
(1.4 [1.4, 1.4] ml ⋅ s−1), the splanchnic ow (0.17 [0.18, 0.16] ml ⋅ s−1), and
the PV ow (0.17 [0.18, 0.16] ml ⋅ s−1). On the other hand, the HA ow
(0.08 [0.07, 0.08] ml ⋅s−1), theMAP (79 [79, 79] mmHg), and the PV pressure
(17.8 [14.4, 21.2] mmHg) decreased due to the reduced vascular resistance of
the systemic circulation. Articially adding blood volume (case II) caused
ows and pressures to increase with a factor of about 1.3. e collateral
network (case III) was implemented to shunt 30% of the total PV ow directly
into the vena cava. As a result, the PV pressure (15.0 [12.4, 17.6] mmHg)
and the PV ow (0.09 [0.10, 0.08] ml ⋅ s−1) decreased, while other systemic
haemodynamics remained more or less unaected.
Compared to control haemodynamics, the combined eect of the three
cases (case I-III) caused the CO (1.8 [1.8, 1.8] ml ⋅ s−1), the splanchnic ow
(0.24 [0.25, 0.23] ml ⋅s−1) and the PV ow (0.17 [0.19, 0.15] ml ⋅s−1) to increase,
while the HA ow decreased (0.1 [0.09, 0.11] ml ⋅ s−1). In this case, the MAP
(104 [104, 104] mmHg) also decreased and the PV pressure (19.7 [16.7, 22.7]
mmHg) increased.e central venous pressure increased from 2.2 [2.2, 2.2]
in control to 3.6 [3.6, 3.6] mmHg in the cirrhotic case I-III.
Alongwith the systemic circulation, changes in the pulmonary circulation
were also observed in the simulation of case I-III.e right ventricular systolic
pressure was elevated (42.5 [42.5, 42.5] mmHg), as were the pulmonary
artery mean (increasing from 22.2 [22.3, 22.1] in control to 35.2 [35.2, 35.2]
mmHg for case I-III) and the systolic pressure (26.7 [26.8, 26.6] in control to
42.5 [42.5, 42.5] mmHg for case I-III).
6.4 Discussion
To the best of our knowledge, the present study is the rst to model the
entire blood circulation of the rat during cirrhogenesis. At four discrete
time points during cirrhogenesis, VCC and µCT imaging were used to nely
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Figure 6.8: Relevant circulatory disorders in the case of cirrhosis were added to
the model by virtue of three cases. eir impact on the mean arterial pressure
(MAP) and portal venous (PV) pressure was simulated for both cirrhotic animals
and compared to values obtained in the absence of any disorder (blue bars) and to
value ranges reported in literature (last bars; minimum in shaded grey andmaximum
in darker grey) [75, 161, 204, 287]. Case I entailed vasodilation of the mesenteric and
peripheral vascular beds, while case II denoted the increase of the circulatory volume.
Case III was implemented to include extra-hepatic shunts such as splenorenal and
portosystemic shunts.
capture and reconstruct detailed geometries of the hepatic vasculature in 3D.
Morphological quantication of the hepatic vascular trees was performed
in a lobe-specic way and according to their diameter-dened branching
topology, as calculated using dedicated soware DeLiver (see section 4.2.4.1
and appendix A).is approach allowed a lobe-specic resistive model of
the rat liver to be developed, based on the principles of the open-loop model
of Debbaut et al. [57]. is lobe-specic liver model was integrated into
a closed-loop model of the systemic circulation as proposed by Audebert
et al. [11]. We successfully adapted and calibrated the integrated model to
mimic rat haemodynamics, enabling us to simulate and analyse intra- and
extrahepatic haemodynamics for dierent time points of cirrhogenesis.
e results of the simulations clearly portray the impact of the changing
hepatic vascular resistances on the haemodynamics during cirrhosis devel-
opment. We noted that the pathological changes of the hepatic vasculature
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instigated PV pressures to rise gradually, eventually leading to PHT.ese
results concur with haemodynamic measurements performed earlier in the
same TAA rat model, indicating that PHT was already present aer 12-week
intoxication [161]. Aer 18 weeks, our simulations without systemic circula-
tory disorders indicated that PV pressures increased up to about threefold its
control value due to a combination of factors. A decreased HA resistance in-
duced HA ow to increase, which, even without any other resistance change,
increases the sinusoidal pressure. Furthermore, HV resistance increased,
inducing a larger HVPG, which is even larger with increased HA ow. Both
lead to an increase of the PV pressure. Hence, the commonly reported ‘IHVR
increase’ (thought of as ‘PV pressure - or HVPG - over PV ow’) potentially
reects in fact a combination of mechanisms.
In addition, the lobe-specicity of the liver model allowed interlobar
ow distributions to be assessed, which, when analysing mean values, were
observed to dier between liver lobes. We encountered that low lobar PV
ow was mostly accompanied by higher HA ow to that specic lobe (or vice
versa). Similar ndings have been documented in [57] and could be related
to the hepatic arterial buer response (HABR) [163], attempting to maintain
constant irrigation of liver lobes, or to the ow competition between the HA
and PV ow [196].
In cirrhotic animals, an abnormal ow pattern was detected with PV ow
being reversed in some lobes (Figure 6.7). Reversal of PV ow is generally
considered a precursor of hepatofugal ow and indicates the presence of
advanced PHT [83].e lobes experiencing reversed PV ow were mostly
accompanied by an atypically high HA ow, suggesting that the HABR
mechanism may still be present in more advanced stages of cirrhosis.
Lastly, the closed-loop model was adapted by means of three cases
to account for circulatory disorders responsible for the hyperdynamic
circulation in cirrhosis [75, 161, 204, 287]. We simulated the impact of each
case on the haemodynamics individually. However, individual cases were
unable to replicate all observed disorders. Vasodilation of the peripheral and
splanchnic vascular beds (case I) inducedmost of the expected hyperdynamic
characteristics, though the increase of CO remained too small [75, 204].e
CO increased by articially increasing the blood volume (case II). However,
case II also led to an increase of MAP, whereas in cirrhosis a decreased MAP
is expected. Increasing the blood volume being shunted around the liver
(case III) reduced the PV pressure, but this had no signicant impact on
the other systemic parameters. e simulation combining the three cases
was found to resemble cirrhotic conditions the closest, as haemodynamics
were in agreement with literature values (see literature values in Figure 6.7
and Figure 6.8) [75, 161, 204, 287]. However, the increase of the CO was still
underestimated in this simulation.
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We concluded that the main circulatory disorders - inherent to a
hyperdynamic state - could be reproduced by combining the three cases.
e combined simulations produced results that were in close agreement
with haemodynamics measurements performed earlier in the same rat model
[161]. Moreover, the simulations suggested that PHT – the main clinical
manifestation of cirrhosis – was initiated by the ‘increased IHVR’ (in the
sense discussed above) and that liver dysfunction was further aggravated by
circulatory disorders, inducing other clinical complications. Furthermore,
pressures in the pulmonary artery and right heart chambers increased when
systemic circulatory disorders were included in the cirrhotic simulations.
Similar observations were reported in [195].e added venous return and
systemic vasodilatation increased the pressure in the right atrium, which
in turn caused the right ventricle and the pulmonary artery pressures to
increase.
Some aspects of this study were very labour-intensive and time-
consuming.is was particularly the case for the segmentation of the µCT
datasets, which is the reason only two liver casts were fully segmented for
each time point. To accurately model all vascular trees, liver casts should
ideally be µCT-imaged at a suciently high resolution to allow the HA to
be reconstructed up to the same generation as the PV.is was, however,
technically impossible with the current computational capabilities, as
diameters of HA branches were typically smaller than PV branches. In
one of the control simulations, we obtained a simulated HA ow (0.014
ml ⋅ s−1, control 2) smaller than reported in literature. We assumed that
either the HA ow was lower than usual in this particular animal or that
the equivalent resistance of the HA was overestimated due to the limited
imaging resolution. Nevertheless, we concluded that the inclusion of HA
trees into the liver model was essential, as it provided better insight into
the adaptive ow distribution between lobes as well as the HA-PV ow
interaction/competition during cirrhogenesis (i.e. low PV ows were most
likely compensated by high HA ows to the lobes).
Towards the future, haemodynamics (e.g. HA/PV pressures and ows,
MAP, and CO) and the percentage of shunted blood should be measured
prior to VCC of rat livers. In this study, we discussed the results in light of
previously performed measurements [75, 161, 204, 287]. Although it did not
allow for a one-on-one comparison/validation, simulated values were in close
agreement with the values measured in a previous study in the same animal
model (except for the CO). We adopted this approach to gain more insight
into a single aspect of cirrhosis, i.e. the impaired perfusion due to vascular
morphological changes. However, analysing (and segmenting) a larger
number of animals could shed more light on the observed haemodynamic
intervariability within groups.
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e lobule-scale was not precisely modelled, even though it is gener-
ally assumed that angioarchitectural changes of the microcirculation play a
pivotal role in the development of cirrhosis. In fact, the sinusoidal network
was merely represented by a single resistor in this model (the last generation
of HV). More accurate 3D models of the healthy and cirrhotic circulation
have been proposed (see chapter 3) [60, 100, 111, 198, 215, 217]. Coupling our
lobe-specic closed-loop model to more detailed models of the microcircu-
lation may facilitate gaining a better understanding of the haemodynamic
alterations at the microlevel during cirrhogenesis. Moreover, the Fahraeus-
Lindqvist eect was not accounted for, thereby assuming a constant blood
viscosity throughout the macro- and microcirculation [72].is assumption,
however, was justied for the present study, as we were mainly interested in
the relative haemodynamic dierences between consecutive time points of
cirrhogenesis.
Lastly, the transition from rat towards human seems inevitable to fully
elucidate this disease process. is would imply implementing a human
liver model accounting for the dierent segments of the human liver. Such
a segment-specic model would provide added value on the internal ow
distribution, which is useful to detect segments aected by hepatofugal ow.
A requisite for such a human liver model, however, is the development of
methods tomeasure or estimate necessarymodel parameters of each segment
noninvasively. Moreover it was not a priori obvious that the implemented
systemic circulatory disorders that came from observations from the human
[28, 90, 195] would lead to rat model outputs that matched rat experimental
data.e model may thus serve to test if cirrhosis triggers similar changing
haemodynamic mechanisms between species.
Besides providing a better insight into liver perfusion and haemody-
namics, the model may also be valuable for assessment of the “mechanistic
treatment” of patients. Oen, a transjugular intrahepatic portosystemic shunt
(TIPS) is placed within the liver to connect the PV to the systemic venous
circulation [197].e immediate eect of this procedure is lowering the PV
pressure, yet at the cost of bypassing the remaining functional hepatocytes
thus bypassing the remnant liver functionality. Our model simulations could
assist in sizing the TIPS (i.e. radius and length) for a specic patient to optim-
ise the trade-o between reducing the PV pressure and diverting unltered
blood around the liver.
6.5 Conclusion
Intra- and extrahepatic haemodynamics were simulated during TAA cirrho-
genesis in rats. At predened time points, VCC was used to nely reconstruct
the hepatic vascular trees in 3D. Quantications of the topology and mor-
phology of the hepatic vascular trees served as input for a lobe-specic liver
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model that was coupled to a closed-loop model of the entire circulation of
rats.e results revealed the impact of cirrhosis-induced hepatic vascular
changes on the hepatic/systemic haemodynamics during cirrhogenesis.e
model indicated that in the case of cirrhosis, an increase in HV resistance
combined with a decrease in HA resistance severely dysregulated liver perfu-
sion by increasing the HA ow, the pressure gradient over the HV system,
and thus the PV pressure.e commonly reported ‘IHVR increase’ reects
these coupled inuences. Systemic circulatory disorders, inherent to the
hyperdynamic state, were also included in the model and their specic inu-
ence on the hepatic, systemic, and pulmonary haemodynamics was studied.
e simulations concurred with haemodynamic measurements performed
earlier at similar time points and in the same animal model [161] when the
combination of systemic circulatory disorders was taken into account. Pul-
monary hypertension was an output of the model, quantifying its link with
liver disease.e impact of this work might be of interest for surgical liver
interventions, e.g. to predict the haemodynamic response aer TIPS surgery.
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Conclusions and future
perspectives
In this chapter, we will recapitulate the most important ndings and conclude
with relevant prospects for future research.
7.1 Looking back
e main objective of this work was to increase our understanding of the
pathogenesis of cirrhosis, especially at the microscopic level. With remodel-
ling of the hepatic vasculature being recognized as a key factor of cirrhogene-
sis, we aimed at clarifying the intricate relation between the progression of the
disease, the hepatic (angio)architectural disarrangement, and the impaired
vascular perfusion. To this end, an interdisciplinary approach was adopted
that ultimately allowed us to integrate the altering vascular morphology of rat
livers throughout cirrhogenesis into a computational model of the rat blood
circulation. In the introduction, we set three research goals, each with its
specic challenges. Below, the key ndings and novelties are summarised for
each of these goals and some methodological considerations are discussed.
148 Chapter 7
7.1.1 Key ndings and innovative aspects
Goal 1. Develop a multilevel methodology to analyse the hepatic vasculature
of rats
Amethodological framework was implemented to quantitatively analyse and
model the intricate vasculature of rat livers across multiple scales (chapter 4).
e framework was rst optimised for healthy rat livers, before we proceeded
to rat livers progressing to cirrhosis (goal 2).is study tackled a number of
known issues involving (i) the data acquisition and (ii) the analysis of the rat
hepatic vasculature.
Data acquisition. Two techniques, i.e. vascular corrosion casting (VCC)
and immunohistochemistry (IHC), were tailored specically for application
to the rat liver and their complementarity was exploited to provide unique
and novel morphological data on the rat hepatic vasculature throughout
cirrhosis development.
e VCC protocol was optimised to allow for dual casting via the hepatic
artery (HA) and portal vein (PV). As such, the combination of VCC and high-
resolution micro-computed tomography (µCT) enabled all hepatic vascular
trees (HA, PV, and hepatic veins (HV)) to be reconstructed from a single rat
liver and at multiple length scales.
e IHC technique, on the other hand, was extended with a chemical
clearing technology (CUBIC protocol) to allow for deep tissue imaging at
submicron resolutions when combined with confocal microscopy.e con-
focal images revealed the ne detail of the hepatic microvascular network.
Although the imaging depth remained conned to the lobule-scale microvas-
culature, unprecedented information retrieval depths of 150–200 µm were at-
tained in rats, thereby increasing the conventional imaging depth (50–60 µm)
by threefold.
Data analysis. Dedicated soware (DeLiver) was developed to segment
and/or analyse the vascular network of µCT and confocal datasets in an
automated and consistent way (see appendix A).e segmentation module
adopted the principles of the TiQuant soware [78]. However, it was
implemented from scratch and optimised for our specic applications by
adding new lters (e.g. cavity lling) to cope with the variable quality
of our images. Especially in datasets of diseased animals, we detected
abundant background autouorescence, necessitating additional image
preprocessing and segmentation steps to enhance the signal-to-noise ratio.
e analysis module, on the other hand, was built based on the source code of
TiQuant for graph construction, but was adapted conform to ourmacro- and
microvascular data. More specically, pruning algorithms were implemented
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to detect and remove erroneous vascular loops as well as “false” dead-end
branches. e module was further extended with a new functionality to
quantify the branching topology of hepatic vascular trees in a logical manner.
e latter was achieved by formulating a novel diameter-dened ordering
method, allowing generation numbers to be assigned based on graph theory.
Also, the diameters of vascular structures were measured using a best-t
approach, as venous blood vessels and sinusoids generally have an ellipsoidal
shape.
Goal 2. Quantify and map the vasculature of the rat liver throughout its
progression towards cirrhosis
e genesis of cirrhosis was revisited following the thioacetamide (TAA)
model to assess vascular remodelling of the rat liver in a controlled way
(chapter 5). At four time points during cirrhogenesis, unique morphological
data on the hepatic macro- and microcirculation was gathered by means of
the developed methodological framework (goal 1).is approach allowed
for unprecedented 3D reconstructions of the hepatic vasculature, revealing
various anatomical abnormalities attributable to cirrhosis development.
At the macroscale, we demonstrated that hepatic vascular trees were
aected by the cirrhosis-induced architectural disruption. From 12 weeks of
TAA intoxication onwards, the excessive deposition of brous tissue and the
formation of regenerative nodules commenced to compress the pliant venous
systems (PV and HV).e HV, in particular, were severely impacted by the
continuous tissue growth, with (partially) collapsed vessel segments impeding
hepatic blood drainage at 18 weeks of TAA intoxication. We anticipated
that this mechanical obstruction may have signicantly contributed to the
progressive increase of the total intrahepatic vascular resistance (IHVR), as
previously characterized haemodynamically in the TAA model for the same
time points [161].
At the microscale, we noticed declines of the microvascular porosity and
sinusoidal radii during cirrhogenesis. Aer 12 weeks of TAA intoxication,
both morphological features signicantly diered from those of control
animals. As mentioned above, macrovascular changes were still relatively
limited at that time point. Hence, knowing that portal hypertension (PHT)
was measured in a previous study [161] at 12 weeks of TAA intoxication, we
hypothesize that the increase of the IHVR - leading to PHT - was initiated at
the microlevel.e mechanical compression of the macrovasculature most
likely aggravated the established PHT later on. In addition, we illustrated that
vascular shunts developed at various length scales in an attempt to alleviate
the progressive PHT, yet at the cost of precluding contact with hepatocytes,
incapacitating as such synthetic and detoxication liver functions.
e datasets generated to reach goal 2 formed the basis of the computa-
tional model as presented below (chapter 6).
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Goal 3. Develop a computational model to assess the haemodynamic con-
sequences of cirrhosis-induced vascular adaptations
A novel closed-loop lumped parameter model was implemented to simulate
the systemic blood circulation of the rat during cirrhogenesis (chapter 6).
It adopted the building blocks of a previously developed model for porcine
applications and was scaled successfully to the rat setting. We integrated a
lobe-specic model of the rat liver, which - for each time point studied
during cirrhosis development - was calibrated based on animal-specic
morphological analyses of the hepatic vascular trees of liver lobes.
e model allowed hepatic and systemic haemodynamics to be predicted
for dierent stages of cirrhogenesis. As such, we demonstrated that the
pathological changes of the hepatic vasculature instigated PV pressure to rise
gradually, eventually leading to PHT.e lobe-specicity of the liver model
also provided unique insights into the blood ow distribution through the
liver, thereby revealing abnormal ow patterns (e.g. retrograde PV ow) in
some lobes of diseased animals. Reversal of PV ow is generally considered
a precursor of hepatofugal ow and indicates the presence of advanced
PHT.is phenomenon is not uncommon in patients with cirrhosis [303].
Moreover, low lobar PV ows were mostly accompanied by higher HA ows
(or vice versa), suggesting that the presented modelling approach captures
intrinsic hepatic ow regulatory mechanisms (e.g. hepatic arterial buer
response (HABR)) solely based on static morphological data.
With these new insights, we extended the cirrhotic model to account
for the hyperdynamic circulation (i.e. vasodilation of extrahepatic vascular
beds and increased circulatory volume) and collateral formation. ese
circulatory disorders were implemented and their impact on the systemic and
pulmonary circulation was assessed.e hyperdynamic circulation increased
the cardiac output (CO), splanchnic ow, and PVow, while themean arterial
pressure (MAP) decreased.e collateralsmainly caused the PV pressure and
ow to decrease, though insuciently to alleviate the PHT. Pressures in the
pulmonary artery and right heart chambers also increased due to the systemic
circulatory disorders. Similar observations have been reported in rats and in
patients with cirrhosis [28, 90, 161, 195]. We concluded that the model not
only provided unique insights in the manifestation of PHT (i.e. initiated by
the increased IHVR and further aggravated by circulatory disorders), but also
shed more light on the impaired systemic and pulmonary haemodynamics
due to cirrhosis-induced adaptations of the hepatic vasculature.
7.1.2 Methodological considerations
While this doctoral research resulted in novel ndings and a better under-
standing of cirrhogenesis, a number of relevant considerations and limitations
were identied as discussed below.
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Several aspects of the methodological framework were labour-intensive
and time-consuming.is was particularly the case for the segmentation of
µCT datasets, which is the reason only two liver casts were fully segmented
for each time point (section 5.3.1). erefore, caution is warranted when
generalising ndings as the reported results must be considered only to
be indicative. Future work may consist of developing automated image-
processing pipelines (e.g. based on machine learning) to facilitate this
procedure and analyse a high(er) number of datasets.
Ideally, liver casts should be scanned at a suciently high resolution to
allow the HA vascular tree to be reconstructed accurately up to the same
generation number as the PV and HV vascular trees. As diameters of HA
branches are typically smaller than those of venous branches of the liver,
this was technically impossible with the current computational and soware
capabilities. A multilevel imaging approach, i.e. scanning incrementally
smaller samples at increasingly higher resolutions, may help to overcome
this limitation and allow the full spectrum of the hepatic vasculature (i.e.
macro-, meso-, and microcirculation) to be studied. However, this approach
will require advanced image processing/segmentation algorithms to cope
with the exponential increase of blood vessels when descending towards the
microscale.
It is also important to address the extent to which theVCCproceduremay
have aected the rat hepatic vasculature. Previous studies on VCC have used
various devices to regulate and maintain the pressure of the injected resin
[154].is approach, however, would have been extremely challenging in our
case (i.e. dual casting and cirrhogenesis), especially when determining the
injection pressures for the abdominal aorta (AA) and PV. As the IHVR
increased progressively during cirrhogenesis and livers were of varying
sizes, maintaining a uniform injection pressure for all livers would probably
not have suced to perfuse all liver lobes adequately, or could have even
destroyed others. In this work, we thus opted to inject the resin manually by a
continuous pressure, which was assured through the air buer in the syringe,
until resin emerged from the vena cava inferior (VCI). Although we did not
attempt tomeasure this pressure, we did collaborate with a team (Department
of Morphology, Faculty of Veterinary Medicine, Ghent University, Gent,
Belgium) having many years of expertise in casting to ensure that all livers
were cast in a consistent way according to a standardized protocol. Since we
were mainly interested in the relative dierences between consecutive time
points of cirrhogenesis, systematic errors introduced by following the same
casting procedure could only have aected our results minimally. Moreover,
the hypothesis that the casting resin may have caused signicant shrinkage
was discredited. We anticipated that the known shrinkage of the cast resin
was compensated for by the pressure exerted during the injection of the
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polymer, as our diameter measurements were in agreement with literature
data. However, at the microlevel, bloating of the sinusoids was observed.
For this reason, we decided to characterize the microcirculation based on
quantitative measurements of IHC rather than VCC microvascular samples.
A limitation of the IHC technique was the denite penetration depth
of antibodies. Although we considerably increased the imaging depth
by optimising the IHC and CUBIC protocol, the confocal visualization
depth remained conned to the lobule-scale microvasculature.e dense
extracellular matrix (ECM) of the liver, which was on the whole not aected
by the CUBIC clearing technique, is most likely accountable for impeding
the passive diusion of antibodies. Recently, electrophoretically-driven
approaches have been explored, applying electric elds over the samples
to increase the delivery depth of the antibodies [138, 170]. However, in the
case of liver tissue, it is still not clear whether molecules within the tissue-
matrix may also sustain stretching or compression due to this eld. Another
option may be to actively inject the antibodies into the specimen using a
syringe pump, which is infused by a solution containing the labelling reagents
[164].
e closed-loop model used to analyse rat haemodynamics was imple-
mented solely based on lumped-parameter components (chapter 6), thereby
encoding a simplication of the actual (patho)anatomical reality and bio-
physics. More specically, the vessel generations of hepatic vascular trees
were represented by single vascular resistances. is approach, however,
was justied as our main interest was focused towards assessing the relative
haemodynamic dierences at various time points during cirrhogenesis. It
also allowed the gap between the hepatic macro- and microcirculation to be
bridged, which is currently impossible with 3D models accounting for all an-
atomical features due to limited computational capabilities. Nevertheless, we
believe that further improvements to the model may be relevant to take into
account the changing (visco)elastic properties of the liver during cirrhogene-
sis (e.g. increased (vessel) stiness), inertial eects of the blood ow, and/or
intrinsic regulating mechanisms of the circulation (e.g. baroreex-feedback).
ese rst two improvements may be integrated by replacing the vascular
resistances, representing the vessel generations of the hepatic vascular trees,
with pi-element Windkessel models (see section 3.2.2.2). As such, the resis-
tance Rd , inductance L, capacitance C, and resistance Rp denote the vascular
resistance of the blood vessel, the inertia of blood, the elasticity of the blood
vessel, and the viscoelastic behaviour of the vessel walls, respectively. On the
other hand, their implementation would require the acquisition of a (large)
number of extra experimental parameters (e.g. Young’s moduli and wall
thickness for each vessel generation of the hepatic vascular trees) [58].
A nal methodological consideration involves the validation of the
presented electrical analog model. In this work, we discussed the simulation
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results in light of haemodynamic measurements performed earlier in the
same TAA rat model and concluded that they were in close agreement.
Towards the future, however, we recommend measuring the haemodynamics
(e.g. hepatic pressures and ows, MAP, and CO) and shunt percentage of PV
blood - prior to casting - to allow for better and animal-specic validation of
the model.
7.2 Looking ahead
We believe that this dissertation is a step forward towards unravelling the
complex pathophysiology of cirrhosis, but it does not dene the nish line.
In this work, we focused on a single facet of cirrhosis, i.e. the intricate re-
lation between the development of cirrhosis, the hepatic (angio)architectural
disarrangement, and the impaired vascular perfusion.e pronounced (vas-
cular) adaptations were observed between 12 and 18 weeks of TAA intox-
ication. For this, it may be relevant to repeat the presented methodology
for more time points and livers to validate our ndings and determine the
“point-of-no-return” more accurately. Moreover, the applicability of the meth-
odological framework is not solely bound to the hepatic vasculature, but may
analogously be used to study the biliary tree, the lymphatic system, or the
vasculature of others organs in physiological and pathological conditions.
e ne structural detail that is revealed by the methodology may also be
useful for the development of pharmaceutical therapies, e.g. to assess the
eects of drugs on the (diseased) vasculature.
Nevertheless, the transition from rat towards pig or human seems
inevitable to further investigate this disease process and pave the way towards
patient-centred therapeutic guidance. In this context, it would be relevant
to continue exploring whether vascular features of cirrhosis (e.g. reduced
HV diameters) are correlated to disease severity in patients, as suggested by
[115, 326]. Our morphological data based on rat livers indicate that the HV
diameter, which progressively decreased during cirrhogenesis, is most likely
inversely related to the hepatic venous pressure gradient (HVPG), which
signicantly increases during cirrhogenesis. As such, we hypothesize that
HV dimensions may represent an independent factor to assess the hepatic
destruction and disease severity, even in the early stages of cirrhosis.e latter
would be an interesting topic to study in future research. If this also applies
to human patients during cirrhogenesis, automated 3D quantication of the
HV aer MRI-imaging may complement other morphological features (e.g.
nodularity, atrophy of the right lobe) to facilitate early detection and staging
of cirrhosis, to follow the disease progression, and to provide therapeutic
guidance. Extending the current research towards the human settingmay also
aect liver surgery, as a patient-specic electrical analog model of the human
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circulatory systemwould allow for prediction of the haemodynamic response
aer mechanistic interventions (e.g. transjugular intrahepatic portosystemic
shunt (TIPS) insertion). However, a lot of ground is yet to be covered
before proceeding to this stage, as non-invasive methods (e.g. 4D ow MRI
and MRI/CT angiography) to measure the model parameters still require
renement.
A nal eld of future study is the integration of other structural, physiolo-
gical, and/or functional models into the presented electrical analog model.
Knowing that the hepatic architecture, liver perfusion, and liver function
are strongly intertwined, a multiscale modelling approach may prove instru-
mental to reveal the complete picture behind the pathophysiology of cirrhosis.
For example, integration of a detailed lobule-scale computational uid dynam-
ics (CFD) model may help to shed light on changing microhaemodynamics
and biomechanical stressors during cirrhogenesis, supposedly triggering
various molecular mechanisms. In this regard, one of the challenges involves
nding a simulation geometry that is representative for the heterogeneity
of the cirrhotic microvasculature, as it can no longer be regarded as com-
posed of repetitive liver lobules. In addition, biological mechanisms may be
integrated by linking the electrical analog model to e.g. compartmental and
agent-based models, allowing the mass-transport of substances and cellular
interactions/tissue regeneration to be described, respectively. Especially in
cirrhosis, this may be useful to assess the interplay between the hepatic per-
fusion and liver dysfunction at dierent time and length scales. e most
pressing concern related to these biological models involves the in vivo ac-
quisition of a (large) number of parameters, generally required to inform the
model quantitatively about the initial conditions.
However, none of the aforestated issues are regarded as insurmountable.
As such, we believe that the work presented in this dissertation is also relevant
for future research on cirrhogenesis modelling.
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DeLiver
A.1 Overview
DeLiver is a soware package of modular design developed to segment
and/or analyse the vascular network of micro-computed tomography (µCT)
and confocal datasets in an automated and consistent way. It is based on
the principles of the TiQuant soware [78], although functionalities were
optimised and extended for our specic applications. e source code is
written in C++ and links to the open-source libraries Qt (e Qt Company,
Espoo, Finland), the insight segmentation and registration toolkit (ITK) [126],
and the visualization toolkit (VTK) [248]. Qt is a customisable application
framework widely used to create graphical user interfaces (GUI). ITK, on
the other hand, provides an extensive library of leading-edge algorithms
for image analysis (e.g. segmentation and registration of data), while VTK
contains a wide variety of visualization algorithms and advanced modelling
techniques. ITK and VTK are both maintained by the same company
(Kitware Inc., New York, USA) and support parallel processing as well as
awless integration with Qt.
e front-end interface of DeLiver is generated byQt libraries and allows
for user input (Figure A.1).e interface is split into three functional panels.
e panel to the top le (outlined in red) contains themodule selectionmenu.
Currently, two main modules have been implemented, i.e. segmentation and
analysis, though the latter has been constructed separately for the hepatic
macro- and microvasculature.ese modules are discussed in more detail
in the next sections. e panel to the bottom le (blue) displays the “job
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Figure A.1: e graphical user interface of DeLiver allows for user input and is
split into three functional panels.e top le panel (red box) contains the module
selection menu.e bottom le panel (blue box) shows the “job manager”, which
allows for job queuing and batch mode processing.e parameters of jobs are edited
in the panel to the right (green box).
manager”, which allows for job queuing. e job parameters are specied
in the panel to the right (green), where they are depicted as item-based
hierarchical lists.e job queue may be processed immediately (with GUI)
or saved to a le for batch processing without GUI.e latter allows job
queues to be run remotely on a server or stand-alone desktop.
e modules have been implemented as so called processing pipelines,
meaning that the input data is processed by a series of consecutive im-
age/graph lters. As such, each lter receives the output of its predecessor,
performs a certain operation (e.g. threshold), and passes it on to the next.
is lter propagation concept - inherent to ITK and VTK - allowed pipelines
to be specically tailored to our macro- and microvascular data.
A.2 Segmentation module
e segmentation module was designed to automatically extract the vascular
structures from the confocal image datasets. e basic principles were
adopted from what was known from literature on TiQuant [78]. However,
the pipeline was implemented from scratch and included extra and new
lters to cope with the variable quality of our images. Especially in datasets
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of animals intoxicated with TAA, we detected abundant autouorescence-
like background noise, necessitating additional image preprocessing and
segmentation steps.
FigureA.2: Illustration of the DeLiver segmentation pipeline. Ae original image
is B preprocessed, C binarized, andD despeckled.ereaer, E a novel cavity-lling
algorithm is executed to restore the vessel discontinuities and close the holes of
the sinusoidal lumens. Fe remaining cavities are closed, G small artefacts are
removed, and nally H small isolated objects are discarded. Ie segmented image
is overlaid on the preprocessed image to validate the segmentation.
Here, we will describe the segmentation pipeline step-by-step (see
also Figure A.2). However, as the quality/intensity of our raw confocal
image stacks diered locally, we rst performed a number of preprocessing
steps in Fiji [246] to improve the overall quality of the dataset: (i) photo-
bleach correction, (ii) reduction of Poisson and Gaussian noise, (iii) 3D
deconvolution, and (iv) application of an adaptive histogram equalization
algorithm (CLAHE) to improve the contrast. It was important that the
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structures to be segmented were clearly distinguishable from the background
or noise artefacts.
Once the dataset was of sucient quality, the segmentation pipeline was
commenced by reading the image stacks in 8-bit TIFF format.e images
were subsequently binarized using an ‘Adaptive Otsu’ [200], ‘Otsu’ [19], or
manual threshold mode. Careful selection and tuning of the threshold mode
was imperative to prevent incorrect segmentation. ‘Salt-and-pepper’ noise
was removed by applying an inverse hole-lling operator and small noise
shells were discarded. A novel cavity lling algorithm was implemented
to restore vessel discontinuities and close holes of the sinusoidal lumina.
e algorithm determined iteratively for each background voxel (black) the
fraction of vectors (N = 40) that go o in spherically evenly distributed
directions and have at least one intersection with a foreground voxel (white)
within a certain distance. If the computed fraction for a specic voxel
exceeded the minimal fraction of surrounding foreground pixels, the voxel
was changed to a foreground voxel. Aer this algorithm, remaining (small)
cavities were lled by a combination of closing and fast hole-lling operations,
while small artefacts were removed by an opening operation. e latter
operations also smoothed the segmented structures to some extent. Finally,
isolated objects smaller than a predened volume were discarded.
A.3 Analysis module
While the segmentation module was implemented from scratch, the analysis
module was built based on the source code of TiQuant for graph construc-
tion. However, we adapted the code to implement two separate pipelines,
one for the hepatic macrocirculation to determine the branching topology
and one for the hepatic microcirculation to quantify the morphological para-
meters (i.e. radius, length, tortuosity, and porosity). Both pipelines require
as input a binary le of the segmentation (8-bit TIFF format) and a skeleton
of the segmented structures. We calculated the skeletons using a 3D thinning
algorithm, which operated by iteratively deleting voxels - without shortening
or fragmentizing the shape - until only 1-voxel wide lines remained, i.e. the
centre lines (Figure A.3).
e graph structureswere created based on this skeleton and subsequently
processed by a resampling lter to determine the fraction of vertices per
branch to be kept. e latter ensured the removal of artefacts introduced
during the skeleton-to-graph conversion. Furthermore, intersection nodes
paired directly to one another within a (small) predened distance were
regarded as articial, and thus merged together. A pruning lter also
removed all dead-end branches with a length or radius smaller than a
specied threshold. For the macrocirculation, additional pruning rules were
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Figure A.3: Schematic illustration of the skeletonization and conversion to a graph
structure. A Voxel-based shape representation aer segmentation. Be skeleton
of the shape is obtained using a 3D thinning algorithm. C Identication of voxels
representing intersection (yellow) or dead-end (red) points. De resulting graph
consisting of several interconnected branches. Adapted from [98].
implemented to identify and handle erroneous vascular loops as well as “false”
branches (which typically appear as dead-end branches; see Figure A.4B).
e latter was probably introduced by the 3D thinning algorithm, used to
calculate the centre lines of the structure. To distinguish “true” from “false”
dead-end branches, we computed the gradient of the distance transform
of the segmented structure [255]. As depicted in Figure A.4A, the main
and relevant branches form the “mountain ridges” of the distance transform,
having steepest gradients close to zero. Side branches, on the other hand, have
steepest gradients in between zero and one. Based on a threshold decision,
we were able to select and discard the irrelevant dead-end branches.
e diameter of vascular structures was measured using a best-t
approach, instead of maximum inscribed sphere method, as venous blood
vessels and sinusoids typically have an ellipsoidal shape.is was achieved by
calculating the normal plane for every node and subsequently measuring the
radius in this plane in eight radially evenly distributed directions (Figure A.5).
e best-t radius was then obtained by averaging over the eight radii.
e analysis module of the macrocirculation was further extended with
a new functionality to determine the branching topology of hepatic vascular
trees in a logical manner. is was accomplished by formulating a novel
diameter-dened ordering method, allowing generations numbers to be
assigned based on graph theory (Figure A.6). First, the inlet (= root) was
selected and branches were combined into coupled branches based on radius
tapering and angle deviations. Branches (starting at the root) were linkable if
the following two conditions were met:
1. e ratio of the mean radius of the daughter branch to the mean radius
of the parent branch was larger than 0.7.
2. e angle between the last segment (last 5 nodes) of the parent branch
and the rst segment (rst 5 nodes) of the daughter branch (α; see
Figure A.6) was larger than 160○.
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Figure A.4: A e distance transform of the segmented tree illustrated as a 3D
visualization where the ridges represent the centre lines.e steepest gradient can
be used as an indication for the relevance of the dead-end branches. Be original
skeleton of the structure as calculated by the 3D thinning algorithm. Notice the
side branches at the right boundary. Ce skeleton aer correction for the noisy
irrelevant side branches. Source: [255].
Figure A.5: Illustration of the best-t radius approach for ellipsoidal blood vessels.
First, the radius is measured in eight radially evenly distributed directions. e
best-t radius is subsequently obtained by averaging over these eight radii.
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FigureA.6: A Example of a converged diameter-dened top-down orderingmethod
for themacrocirculation (black structures).e analysis is applied to the graph of the
macrocirculation (white lines), whereby intersection nodes are indicated as yellow
circles. Branches are connected to at least one intersection node. For the ordering
method, branches (e.g. 3 branches belonging to the inlet) are rst combined into one
coupled branch if the tapering of the radius is not lower than 0.7 and the angle (α)
between the last segment (last give nodes) of the parent branch and the rst segment
(rst ve nodes) of the daughter branch is larger than 160○.e generation numbers
are then iteratively reordered based on the mean radius of the coupled branches
compared to the mean radii (Rn) and standard deviations (SRn) of the generations.
At each intersection node, only the most suitable daughter branch (least
tapering and largest angle) was coupled to the parent branch. From then
onwards, it was considered part of the parent branch. e tapering ratio
and branching angle were manually calibrated based on the 3D branching
topology of the largest vessels. Secondly, generation numbers (n) were
assigned to the coupled branches. It commenced by assigning generation 1 to
the inlet (= root) of the vascular tree and consecutively allocated generation
2 to its daughter branches. e method continued to travel downstream
until reaching the terminal vessel branches and assigned generation n+1 to
daughter branches, with n denoting the generation number of their respective
parent vessel. irdly, the assigned generation numbers were iteratively
reordered based on the mean radius of the branches. For each iteration, the
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mean radius (Rn) and standard deviation (SRn) were calculated for every
generation (n). One iteration entailed comparing themean radius of a branch,
initially belonging to generation n, with the range [Rn – SRn; Rn + SRn] (see
also FigureA.6). If its value did not lie within that range, but insteadwas lower
than (Rn+1 + SDn+1) or higher than (Rn-1 – SDn-1), its generation number
was increased to n + 1 or decreased to n − 1, respectively.is process was
repeated – always starting at the inlet (= generation number 1) – until the
generation numbers of the branches converged and remained unchanged.
Finally, the interface of the graphs (see Figure A.7) was adapted for
better visualization (e.g. predened camera views, background and axes
ON/OFF), to allow for some interactivity such as root selection, extraction
of branch data, and to generate histograms of morphological parameters for
statistical interpretation. We also included the option to save graphs and their
morphological data for import into other soware packages (e.g. Paraview).
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